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SYNOPSIS 
The first chapter of this thesis comprises a review of thyroxine-
binding proteins of man, with emphasis on TBG and, to a lesser extent, 
TBPA. The identification, isolation, physicochemical and physiological 
characteristics, and genetic variations of both proteins are included. 
The changes in protein concentration in disease are reviewed -and the 
indications for the present study are presented. 
Subsequent chapters describe the purification of TBPA and partial 
purification of TBG. The production of monospecific antisera to TBG and 
TBPA, and development of immunoelectrophoretic assays for both proteins 
are described. 
TBG was measured in healthy ' persons, and the effects of age and sex 
on TBG were assessed, as was the effect of thyroid disease. 
TBG, TBPA and thyroid hormones were measured in patients after surgery, 
myocardial infarction and starvation. The inter-relationships of protein 
and free hormone concentrations were explored. 
Finally, nineteen families with inherited abnormalities of TBG 
concentration were studied. The typical case histories and biochemical 
findings of individuals with TBG abnormality were noted, especially when 
TBG abnormality coexisted with thyroid disease. Deficiencies of 
conventional thyroid function tests were found in TBG abnormality, and 
the use of T4 :TBG ratio as a means of assessing thyroid function was 
assessed retrospectively and prospectively. 
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CHAPTER 1 INTRODUCTION 
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2) Isolation of TBP 
3) Phy~chemical characteristics of TBP 
a) Molecular properties and structure 
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b) Non-thyroidal-illness 
i) Acute and chronic illness 
ii) Surgery 
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iv) Hepatic disease 
v) Renal disease 
6) Indications for present study. 
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INTRODUCTION 
1) IDENTIFICATION OF THYROXINE-BINDING PROTEINS 
The strong association between thyroxine and serum components was 
apparent from work performed at the start of this century, which showed that 
serum iodine was not dialysable (Gley and Bourcet, 1900) and not ultra-
filtrable (Trevorrow, 1939). Attempts to identify the molecules responsible 
by iodine analyses of plasma protein fractions were unsuccessful (Taurog and 
Chaikoff, 1948; Salter, 1949), and the existence of a specific th yroxine-
binding protein was not appreciated until 1952, when Gordon and co-workers 
applied the technique of zone electrophoresis (Gordon et aI, 1952). At 
about this time, several groups of workers (Gordon et aI, 1952; Larson, 
Deiss and Albright, 1952; Robbins and RaIl, 1952; Winzler and Notrica, 
1952; Horst and R~sler, 1953) demonstrated that with small amounts of added 
thyroxine, most of the thyroxine in serum was bound to a protein which 
electrophoresed in barbital buffer, pH 8.6, to a position intermediate 
between the cC-1 and ~2 globulins. This protein is now designated 
thyro xi ne - binding globulin (TBG). A smaller amount of bound T 4 was found 
in the albumin zone, but because the early workers were using barbital 
buffer, which inhibits T4-binding to human prealbumin, the existence of 
thyroxine-binding prealbumin was not established until 1958 (Ingbar, 1958). 
Much subsequent work was performed using a reverse-flow paper electro-
phoretic system (Robbins, 1957) and glycine acetate buffer, pH 8.6. Using 
"tracer" amounts of T4 (~ 40 nmol/l) added to normal human serum, 
approximately 60% of T4 was bound to TBG, 30% to TBPA and 10% to albumin 
(Sterling and Tabachnik , 1961; Oppenheimer et aI, 1963; Inada and Sterling, 
1967b). The above conditions of buffer and pH can hardly be regarded as 
physiological, and experiments utilizing immunoprecepitation (Woeber and 
Ingbar, 1968) and electrophoresis at pH 7.4 (Lutz and Gregerman, 1969), 
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have since shown that the actual fraction of T4 carried by TBPA is 
probably about 15%, with albumin carrying 10% and TBG 70 - 75%. 
Binding in additional electrophoretic zones, demonstrated in a variety 
of buffer and electrophoresis systems in early studies, was variously 
attributed to artefact due to long-term freezing and storing (Blumberg 
and Robbins, 1960), to altered TBG mobility due to interaction with albumin 
(Refetoff, Robin and Fang, 1970), or to additional T4-binding proteins 
(Tata, Widnell and Gratzer, 1961). It is now thought that the additional 
T4-binding protein, with slower electrophoretic mobility than TBG, 
represents a partially desialylated TBG, or "slow" TBG (Premachandra, 
Perlstein and Blumenthal, 1970; Marshall, Pensky and Green, 1972). 
Other T4-binding proteins have been described in human serum, but 
elucidation of the nature and extent of these has required the advent of 
more sensitive techniques such as immunoelectrophoresis (Lightfoot and 
Christian, 1966; Freeman and Pearson, 1969), post electrophoresis-labelling 
(Freeman and Pearson, 1969; Hoch and Lewallen, 1974) and altered anodic 
mobility in T4-containing gel (Hoch and Lewallen, 1974). These techniques 
have now clearly shown T4-binding to oC-1-lipoprotein and j3-lipoprotein. 
Even though these proteins only account for 1% and 2% of total T4 
respectively (Miyai et aI, 1968; Hoch and Lewallen, 1974), it is still 
possible that they may have an important r~le in thyroid physiology, 
although evidence for this is lacking. 
T4-binding by gamma globulins was first reported in a woman with 
thyroid carcinoma by Robbins and co-workers in 1956, (Robbins, RaIl and 
Rawson, 1956) and seems to occur as part of a specific immune response. 
Gamma globulin binding of T4 , T3 , or both, has been noted in thyrotoxicosis 
(Staeheli, Valloton and Burger, 1975), Hashimoto's thyroiditis and primary 
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myxoedema (Premachandra and Blumenthal, 1967; Ochi et aI, 1972; Staeheli et aI, 
1975; Herrmann et aI, 1977), and nodular goitre (Wu and Green, 1976). Apart 
from gross derangement of thyroid hormone radioimmunoassays (Wu and Green, 1976; 
Jorgensen, Skovsted and Jensen, 1979), an important clinical effect of such 
antibodies may be the production of hypothyroidism (Karlsson, Wibell and Wide, 
1977). 
Other examples of anomalous T4-binding proteins include diminished TBG-
binding and increased albumin binding of T4 in bisalbuminaemia (Barboree and 
Decker, 1971), and autosomal dominant inheritance of a protein with different 
T4-binding and antigenic properties, and different electrophoretic mobility 
from TBG (Lee et aI, 1979). 
2) ISOLATION OF THYROXINE-BINDING PROTEINS 
A number of problems were encountered during early attempts to purify 
TBG (see Robbins, 1976 for review). In part these were due to the low serum 
concentration of TBG, but other factors may have been: 
a) The instability of T4-TBG interaction at pH~ 5 (Marshall and Pensky, 1971) 
and the irreversible first-order structural transition which occurs at low 
pH (Gershengorn et aI, 1977b). 
b) The susceptibility of purified TBG to denaturation by mechanical agitation, 
and the loss of T4-binding activity during a single freezing and thawing 
(Korcek and Tabachnik, 1974). 
c) The desialylation of TBG preparations by neuraminidase-contamination of 
Sepharose columns (Marshall et aI, 1972). 
d) The variable T4-contamination of TBG preparations (Gershengorn et aI, 1977a) • 
. A major advance in the isolation of TBG was the application of affinity 
chromatography by Pensky and Marshall (1969), in which TBG in serum was 
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bound to covalently-linked T4-agarose, and then eluted with 2mM KOH. 
Even after this procedure, multiple-step chromatographic or gel-filtration 
procedures were still necessary in order to obtain pure TBG (Marshall, 
Pensky and Williams, 1973; Korcek and Tabachnik, 1974; Gershengorn et aI, 
1977a). Early attempts to improve TBG yield by the use of carbon-chain 
spacers attached to agarose were not thought to be successful (Pages and 
Cahnman, 1972; Korcek and Tabachnik, 1974), although these have been 
utilised in recent studies (Horn et aI, 1977; Kagedal and Kallberg, 1977). 
Pure TBG preparations have recently been obtained in a 2-step procedure 
utilising affinity chromatography followed by ion-exchange chromatography 
with a buffer gradient (Cheng, Morrone and Robbins, 1979). 
In contrast to the great difficulties encountered with TBG purification, 
TBPA has proved amenable to purification by conventional methods, and a 
number of workers have reported the successful isolation of TBPA (see 
Robbins, 1976 for review). 
3) PHYSICOCHEMICAL PROPERTIES OF THYROXINE-BINDING PROTEINS 
a) Molecular properties and structure 
i) TBG 
Some early studies on the molecular properties of TBG can no longer 
be regarded as reliable, for reasons mentioned above (e.g. Giorgio and 
Tabachnik, 1968; Sterling et aI, 1971). Later studies utilising affinity 
chromatography are in general agreement that the molecular weight of TBG 
is between 53,000 and 64,000 Daltons (Marshall and Pensky, 1971; Korcek 
and Tabachnik, 1974; Nilsson and Peterson, 1975; Gershengorn et aI, 1977a; 
Petek, 1979). Despite one claim that TBG is a tetramer pomposed of four 
identical subunits (Nilsson and Peterson, 1975), subsequent work by 
Gershengorn et a1 (1977a) has provided convincing evidence in support of 
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the claim that TBG consists of a single polypeptide chain (Marshall and 
Pensky, 1971; Korcek and Tabachnik, 1974). 
TBG is a glycoprotein, and rather variable amino acid and carbohydrate 
contents have been estimated by different groups (Table 1.1). It is 
interesting to note however, that there is reasonably good agreement 
between the studies of Korcek and Tabachnik (1974), Gershellgorn et al 
(1977a) and Zinn et al (1978a), who all used the affinity chromatographic 
separation procedure of Marshall et al (1973). 
Gershengorn et al (1977b) suggested that the C-terminal sequence of 
TBG is (Ala-Ser)-Leu, while the N-terminal amino acid sequence is said to 
be Ala-Ser-Pro-Glu-Gly-Lys-Val-Thr-Ala-Asp-Ser-Ser-Ser-Glu-(Pro)-(Cheng, 
1977) • 
The carbohydrate moiety of TBG is rich in sialic acid (Table 1.1), and 
this accounts for the low isoelectric point of pH 4.2 - 5.2 (Robbins, 
Petermann and RaIl, 1955; Marshall et aI, 1973). Varying degrees of 
desialylation account for the "slow" TBG found in obese patients (Prema-
chandra et aI, 1970) and in cirrhotics (Marshall et aI, 1972 - and see 
Chapter 1 - ~. a .iv.). The glycopeptides and oligosaccharides of TBG have 
been subjected to further study by Zinn et al (1978a, b), who have proposed 
that TBG contains 4 oligosaccharide side chains. They have designated the 
chains Glycopeptide I, oligosaccharide A and oligosaccharide B. It is 
proposed that each TBG molecule contains one unit of glycopeptide 1, 2 units 
of oligosaccharide A and one unit of oligosaccharide B (Fig. 1.1). 
The secondary and tertiary structure of TBG was investigated by 
Ger shengorn et al (1977a), using circular dichroism in the near ultraviolet, 
and polarization of dansyl-TBG flUorescence. They found that approximately 
AMINO ACID 
Lysine 
Histidine 
Arginine 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
\ -Cystine 
Valine 
Methionine 
Isolencine 
Lencine 
Tyrosine 
Phenylalanine 
Tryptophan 
Number of 
residues 
Molecular 
weight 
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Table 1.1 
Moles per mole 
Reference* (see foot of 
1 2 3 
12 18 25 
11 7 10 
22 4 16 
25 26 38 
18 20 25 
19 24 34 
34 30 52 
27 16 30 
25 23 25 
27 32 31 
5 3 8 
12 21 23 
3 6 5 
8 12 9 
43 28 44 
7 4 10 
14 12 18 
4 3 4 
316 289 407 
59,000 36,000 58,000 
Table) 
4 5 6 
22 29 28 
14 12 11 
16 17 6 
42 45 36 
26 28 25 
32 49 29 
63 61 42 
29 20 15 
32 29 19 
35 30 28 
11 8 5 
27 25 27 
11 8 12 
19 17 18 
47 37 38 
12 15 9 
22 17 22 
ND 4 4 
464 440 380 
53,200 54,000 
AMINO ACID AND CARBOHYDRATE COMPOSITION OF THYROXINE-BINDING GLOBULIN 
PREPARATIONS FROM DIFFERENT LABORATORIES 
7 
26 
11 
7 
40 
28 
35 
46 
13 
28 
ND 
8 
26 
16 
22 
44 
8 
22 
ND 
387 
CARBOHYDRATE 
Glucose 
Galactose 
Mannose 
Fucose 
Xylose 
Glucosamine 
Galactosamine 
Sialic acid 
Total % 
Carbohydrate 
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Table 1 .1 
Reference 
1 2 
2 
6 
5 
19 0 
1 
11 
0 
9 4 
32 15 
* 1 = Seal and Doe, 1964 
2 = Sterling et aI, 1971 
3 = Giorgio and Tabachnik, 1968 
4 = Korcek and Tabachnik, 1974 
5 = Nilsson and Peterson, 1975 
6 = Gershengorn et a1, 1977a 
7 = Zinn et aI, 1978a 
(cont. ) 
3 4 5 6 7 
2 0 6 0 
6 7 13 9 
12 7 6 11 
0.2 0 1 0 0 
0 0 0 0 
12 12 7 22 16 
3 47 0 0 0 
5 6 0 10 10 
13 7.5 23 15 
NeuNAc a2,6 .. Gal ~I,4 .. GlcNAc ~I,2. Man 
" al,3 
" Man S~4. GlcNAc ~I,4. GlcNAc JL...Asn jI 
cal,6 
a26 RI-4 R~ / NeuNAc :::::z=. Gal ~GlcNAc~ Man 
Proposed structure for glycopeptide I. 
NeuNAc ~ Gal ~GIcNAc SI,2/t Man 
" 
al,3 
A-I ; Man ~ GlcNAc ~ GicNAcH2 
cal,6 
81 I NeuNAc ca2,6. Gal SI,4. GlcNAc S~216. Ma{ 
DI( ;' 
NeuNAc ca2,3. Gal~GlcNAc ' 
Proposed structures for oligosaccharides A and B. 
Figure 1.1 
(From linn et \0 
aI, 1978a) 
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half the peptide residues of TBG were unordered, with the vemainder being 
distributed approximately equally between oC-helices and p-structures. 
ii) TBPA 
Although early studies suggested a molecular weight for TBPA of 
60 - 70,000 (Robbins, 1976), the complete amino acid sequence of TBPA is 
now established (Kanda et aI, 1974) and gives a molecular weight of 
55,000. The higher values in early studies may have been due to inclusion 
of retinol-binding protein (M.Wt. 21,000, Kanai, Raz and Goodman, 1968) 
with the TBPA molecule. 
TBPA is a tetramer, consisting of 4 identical subunits, and this has 
been beautifully confirmed using X-ray diffraction studies of purified 
crystalline TBPA (Blake et aI, 1971, 1974). The original deductions 
concerning the tetrameric structure of TBPA were based on a study of TBPA 
polymorphism in the rhesus monkey (Alper, Robin and Refetoff, 1969; 
Bernstein, Robbins and RaIl, 1970). 
TBPA shows a two-fold symmetry, with the subunits arranged as two 
dimers, which are in turn arranged with two opposing pleated sheets of 
p-structures, so as to form a slot within the molecule, with the dimensions 
25~ long by 8~ diameter (Blake et aI, 1971, 1974; Blake and Oatley, 1977, 
Figs. 1.2 and 1.3). In addition to T4-binding, TBPA also interacts strongly 
with retinol-binding protein (RBP) and normally circulates as a 1 - 1 molar 
complex of TBPA - RBP (Fig. 1.4) (Raz et aI, 1970). Like albumin, TBPA does 
not contain carbohydrate, and it is also unusual in its extreme resistance 
to denaturation by heating, acid, alkali, urea, guanidine and detergents 
(Raz et aI, 1970; Branch, Robbins and Edelhoch, 1971; Rask et aI, 1971; 
Branch, Robbins and Edelhoch, 1972). 
z I 
A schematio drawing of the main-ohain oonfonnation in the prealbumin dimer 
. The arrows indicate p-Bheet strands, labelled A to H in one monomer and 
A' to H' in the other, in the order in whioh they occur in the polypeptide ohain. The molecular x' 
and z-axes are indicated. N indicates residue 10 and C indioates residue 126. 
-" 
-" 
Figure 1.2 
(From Blake et 
al, 1974) 
A stereo-view of the prea.lbumin tetramer down the molecular y'-axis_ N "" residue 10; 
C "" residue 126_ T---T represents the two di-iodotyrosyl residues of thyroxine located on 
the molecular z-axis_ 
stereo-view of the prealbumin tetramer looking down the molecular z-axis, shown 
by the dot, with the molecular x' and y'-axis horizontal and vertical, respectively. The thyroxine 
binding sites are superposed along the z-axis. 
--" 
N 
Figure 1.3 
(From Blake et 
aI, 1974) 
PA 
,~ 
I \ , , 
~" , " , ...... _#' 4 ,-..-... , , ... , " , " , , , 
" 
, 
- - -- ---- ----------
Cartoon model for the RBP-prealbumin complex. Prealbumin is shown as a tetramer 
containing a central channel which is the site of thyroxine (T4) binding. The locations of 
the different binding sites suggest the known relations between the several interactions: RBP 
and T4 bind at independent sites on prealbumin, whereas the binding of retinol to RBP is 
stabilized by formation of the protein-protein complex. 
Figure 1.4 
-" 
I...N 
(From Goodman, 1976) 
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b) Thyroid hormone binding sites and hormone-protein interaction 
T4 is relatively tightly bound to TBG, and estimates of the affinity 
constant (Ka) for this reaction based on ultrafiltration and equilibrium 
dialysis measurements range from 1.6 x 109M-1 to 2.3 x 1010M-1 (Green et al, 
1972; Nilsson and Peterson, 1975; Korcek and Tabachnik , 1976, 1978; 
Snyder et al, 1976; Cheng et al, 1979). It is generally accepted that there 
is one TBG binding site for T4 (Marshall and Pensky, 1971; Green et al, 1972; 
Gershengorn et al, 1977a). 
The association of T4 and TBG is pH-dependent (Marshall and Pensky, 
1971; Korcek and Tabachnik, 1976, Gershengorn et al, 1977b), with maximal 
binding in the region of physiological pH, pH 6.8 - 7.7 and a 25% reduction 
at pH 8.6 (Korcek and Tabachnik, 1976). Binding diminishes progressively 
with temperature increase from 5°C to 37°C (Korcek and Tabachnik, 1976) and 
, 
is also dependent on ionic strength and concentration of chloride and 
phosphate ions (Spaulding and Gregerman, 1972). Thermodynamic studies of 
T4 -TBG binding have shown a hi gh positive entropy change, suggesting 
hydrophobic bonding (Green et aI, 1972, Korcek and Tabachnik, 1976). 
Removal of sialic acid residues does not greatly affect T4 binding 
(Marshall et aI, 1972, 1973), and even 86% deglycosylation resulted i n 
only a 3-fold reduction in T4 binding (Cheng et al, 1979). 
The nature of the TBG binding site has been explored using 
derivatisation with a number of protein-modifying agents (Robbins et aI, 
1978; Siegel et aI, 1979). These studies suggest the importance of the 
(-amino group of a lysyl residue at or near the T4-binding site. Other 
work has suggested that the binding site on TBG may be commodious, and 
able to accommodate thyroxyl peptides (Tabachnik, Hao and Korcek, 1971). 
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The binding affinity of TBG for T3 is approximately ten times less 
than the affinity for T4 , and is also less than that of rT3• Table 1.2 
shows the relative potency of various T4-analogues for binding to TBG, and 
also compares binding to TBPA, albumin and hepatic nuclei. Comparison of 
the binding potencies of various analogues has shown that most of the 
structural characteristics of T4 are necessary for optimal binding, 
including an intact alanine side chain, iodine atoms at positions 3', 5', 
iodine or bromine at positions 3, 5, an intact phenolic hydroxyl group, 
and a diphenyl ether structure (or sulphur or methylene bridge)(Snyder et aI, 
1976; Tabachnik and Korcek, 1978). 
Early studies of T4-TBPA binding were thought to show only one binding 
site on the TBPA molecule (Raz and Goodman, 1969). This was difficult to 
reconcile with the fact that several thyroxine analogues and ANS appeared 
to occupy two equal sites on TBPA (Nilsson and Peterson, 1971; Pages, 
Robbins and Edelhoch, 1973). The problem was eventually resolved by two 
groups of workers. Firstly, the elegant work of Blake and co-workers 
(Blake et aI, 1974; Blake and Oatley, 1977) showed clearly that there were 
two symmetrically equivalent binding sites for both T4 and T3, comprising 
the opposite ends of the slot which runs through the TBPA molecule (Vide 
SUpra). Secondly, Robbins' group demonstrated that there were two T4 
binding sites on TBPA, but that they displayed the feature known as "negative 
cooperativity" whereby occupation of the first site by T4 made binding to 
the second site more difficult. The apparent Ka's for the two sites differed 
by a factor of 100 (Ferguson et aI, 1975). 
The binding of T4 to TBPA is lower than the binding to TBG by two 
orders of magnitude (Pages et aI, 1973; Ferguson et aI, 1975 and see 
Table 1.2). T3 binding to TBPA was not observed in early studies (Ingbar, 
1963) but has subsequently been shown to occur with an affinity ten times 
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Table 1.2* 
HEPATIC NUCLEIc ALBUMINd 
T4 100(2x101OM-1) 100(2x10SM-1) 100(0.Sx10SM-1) 100(2x106M-1) 
T3 9 S SOO 55 
rT 3 3S 0 100 
3'-Isopropyl T2 3.5 SOD 
T4 Propionate 3.6 160 135 
T4 AC 1.7 160 110 
T3 AC 0.3 SOD 
D T4 54 ' 100 
D T3 560 
a. Snyder et al (1976). Affinity constant from Korcek and Tabachnik (1976). 
b. Cheng et a1 (1977). Affinity constant for first site. 
c. Oppenheimer et al (1976); Koerner et a1 (1975). 
d. Tabachnik and Giorgio (1964). Affinity constant from Steiner et a1 (1966). 
* from Robbins et a1 (1978). 
THE RELATIVE AFFINITY OF THYROID HORMONES AND ANALOGUES 
FOR PLASMA AND NUCLEAR BINDING PROTEINS 
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less than that of T4 (Davis, Handwerger and Gregerman, 1972; Cheng et aI, 
1977) • 
The concentrations and clearance rates of the TBP are given in Table 
1.3. This also shows the amount of T4 and T3 carried by the different 
binding proteins, and brings out the fact that because the serum concentration 
of TBPA is much greater than that of TBG, less than 0.5% of TBPA molecules 
are bound to T4 , whereas 30% of TBG molecules carry T4• 
There are two other unique features of TBPA which make it of great 
physiological and theoretical interest. The first is the existence of a 
binding site for RBP on each TBPA subunit. TBPA may thus participate in 
vitamin A metabolism, especially as a means whereby RBP is retained within 
the circulation. T4-binding may be purely incidental to this function 
(see Goodman 1976 for review). Secondly, Blake and Oatley (1977) have 
discovered that the surface of the TBPA tetramer has two symmetrical 
depressions which complement the structure of double-helical DNA. They 
propose that this may at least constitute a model of the thyroid hormone 
nUclear receptor, while there is no evidence for the other possibility of 
a direct DNA-TBPA interaction. 
4) PHYSIOLOGY OF THYROXINE-BINDING PROTEINS 
a) TBP and thyroid hormones in plasma 
i) The concept of "free" hormone 
In 1952, it was first proposed that thyroid hormones (T4 and T3) only 
exert their physiological activity when in the "free" form (Le. uriJound 
to plasma proteins) (Recant and Riggs, 1952). This proposal was developed 
and extended by the work of Robbins and RaIl (1957, 1960) into a concept of 
thyroid hormones in plasma being part of a multi-equilibrium system, 
Ji 
ii 
j 
- 18 -
Table 1.3. 
K 
Fraction/ ml/hour 
day 
TBG 0.14 40 
TBPA 0.36 90 
ALBUMIN 0.05 13 
T4 0.10 50 
T 4-TBG 10 
T4-TBPA 2x10-
1 
T4-ALB 2x10-
4 
T3 0.57 1,100 
T3-TBG 2x10-
1 
T 3-TBPA 3x10-3 
T3-ALB 1x10-
5 
(Adapted from Robbins, 1976 
Robbins et aI , 1978 
Princ~ and Ramsden, 1977) 
concentration 
mg/l nmol/l 
15 220 
340 6,200 
40,000 580,000 
70x10-3 90 
67 
13 
9 
1. 4x1 0 -3 2.1 
0.17 
0.02 
0.02 
SERUM CONCENTRATIONS AND CLfARANCE OF MAJOR 
IHYRONINES, BINDING PROTEINS AND HORMONE-PROTEIN COMPLEXES 
I' 
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obeying the laws of mass action. T4 and T3 bound to any prot~in binding 
site are considered to be readily exchangeable with hormones on other 
binding sites and with free hormone, the actual distribution within the 
system being governed by the concentration of hormones and the concentration 
and affinities of the various binding sites. 
Robbins and Rail gathered together a considerable amount of clinical 
and theoretical evidence supporting the idea that the metabolic degradation 
of thyroxine was proportional to the amount of free hormone. Later work, 
in which free T4 concentration was measured directly and found to correlate 
with T4-half-time in non-thyroidal illness (Inada and Sterling, 1967a, 
Bellabarba et aI, 1968) lent further support to the hypothesis. It followed 
that factors such as increased temperature and altered pH, which are known 
to diminish the affi~ity of TBG for T4 , had a pronounced effect on free T4 
and T4 degradation (Oppenheimer, 1968). 
Although the concept of free T4 has proved useful over a number of 
years, and has generated considerable research work and served to emphasise J 
the importance of the T4-binding proteins, doubts have recently been 
eXpressed as to whether free T4 should always be regarded as the sole 
determinant of physiologically active hormone. Ekins (1979) has drawn 
attention to the fact that the delivery of hormone to target cells is a 
dynamic process, whereas assessment of free hormone is made at equilibrium. 
If hormone delivery to the target tissue is viewed as a "flow" from protein-
bound hormone --~) free hormone in plasma --~) across capillary 
membrane to extracellular fluid ----~) across cell membrane to target cell, 
then the rate of delivery of hormone can be shown in theory to depend on 
factors including the amount of bound hormone in plasma, and the dimensions 
of the capillary vessel. Ekins has suggested that an influence of protein-
bound hormone on hormone delivery may explain the finding of low free hormone 
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concentrations in pregnancy (Ingbar et al, 1965; Sterling and Brenner, 1966). 
An additional factor to consider in relation to the delivery of thyroid 
hormones to their site of action is the existence of cellular receptors 
(Oppenheimer, 1968; Oppenheimer et al, 1976). High-affinity, low-capacity 
T3 binding sites have been demonstrated in the pituitary (Schadlow et al, 
1972), and in liver and kidney nuclei (Oppenheimer et al, 1972). Alterations 
in such receptors could well influence the cellular uptake of thyroid hormone. 
ii) Measurement of TBP 
Measurement of both TBG and TBPA was originally accomplished by electro-
phoresis and capacitance techniques, whereby the amount of radio-labelled T4 
taken up by the protein at saturating concentrations of non-radioactive T4 was 
measured. The binding capacity of TBPA WaS found to be between 216 and 342 ~g 
T4 (280 - 445 nmol) per 100 ml of serum (Oppenheimer, Martinez and Bernstein, 
1966) and of TBG, 16 - 25 f g T4 (21 - 33 nmol) per 100 ml (Robbins, 1956). 
The serum concentration of TBPA (Table 1.3) was sufficiently great to allow 
direct quantitation by densitometric techniques after electrophoretic separation, 
but the low serum concentration of TBG caused problems, and resulted in the 
development of a variety of indirect assay systems (see Chapter 3.3). The 
development of monospecific antisera to TBG (Levy, Marshall and Velayo, 1971; 
Bradwell et al, 1976) eventually enabled the use of radioimmunoassay and 
immunoelectrophoretic measurement of TBG. 
The lack of a direct assay for TBG was probably also the stimulus for 
the development of a number of other indirect assays of T4-protein binding. 
Most of those assays purport to measure the unoccupied protein binding sites 
125 131 . 
of plasma samples by the uptake of I or I labelled thyron~nes (T3 or T4). 
These assays include the red-cell (Hamolsky, Stein and Freedberg, 1957) and 
resin (Mitchell, 1958; Sterling and Tabachnik, 1951) uptake tests, and 
Sephadex uptake tests (Clark and Brown, 1970). The main importance of these 
I 
" 
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tests lies in their wide clinical routine application as a measure of TBP, 
and in particular their combination with total T4 measurements to derive 
a free T4 index (FTI = T4 x T3 resin x 100, or FTI = T4 
----~---
x 100) 
T3 uptake 
as an approximation of the free T4 concentration (Clark and Horn, 1965; 
Wellby and O'Halloran, 1966). 
The plasma concentrations of the T4-transport proteins are shown in 
Table 1.3. The distribution of TBP in other fluids has been reviewed 
(Robbins and RaIl, 1960; Ingbar and Freinkel, 1960). TBG and TBPA have 
been repeatedly demonstrated in lymph, and in pleural, peritoneal and 
synovial fluids. Both proteins have been identified in cerebrospinal fluid, 
where the proportion of TBPA relative to TBG and other plasma proteins was 
found to be ten times greater than in plasma (Alpers and RaIl, 1965; 
Hagen and Elliot, 1973). 
TBG in urine was initially recognised only in patients with nephrosis 
(Robbins, RaIl and Petermann, 1957; Gavin et aI, 1978). However, TBG has 
now been identified in normal urine, at a concentration of 1.7 fg/100 ml, 
where it apparently has minor conformational changes resulting in decreased 
affinity for T4 (Gavin et aI, 1979). 
iii) Biosynthesis and metabolism 
Synthesis of TBG by isolated monkey hepatocytes has been clearly 
demonstrated by Glinoer, Gershengorn and Robbins (1976), and the enhancement 
of synthesis by oestrogen-pretreatment of female monkeys has also been shown 
(Glinoer et aI, 1977a). In vivo administration of p-oestradiol resulted in 
stepwise increase in TBG production within 24 hours (Glinoer et aI, 1977b). 
In vitro work with monkey hepatocarcinoma cells also demonstrated that at 
I, 
I' 
I 
I 
~I; I . 
I 
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physiological concentrations or lower, T4 itself stimulated TBG synthesis, 
while at higher concentrations, TBG synthesis was inhibited (Robbins et aI, 
1978, Glinoer et aI, 1979). This effect was thought to be a manifestation 
of thyroid hormone action on protein synthesis in general, rather than an 
example of a hormone eliciting the production of its own transport protein 
(cf vitamin A causing acute release of RBP from hepatocytes, Smith et ai, 
1973) • 
As with other glycoproteins, TBG is protected from hepatic degradation 
by its sialic acid residues. Refetoff, Fang and Marshall (1975) showed that 
desialylated TBG was rapidly cleared from the circulation of normal subjects, 
while desialylatedTBG has been shown to accumulate in the serum of 
cirrhotics (Marshall et aI, 1972; Gartner et aI, 1979). Asialo-TBG has been 
shown to bind in vitr~ to hepatic membranes, and asialoglycopeptides of TBG 
inhibit this binding, thus confirming the in vivo findings (Zinn et aI, 
1978b) • 
iv) Physiological significance of the thyroxine-binding proteins 
,. 
In spite of an enormous amount of research into the nature and role of 
thyroxine-binding proteins since the discovery of TBG in 1952, their 
fUnction remains obscure. Phylogenetic studies of TBP have been performed 
(Farer et aI, 1962; Tanabe, Ishii and Tamaki, 1969; Refetoff, Robin and 
Fang, 1970); but are unfortunately of limited help. TBG can be identified 
in most mammals, but there are exceptions in the case of the rat and rabbit 
(Sutherland and Brandon, 1976). Prealbumin is more widely distributed than 
TBG among vertebrates, and is the major transport protein of several avian 
species. 
Genetic studies have been more helpful, in demonstrating complete 
absence of TBG. in perfectly healthy males (see Chapter 1.4.b. i . ) , thus showing 
II 
II 
I 
I, 
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that TBG cannot have any vital r~le. The same cannot be said of TBPA, since 
there are no reliable reports of total absence of this protein, although 
levels may be very low in severe illness (see Chapter 4.5). 
One function of thyroxine-binding proteins in general may be that of 
providing a means whereby a relatively insoluble, hydrophobic hormone may 
be held in quite large quantities in aqueous solution in the blood. In 
addition, it is believed that the TBP may limit the renal and possibly 
gastrointestinal loss of thyroid hormones, as well as controlling the 
amount of hormone available for degradation or the induction of metabolic 
effects. Short-term alterations in the concentration of TBP (especially 
TBPA with a short biological ~ life), may also be able to modulate the 
turnover of thyroid hormones. 
The .above hypothesis conceives the role of TBP as being rather passive, 
but more active roles, such as the delivery of hormone to specific sites of 
action by hormone-plasma protein complexes, have also been proposed 
(Robbins, 1976). However, the presence of binding protein does not seem to 
be necessary for cellular uptake of thyroid hormones, and kinetic studies 
SUggest a barrier for TBG diffusion at the capillary wall (Irvine and 
Simpson-Morgan, 1974). Some plasma binding proteins (e.g. RBP) have been 
shown to play an active role in hormone delivery by binding to cell surfaces 
(Rask and Peterson, 1976). Evidence for this does not exist for the TBP, 
but the mechanism could operate for one or more of the protein-thyroid 
hormone complexes, perhaps for specific target sites. 
TBPA would appear to be a more likely candidate than TBG for this ~le -
being apparently essential for life, and having a rapid metabolic turnover. 
In this context, an interesting and unexplained phenomenon is the ten-fold 
increase in TBPA in CSF relative to other proteins (Tourtellotte, 1970; 
• 
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Hagen and Elliot, 1973). 
v) Consequences of altered thyroxine-binding protein concentration 
As mentioned above (Chapter 1.4.a.i.) the concept of binding proteins 
and hormones in plasma as being an isolated multi-equilibrium system is 
probably an over-simplification since it ignores dynamic and cellular 
factors which may be concerned with hormone uptake by target tissues. 
However, in considering the effects of alterations in binding protein 
concentration, a model based on the law of mass action is of value. 
Several groups of workers have derived multi-ligand/multi-protein-binding 
site equations, usually requiring computer techniques, which may be used 
to predict the effects of binding protein changes on total and free T4 
concentrations (DiStefano and Chang, 1971; Wosilait and Nagy, 1976; 
Prl.°nc'e and Ramsden, 1977). The most comprehensive programme is that of 
P o / f T T rl.nce and Ramsden, which not only allows for the interaction a 3 on 4 
binding and vice versa, but also takes into account the two negatively 
interacting binding sites of TBPA, and up to six secondary binding sites 
on albumin (Steiner, Roth and Robbins, 1966). 
Using their model, Princ~ and Ramsden made a number of predictions of 
the effect of different thyroid states on the distribution of thyroid 
hormones among the binding proteins, and of the effect of changes in 
binding protein concentration on free and total concentrations of T3 and 
T4• Among the more important of these predictions was that the number of 
secondary binding sites on albumin had an appreciable influence on the 
distribution of bound ligand, and also that a slight elevation of serum T4 , 
With normal concentration of total T3 (so-called T4-toxicosis-Hadden et aI, 
1975) caused a profound increase in serum free T3• 
Table 1.4summarises the effects of binding protein changes on free and 
*Table 1.4 
Normal Low TBG Low TBG High TBe; x 2 Reduced Reduced 
normal free T4 normal free T4 TBPA(5m6) Alb(5U~6) 
Total T4 mol/l 1.09x10 -7 1.09x10 -7 3.5x10 -8 1.85x10 -7 1.09x10 -7 1.09x10-7 
~6 free T 4 0.0355 0.1118 0.111 0.0213 0.U4U8 0.U397 
Free T4 mol/l 3.87x10-11 1.22x10-1O 3.89x10-11 3.93x10-11 4.45x10-11 4.33x10-11 
Total TBG mol/l 1.70x10 -7 1.70x10-1O 1.70x10-1O 3.40x10 -7 1.70x10 -7 1.70x1U-7 
%T4 bd. by TBG 68.08 0.11 0.21 80.91 73.42 72.36 N \J'I 
Total TBPA mol/l 4.50x10 -6 4.50x10 -6 4.50x10 -6 4.50x10 -6 2.25x1U-6 4.50x10 -6 
%T4 bd by 1st TBPA 17 .52 54.60 54.76 10.48 10.05 19.56 
site 
Total ALB mol/l 7.35x10 -4 7.35x10 -4 7.35x10 -4 7.35x10 -4 7.35x10 -4 3.68x10 -4 
%T4 bd by 1st ALB 10.45 32.86 32.66 6.25 11.99 5.84 
site 
~a 4 bd by five 3.92 12.32 12.25 2.34 4.50 2.13 
secondary ALB sites 
/ 
* From Prince and Ramsden, (1977). 
EFFECT OF ALTERATIONS I N THYROXI NE-BINDI NG PROTEI N CONCENTRATION ON THE DISTRIBUTION UF T4 
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total hormone concentrations. The most important changes to note with 
respect to work to be presented in this thesis ar e that in the absence of 
TBG, with normal free T4 , a total T4 concentration of 35 nmol/l is 
predicted and that a 50% reduction in TBPA causes an increase in free T4 
f -11 / -11 / rom 3.87 x 10 moll to 4.45 x 10 moll. 
b) Genetic variations of thyroxine-binding proteins 
i) TBG concentration 
The phenomenon of genetically-determined variations in TBG 
concentration has been thoroughly investigated and reviewed (Refetoff et aI, 
1972; Robbins, 1973). The first family study of TBG elevation was thought 
to show an autosomal dominant inheritance (Beierwaltes and Robbins, 1959), 
but was also compatible with an X-linked dominant inheritance which was 
Suggested by later studies (Nikolai and Seal, 1966). It is now known that 
there are three types of inherited TBG abnormality, resulting in TBG 
elevation, reduction or absence. As with other X-linked abnormalities, the 
males are most severely affected, possessi ng only an abnormal X-chromosome, 
while females are heterozygous and have intermediate TBG concentrations. 
The abnormalities of TBG have been shown to result from altered 
concentration of an immunologically normal protein, and not due to 
defective T4-binding (Hansen and Siersbae k-Nielsen, 1972; Levy et aI, 1971; 
Refetoff et aI, 1972). The defect has been shown to be an abnormality of 
TBG synthesis, and it has been suggested that the abnormalities result from 
mutations at a single genetic locus controlling TBG synthesis (Refetoff 
et aI, 1976) (see Chapter 5). Robbins (1973) has produced alternative 
eXplanations, in particular that a somatic point mutation of the protein 
may occur and lead indirectly to alterations of synthetic rate; this has 
been shown to occur with glucose-6-phosphate dehydrogenase-Hektoen, which 
is one of the few proteins apart from TBG to undergo a genetic increase 
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(Yoshida, 1970). 
The main physiological importance of the genetic absence and excess of 
TBG lies in the fact that affected individuals are clinically euthyroid, 
and, despite some reports to the contrary, free T4 concentrations are 
probably normal (Robbins, 1973). In support of this, the TSH response to 
TRH injection has been found to be normal in TBG deficiency (Hansen et aI, 
1975, Konno, 1976). The normality of individuals with highly abnormal TBG 
concentrations, and the normal T4 degradation rate in hereditary TBG 
decrease (Ingbar, 1961) and increase (Jones and Seal, 1967) constitute 
powerful evidence against any rSle of the T4-TBG complex in thyroid 
hormone action. 
ii) Microheterogeneity of TBG 
Microheterogeneity of TBG was first elegantly demonstrated by Marshall 
and co-workers (1973), who described 9 bands in purified TBG subjected to 
isoel t· f . (I E F) All bands bound 125IT4, and pers;sted ec r~c ocus~ng •• • ~ 
after desialylation. A difference in the number of bands was observed 
between TBG from pooled serum and from a single donor. The authors 
therefore felt that TBG exists in serum as a heterogeneous collection of 
.proteins differing by subtle changes in amino acid composition. 
The findings of Henze, Gartner and Horn (1979) are in complete contrast. 
They identified four TBG bands during IEF, and these were reduced to one by 
complete d~sialylation. Quantitative analysis revealed that the bands 
differed in their content of N-acetyl neuraminic (sialic) acid. Ramsden 
and Burnett (1980) have carried out IEF for TBG on microlitre quantities 
of serum from different donors, and have found multiple bands, which are 
reduced in number, but not abolished by desialylation. They feel that the 
persisting bands may represent true polypeptide microheterogeneity of TBG, 
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although incomplete desialylation would also explain the findings. 
iii) Genetic polymorphism of TBPA 
Genetic polymorphism of rhesus monkey pre albumin has already been 
mentioned (v.s. Chapter 1.4.a), because the five components of the 
intermediate variety of rhesus TBPA provided the first indication of the 
tetrameric structure of TBPA (Alper et aI, 1969; Bernstein et aI, 1970). 
The inheritance of the polymorphic forms of rhesus TBPA is autosomal 
codominant, and the two homozygous forms have been shown to at least differ 
by one amino acid in the 5 position from the N-terminal (Van Jaarsveld et aI, 
1973b). The different polymorphic forms of TBPA resulted in differing TBPA 
concentrations (Van Jaarsveld et aI, 1973c), which is an interesting 
finding in view of the genetic variations of TBG concentration. 
Polymorphism of TBPA has not been demonstrated in man (see Robbins, 
1976 for review). 
5) THE THYROXINE-BINDING PROTEINS IN DIFFERENT PATHOLOGICAL STATES 
a) Thyroid disease 
An increase in TBG concentration in myxoedema and a decrease in 
thyrotoxicosis was noted in early studies using capacitance methods 
(Inada and Sterling, 1967b). Direct measurements have tended to confirm 
these observations, when appropriate control populations are studied (see 
Chapter 3.1.e and 3.3 for detailed discussion). 
The changes in TBPA capacity in thyroid disease were also studied by 
Inada and Sterling (1967b). No consistent change was found in myxoedema, 
but in active thyrotoxicosis, TBPA was invariably reduced, by a mean of 
approximately 40%. 
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B) Non-thyroidal illness 
i) Acute and chronic illness 
Studies carried out in a wide variety of different diseases, 
characterised mainly by weight loss, fever and debilitation (including 
leukaemias, carcinomatosis, tuberculosis and a miscellany of acute and 
chronic illness), showed diminished protein binding of thyroxine, evidenced 
by an increased dialysable fraction (Richards, Dowling and Ingbar, 1959; 
Oppenheimer et aI, 1963; Ingbar et aI, 1965). This was initially attributed 
to a reduced concentration of TBPA (Oppenheimer et aI, 1963) although 
subsequent studies showed that TBG also was reduced, especially in chronic, 
seVere illness (Bellabarba et aI, 1968; Harvey, 1971). Kinetic studies 
with purified TBPA demonstrated that it had a very short half life of only 
2 - 3 days, and that serum TBPA underwent a rapid fall in a variety of 
stressful situations as a result of reduced synthesis (Socolow et aI, 1965; 
Oppenheimer et aI, 1965). Since T4 disposal rate was shown to be increased 
five-fold during fever (Gregerman and Solomon, 1967) and T4 disposal 
correlated strongly with measured free T4 (Bellabarba et aI, 1968), the 
above was taken to be strong evidence in favour of the control of T4 
metabolism by changes in TBPA, and to a lesser extent TBG. The sequential 
studies of Lutz et al (1972), during experimental acute infections 
demonstrated, however, that changes in % FT4 and free T4 concentration were 
not related in time to acute alterations of TBPA and TBG concentration. 
These authors suggested instead the appearance of inhibitors of T4 binding 
during infection. 
More recent studies of the effect of non-thyroidal illness on thyroid 
fUnction have focussed on the peripheral metabolism of T4• Following 
the initial report of Chopra et al (1974) of low serum T3 concentrations in 
hepatic cirrhosis, this finding has been noted in a wide variety of acute 
and chronic illnesses (Carter et aI, 1974; Bermudez, Surks and Oppenheimer, 
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1975; McLarty et aI, 1975). It has further been demonstrated that the 
monodeiodination of T4 may be either from the phenolic ring to yield 
3,3',S,-triiodothyronine (T3) or from the inner tyrosyl ring to yield 
3,3',S'-triiodothyronine (reverse T3 ,rT3), which is thought to be 
metabolically inactive (Pittman, Brown and Register, 1962). Illnesses and 
acute stresses causing low T3 have almost always been shown to result in 
reciprocal elevation of rT3 (Chopra et aI, 1975a, Burr et aI, 1975; 1976; 
Burger et aI, 1976). 
Kinetic studies are consistent with the idea that the changes result 
from inhibition of thyronine S'-deiodinase (Chopra, Sack and Fisher, 1975; 
Vagenakis et aI, 1977; Visser, 1978), which leads to reduced 3,3',S-tri-
iodothyronine (T3) production and 3,3',S'-triiodothyronine (rT3) degradation. 
It is not known whether the thyroxine-binding proteins have any 
function in mediating the changes described above, but current thinking 
A 
would hold that they do not have any role and that the changes are more 
likely to result from subtle changes of the redox state and availability 
of -SH groups within cells (Visser, 1978; Harris et aI, 1979). 
The changes in thyroid hormones and binding proteins attributable to 
non-thyroidal illness are summarised in Table 1.S. 
ii) Surgery 
Surgery results in a decrease in TBPA binding capacity (Surks and 
Oppenheimer, 1964; Kirby, Clark and Johnston, 1973) and concentration 
(Minchin-Clarke et aI, 1971; Aronsen et aI, 1972). The fall is apparent 
within a few hours of surgery (Surks and Oppenheimer, 1964) and is maximal 
on about the third postoperative day, when concentrations of 50% of the 
preoperative concentration have been noted after uncomplicated abdominal 
T4 
~~ Free T4 
Abs. Free T4 
T3 
~~ Free T3 
Abs. free T3 
rT3 
TBG 
TBPA 
Alb. 
T4 Production 
rate 
Urine T4 
Urine T3 
TSH 
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Table 1.5 
Acute and 
chronic illness 
J, (10-15) .J,.J, in severe 
illness 
t (80) 
t (40-50) 
.J. (15-80) 
t (40) 
--t J, (0-50) 
t (180) 
~ (15-25) 
,J., (50) 
J, (20) 
-7 
-j arJ, 
Febrile 
illness 
---t 
l' (25-10U) 
t (50) 
.j" (30-50) 
t (8U) 
J, (30-5U) 
l' (80) 
~ 
t (5U) 
J.-
t (500) 
--7 
Surgery 
Variable -
see text 
t (50-60) 
l' (40-60) 
-1- (30) 
t (20) 
-1- . (50) 
t (7U-140) 
~ 
t (50-7U) 
J,. (15-20) 
t (20) 
t (100) 
~ art 
See Appendix A for references on which this table was based. 
THE EFFECTS OF ILLNESS AND SURGERY ON THYROID HORMONES AND 
BINDING PROTEINS 
(Figures in parentheses refer to approximate percentage change) 
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operations (Surks and Oppenheimer, 1964; Minchin-Clarke et aI, 1971; Aronsen 
et aI, 1972). As in other types of illness, the fall in TBPA is thought to 
be caused by reduced synthesis (Socolow et aI, 1965; Oppenheimer et al, 
1965). A postoperative increase in free T4 (Surks and Oppenheimer, 1964) 
and percentage free T3 (Kirby et aI, 1973) has been attributed to decreased 
TBPA concentration. 
Serum TBG concentrations have not been found to alter after 
uncomplicated surgery (Surks and Oppenheimer, 1964; Kirby et aI, 1973). 
Thyroid hormone changes after surgery are basically similar to those 
occurring after other types of illness (Table 1.5). There is a reduction 
of serum TBPA, which mayor may not be enough to account for increases in 
the percentages of free T4 and free T3• Serum total T4 concentrations 
have been variously reported to be unchanged (Kirby et aI, 1973; Ramsden 
et aI, 1978), slightly reduced (Burr et aI, 1975; Chan, Wang and Yeung, 
1978; Kehlet, Klauber and Weeke, 1979) or even increased (Prescott et al, 
1979). The differences may relate to differences in anaesthetic agent, or 
to postoperative fluid replacement. Peroperative T4 changes have certainly 
been highly variable, perhaps as a result of T4 displacement by some 
anaesthetic agents (Oyama, 1973). 
After operation, T4 metabolism is altered as in other types of illness, 
So that total T3 falls, and free T3 is reduced in spite of increased 
percentage free T3• Serum rT3 increases, suggesting altered peripheral 
monodeiodination of T4 (Burr et aI, 1975; Chan et aI, 1978; Kehlet et al, 
1979; Prescott et aI, 1979). 
iii) Malnutrition and fasting 
Both TBPA and TBG are reduced in protein-calorie malnutrition 
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(Ingenbleek, de Visscher and deNayer, 1972; Ingenbleek, deNayer and 
deVisscher, 1974). The concentration o~ TBPA falls rapidly during fasting 
(~ 30% fall in one week) (Frey et aI, 1979; Shetty et aI, 1979) - perhaps 
because of its high tryptoph an content and short biological half-life 
(Ingenbleek et aI, 1975). It has been suggested that TBPA (and RBP) 
measurement may be useful in the assessment of protein-calorie malnutrition 
(Ingenbleek et aI, 1975) and of sub-clinical malnutrition (Shetty et aI, 
1979), although such proposals disregard the non-specific nature of changes 
in TBPA concentration (Minchin-Clarke, Freeman and Pryse-Phillips, 1971; 
Johansson et aI, 1972). TBG undergoes a gradual fall during total fasting 
for 7 - 15 days (Scriba et aI, 1979) and after calorie restriction for two 
weeks (Moreira-Andres et aI, 1980). 
It should also be mentioned at this point that fasting induces similar 
Changes in peripheral T4 monodeiodination to those mentioned in section 
1.5.b.i., with low T3 and increased rT3 concentration (Rothenbuchner et aI, 
1973; Vagenakis et aI, 1975; Danforth et aI, 1975). 
iv) Hepatic disease 
Abnormalities of PBI measurements were observed many years ago in 
patients with a variety of hepatic diseases. TBG-capacity measurements 
Were subsequently shown to be very variable - either low, normal or raised, 
thus explaining the variation of PBI (Kydd and Man, 1951, Vanotti and 
~ 
Beraud, 1959; Inada and Sterling, 1967a). TBG becomes elevated early in 
the course of viral hepatitis (Vanotti and B~raud, 1959), and high 
concentrations have also been noted in chronic active hepatitis and primary 
biliary cirrhosis (Schussler, Schaffner and Korn, 1978). In cirrhosis of 
the liver TBG capacity was found to be reduced (Inada and Sterling, 1967a), 
While a relative increase in desialylated TBG has been observed and 
attributed to impaired removal of partially-denatured TBG (Marshall et aI, 
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1972; Gartner et aI, 1979). The alterations in TBG concentration in hepatic 
disease have not been fully explained, but the variable l evels ar e presumably 
due to different combinations of impaired synthesis, impaired degradation, 
and possibly increased synthesis secondary to high oestrogen levels. 
TBPA capacity in hepatic disease, as in other chronic illness, has 
been found to be low (Inada and Sterling, 1967a). 
v) Renal disease 
Abnormalities of the thyroxine-binding proteins in nephrosis were 
first demonstrated by Robbins and co-workers (Robbins et aI, 1957), who 
found low TBG-capacity in 5 of 7 patients with the nephrotic syndrome. 
However, most of these patients were receiving adrenal corticosteroids, 
which are now known to lower serum TBG (vide infra, Chapter 1.5.c). Other 
workers have reported normal TBG levels in nephrosis (Musa, Seal and Doe, 
1967), and recently Gavin et al (1978) clearly showed that serum TBG 
concentrations in the nephrotic syndrome are normal in all but the most 
extreme cases, in which there is gross proteinuria. 
In renal failure without nephrosis, TBG concentrations have only been 
assessed by capacitance measurements, or by indirect methods such as resin 
Uptake tests. These assays might in theory be unreliable in renal failure, 
because of the presence of indoles and phenols which could interfere with 
T4 binding (Spaulding and Gregerman, 1972). In fact, most reports suggest 
that TBG concentration is normal in renal failure (Oddie et aI, 1970; 
NeUhaus et aI, 1975; Ramirez et aI, 1976; Hershman et aI, 1978), although 
in two studies, a low concentration was found (Joasoo et aI, 1974; Lim et aI, 
1977). It would appear that reduction of TBG concentration in uraemia is 
not sufficient to explain the low T4 concentrations reported by many 
investigators (Musa et aI, 1967; Silverberg et aI, 1973; Joasoo et aI, 1974, 
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Ramirez et aI, 1976; Spector et aI, 1976; Lim et aI, 1977, Hershman et aI, 
1973; Gomez-Pan et aI, 1979). An unexplained feature of renal failure is 
that patients remain clinically euthyroid in spite of apparently low total 
and free thyroid hormone levels (Spector et aI, 1976). 
There have been very few studies of TBPA metabolism in renal failure, 
but Vahlquist, Peterson and Wibell (1973) reported that serum TBPA 
concentration, metabolic clearance and production rates were all normal in 
chronic renal failure. 
c) Drugs and hormones 
The increase in TBG concentration following oestrogen administration is 
now well-e~tablished (Dowling, Freinkel and Ingbar, 1956a; Engbring and 
Engstrom, 1959) and oestrogen is thought to be responsible for the equally 
well-established increase of TBG concentration in pregnancy (Dowling, 
Freinkel and Ingbar, 1956b). These observations have been recently given 
a sound physiological basis by the work of Glinoer et al (1977a, b) showing 
increased hepatic synthesis of TBG in response to oestrogen. Oestrogens 
and pregnancy cause a slight reduction in TBPA concentration (Oppenheimer 
et al, 1963; Sakurada et al, 1967). Androgens and anabolic steroids have 
the effect of decreasing TBG concentration, and increasing TBPA concentration 
(Federman, Robbins and RaIl, 1958; Braverman and Ingbar, 1967), and adrenal 
Corticosteroids produce similar effects (Oppenheimer and Werner, 1966) which 
are apparently mediated via decreased TBG synthesis and increased TBPA 
synthesis (Braverman and Ingbar, 1967; Braverman et aI, 1968). 
Other conditions and drugs associated with TBP changes are shown in 
Table 1.6. The most recent, and intriguing addition to this list is 
L-asparaginase (Garnick and Larsen, 1979), the anti-leukaemic agent, which 
apparently inhibits TBG synthesis almost completely within a few hours of 
.. 
TBG 
TBPA 
INCREASE 
PREGNANCY 
HEPATIC DISEASE: 
Viral hepatitis 
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1 Table 1.6 
Chronic active hepatitis 
Primary biliary cirrhosis 
MYXOEDEMA 
DRUGS: 
Oestrogens 
Phenothiazines 
Clofibrate 
Methadone2 
ACUTE PORPHYRIA 
ANALBUMINAEMIA 
GENETIC 
AGE < 5 years 
FEMALES 
ENDOCRINE DISEASE: 
Acromegaly 
Cushing's syndrome 
DRUGS: 
Corticosteroids 
Androgens 
Anabolic steroids 
DECREASE 
PROTEIN-CALORIE MALNUTRITION 
and FASTING 
MAJOR ILLNESS 
CIRRHOSIS 
NEPHROTIC SYNDROME 
ENDOCRINE DISEASE: 
Thyrotoxicosis 
Acromegaly 
Cushing's syndrome 
DRUGS: 
Androgens 
Anabolic steroids 
L-Asparaginase 
\' Phenytoin 1 3 
(Salicylates 5 
MALES 
ACUTE OR CHRONIC ILLNESS 
SURGERY 
PROTEIN-CALORIE MALNUTRITION 
and FASTING 
THYROTOXICOSIS 
1. Based on Oppenheimer (1968), additions referenced in text. 
2. TBG increase in drug addicts may be due to liver dysfunction. 
3. Low T4 and TBG-capacity, probably due to competition for T4-binding site. TBG concentration normal. 
[ACTORS CAUSING ALTERATIONS IN THYROXINE-BINDING PROTEIN CONCENTRATION 
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administration. 
6) INDICATIONS FOR THE PRESENT STUDY 
a) Assay of TBG and TBPA 
Early attempts to quantitate the thyroxine binding proteins relied 
Upon binding-capacitance assays (v.s. Chapter 1.4.a.ii.). Not only were 
these assays time-consuming and cumbersome to perform - so that they were 
not suited to the processing of large numbers of samples - but they were 
also open to the criticism that they were not a direct measure of protein 
concentration and could be subject to interference by inhibitors of T4 
binding. Thus, although pregnancy was known to increase TBG-capacity, it 
Was not known for certain whether this was due to a quantitative increase 
in protein, or to an alteration of the protein, causing increased T4-
binding affinity, or an increased number of binding sites. 
To circumvent these problems, an assay was required for TBG which was 
direct, simple, rapid and reproducible. When the present study commenced, 
seVeral direct assays for TBG had been described (Freeman and Pearson, 1969; 
Nielsen et aI, 1972), but these were cumbersome, time-consuming and involved 
handling relatively large quantities of radioactivity. A radioimmunoassay 
for TBG had been described (Levy et aI, 1971), but because of the difficulties 
involved in purifying TBG (v.s. Chapter 1.2) it was not known to what extent 
this assay might be subject to errors due to impurity or denaturation of TBG. 
A major aim of this project was therefore to develop suitable assays 
for TBG and TBPA. 
b) RSle of TBG and TBPA 
The second aim of this study was to gain further information concerning 
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the function of thyroxine-binding proteins, particularly in relation to 
changes in thyroid hormone metabolism and alterations in free hormone 
concentration. The thyroid hormones and binding proteins were therefore 
measured in patients before, during and after non-thyroidal surgery. 
Earlier studies had shown that this stress would result in a reduction in 
serum TBPA (see chapter 1.5.b.ii). 
Profound alterations of TBPA were observed, together with lesser 
changes of TBG. Serum T3 was markedly reduced, and there were also changes 
in free hormone concentration. The study was therefore extended, in order 
to discover whether the findings were specific to surgery, or were applicable 
in general to patients with non-thyroidal illness. A group of patients 
with recent myocardial infarction were selected, and, as a final control 
group, a series of obese patients undergoing therapeutic starvation were 
studied. 
c) Use of TBG assay in the assessment of thyroid function 
With increasing use of the TBG assay a considerable number of patients 
Were identified with absent, low or increased TBG concentration. In general, 
these patients were fit, euthyroid and on no drug therapy. They were shown 
to have hereditary abnormalities of TBG concentration. Routine thyroid 
fUnction tests in these people were frequently abnormal, predicting either 
mYXoedema or thyrotoxicosis when individuals had low and high TBG 
respectively. 
125 In the final part of this study, the IT3-uptake test was tested for its 
ability to measure low and high concentrations of TBG. Certain "limitations 
Were identified, and the direct measurement of TBG was evaluated as a 
replacement for T3-uptake tests in the assessment of thyroid function. 
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a) anti-TBG 
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v) T3 uptake 
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Chapter 2 MATERIALS AND METHODS 
1) MATERIALS 
Sephadex G100 and G150 was obtained from Pharmacia (Great Britain) Ltd., 
London. 
Diethyl aminoethyl cellulose (DEAE cellulose) grade DE32 from Whatman 
Biochemical Ltd., Maidstone, U.K., prepared according to the manufacturers 
instructions. 
Agarose was obtained from British Drug Houses (BDH), Poole, U.K. or 
L'Industrie Biologique Francaise, GSlnevilliers, France. 
Radioiodine and radioiodinated T4 from the Radiochemical Centre, 
Amersham, U.K.; labelled T4 and T3 was also prepared in the laboratory 
according to the method of Weeke and Orskow (1973), and high specific 
activity 1125T3 was obtained from Abbott Laboratories, Queensborough, Kent. 
Coomassie Blue and Triethyl-aminoethyl cellulose (TEAE) were obtained 
from Sigma Chemical Company Ltd., Kingston-upon-Thames, U~K. 
The Department of Experimental Pathology, Birmingham University, 
kindly provided Freund's complete adjuvant and sheep anti-whole human serum 
(Dr. A. R. Bradwell). 
Other antisera were obtained from Wellcome Diagnostic Reagents Ltd., 
London (sheep anti-whole human serum) and Dakopatts (rabbit anti-human 
prealbumin), British agents for Dakopatts are Mercia Diagnostics Ltd., 
Watford, U.K. 
X-ray film was obtained from Kodak U.K. Ltd., London (RP/LX-Omat) 
or Ilford Ltd., lIford, U.K. (Rapid R, type S), and was developed in the 
X-ray Department, Queen Elizabeth Hospital, Birmingham, using an X-Omat 
Processor Model M 6-N (Kodak U.K. Ltd.) by courtesy of Dr. O. E. Smith. 
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Visking dialysis tubing was obtained from Scientific Supplies Company 
Ltd., London, ultrafiltration membranes, cells and concentrators ("Minicon") 
from Amicon Ltd., High Wycombe, U.K. and Millex disposable filters from 
Millipore (U.K.) Ltd., London. 
A heated levelling plate was manufactured in the workshops of the 
Department of Medicine, Birmingham University, and a sample dispenser for 
use with a Hamilton 700 Series microlitre syringe and Chaney Adaptor 
(Hamilton Micromesure N.V. - U.K. Agents V. A. Howe and Co. Ltd., London) 
was purchased from the Department of Experimental Pathology, University of 
Birmingham. 
Glass electrophoresis plates (24 x 8 cms) were obtained from Pearce 
and Cutler Ltd., Birmingham, U.K. and from A. Gallenkamp Co. Ltd., 
Birmingham, U. K. (76 x 50 mm). 
Direct current power equipment, type BES-2 was manufactured by 
PCD Ltd., Farnborough, U.K. and electrophoresis tanks were obtained from 
Chem Lab Instruments Ltd., lIford, U.K., or were constructed in the 
Department of Medicine, Birmingham University. 
Glass-fibre paper (Whatman GF/A) and ashless tablets (Whatman) were 
obtained from A. Gallenkamp Co. Ltd., Birmingham, U. K. 
All other chemicals used were obtained either from BDH Ltd., Poole, 
U.K. or Hopkins and Williams, Chadwell Heath, U.K. 
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2) METHODS 
Although TBG measurements were initially made with an immunoelectro-
phoretic technique utilising antiserum to whole human serum and radio-
autography (see Chapter 2.2.c.i.) assays for both TBG and TBPA were 
eventually based on monospecific antisera. These antisera were prepared 
in the Department of Medicine, and their production required preliminary 
purification of TBPA and TBG. The qualitative and quantitative methods to 
/ 
be described were carried out in collaboration with Dr. H. P. Prince. 
A) QUALITATIVE METHODS 
i) Two~Di~ensional immunoelectrophoresis (2-DIEP) 
This technique was first described by Laurell (Laurell, 1965) and is 
frequently referred to by his name. In the first dimension, the proteins 
are separated according to their electrophoretic mobilities by electro-
phoresis at relatively high voltages in agarose gel. A second electro-
phoresis, carried out at 90° to the first, and at lower voltage, forces 
the proteins into a bed of agarose gel containing antiserum. Immuno-
precipitation occurs when protein and antiserum are present in equivalent 
amounts. The initial precipitate is soluble in antigen excess, and a 
precipitation line is formed which advances into the antiserum gel until 
the supply of antigen is exhausted. Gaussian, or near-Gaussian peaks are 
formed (Fig. 2.1), whose area is directly proportional to the amount of 
antigen in the sample. 
The proteins within a sample may be identified by their electrophoretic 
mobility, specific staining characteristics, by their ability to form 
precipitation lines with known added antigens, and in the case of transport 
proteins, by their ability to bind radiolabelled ligands. 
r 
Figure 2.1 
Two dimensional immuno-
electrophoresis of whole 
human serum into antiserum ~ 
~ 
to whole human serum, plate I 
stained with Coomassie 
Brilliant Blue to show near-
Gaussian peaks of individual 
proteins separated according 
to electrophoretic mobility. 
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The first dimension electrophoresis was performed under refrigeration 
(+SOC) at 10 V/cm in 60 mM barbitone buffer, pH 8.6, containing 3mM sodium 
azide as preservative. The support consisted of a 1% agarose gel strip, 
1 mm x 1 cm x 5 cm, in which a 2 mm origin well had been cut with a sharp-
edged metal punch. The progress of the electrophoresis was monitored by 
using 1% bromophenol blue in water as a marker. 
After completion of the first electrophoresis, the agarose strip was 
carefully aligned at the base of a 76 x 50 mm slide, onto which was then 
poured a 1 mm layer of 1% agarose containing antiserum. The second 
dimension electrophoresis was then carried out overnight, at room 
temperature at 2 V/cm. The plates were then dried with filter paper and 
paper towels, under pressure and without washing. They were stained with 
0.5% Coomassie Brilliant blue in a mixture of glacial acetic acid:methanol: 
water (1 Vol:5 Vols:S Vols). 
ii) Autoradiography 
For experiments involving the purification and quantitation of TBG 
and TBPA, the protein peaks were identified by autoradiography following 
labelling with 1251_T4 (Freeman and Pearson, 1969). Radiolabelled T4 was 
added prior to electrophoresis (Nielsen, Buus and Weeke, 1972), but problems 
were then encountered due to stripping of T4 from the binding proteins when 
barbital buffer was used (Drysdale et al, 1975). The problems were overcome 
by using 0.05M phosphate buffer at pH 7.4, which improved labelling of TBPA 
and TBG. However, this was achieved at the expense of a considerable 
increase in electroendosmosis due to negatively charged agaropectins 
Contained in the agarose gel (Grubb, 1973). Electroendosmosis was reduced 
by removal of these negatively charged molecules using TEAE-cellulose as an 
insoluble adsorbent. 
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A 2% solution of agarose in distilled water was made up and placed on 
a heated stirrer. An aqueous slurry of Triethylaminoethyl cellulose (TEAE-
containing sufficient to make a final concentration of 10 gil) was added, 
and the mixture stirred rapidly. TEAE-cellulose and adsorbed materials were 
removed by hot vacuum filtration through glass-fibre paper (Whatman GF/A) 
and a suspension of ashless cellulose filter tablets (Whatman). This 
procedure was found to reduce electroendosmosis (measured by migration of 
Dextran 70) from 1.2 mm/V/hr to 0.6 mm/V/hr. 
Autoradiography was carried out before or after drying of the 
electrophoresis plates according to requirements. In the former case, the 
gel was covered with a polythene film and placed in contact with the X-ray 
film. Dry plates were placed with gel facing the film, and were then 
placed in an ordinary X-ray cassette. Autoradiography was carried out at 
-70 DC to increase the sensitivity of the X-ray film, and exposure lasted 
from 1 - 7 days, after which the film was automatically developed in the 
X-O mat M-6N Processor. 
iii) Analytical polyacrylamide gel electrophoresis 
This was carried out in a Labora serial disc electrophoresis apparatus 
(Linton Instrumentation, Harlow, U.K.), as shown in figure 2.2, which also 
shows the buffer compositiDns. Gels consisted of acrylamide together with 
5~~ NN' -methy lenebisacry lamide as a crosslinking agent. 25)Jl of a 0.5 mg/ml 
solution of protein(s) was applied to the starter gel and electrophoresed 
for 45 minutes at a constant electrical potential of 120 V. Gels were 
stained in a 0.1 ~6 solution of amido black in 1.2 M acetic acid, and 
Washed overnight with 1.2 M acetic acid in which they were also stored. 
Autoradiography of gels was carried out after prior labelling with 
[131 I ]T4· 
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Figure 2.2 
UPPER BUFFER TANK 
STACKING (UPPER) GEL 
Polymerization catalyst:riboflavin 
Concentration:50 gil 
SEPARATING (LOWER) GEL 
Polymerization catalyst:ammonium 
persulphate + TEMED 
Concentration:variable 
UPPER BUFFER = LOWER BUFFER 
Glycerine (384 mM)/Tris, pH 8.2 
Upper gel buffer: 
Tris (56 mM)/phosphate p~7.0 
Lower gel buffer: 
Tris (375 mM)/Chloride, pH 9.5 
Running pH 9.2 (after equilibration) 
LABORA DISC-GEL APPARATUS 
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B) PREPARATIVE METHODS 
i) Fractionation of TBG and TBPA from human serum 
Outdated citrated whole blood, obtained from the Blood Transfusion 
Service, was pooled according to blood group, centrifuged at 1000 G for 
15 minutes and the red cells discarded. The plasma was dialysed against 
buffer (50 mM Tris/chloride, pH 8.0) containing 10 mM calcium chloride to 
induce clotting. After removal of the clot, serum was dialysed against 
calcium-free buffer, and 0.5 fCi of 125I _T4 was added. This constituted 
"starting serum". 
The starting serum was subjected to a preliminary fractionation 
using ion-exchange chromatography (step a). This produced separate 
radioactive peaks corresponding to TBG and TBPA and these were subjected 
to separate further procedures:-
Step a Ion-exchange chromatography 
~ ~ 
TBG peak TBPA peak 
~ ~ Step b Ion-exchange chromatography Ion-exchange chromatography 
J, .1 
Step c Sephadex G150 chromatography Sephadex G150 chromatography 
J, 
Step 
J, 
d Preparative polycrylamide Preparative polycrylamide 
gel electrophoresis gel electrophoresis 
.§..tep a (Figure 2.3A) 
The first ion-exchange chromatography was carried out on a DEAE 
cellulose column (60 cm x 5 cm) using increasing concentrations of 
50 mM - 500 mM Tris/HCl buffer, pH 8.0, for elution. A linear concentration 
gradient generated by an lKB Ultrograd (lKB Instruments ltd., South Croydon, 
U.K.) formed the basic elution gradient but this gradient was varied using 
an LKB Level Sensor, preset to hold the buffer concentration when effluent 
transmittance was (65% of starting buffer transmittance. 
% Absorption 
254nm 
80 
60 
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Figures 2.3.A,B,C. 
FIRST ION EXCHANGE STEP 
A 
40 LEVEL 
20 SENSOR 
o 
o 100 200 300 
254nm SECOND ION EXCHANGE STEP 
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c 60 0 
-a.. L.. 
0 40 on 
..0 
« LEVEL 
cf. 
-SENSOR 20 
400 
125 1 - 4 
cpm x 10- 3 
·40 
30 
lJ 
10 
0 
1251-T4 
cpm x 10-3 
16 
12 
8 
4 
0 
10 20 30 40 50 60 70 80 90 0 
254nm 
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c: 
0 
- 60 a.. L.. 
0 
on 
..0 
« 
~ 40 0 
20 
0 
GEL CHROMATOGRAPHY 
G 150 
10 20 
FRACTION NUMBER 
CHROMATOGRAPHIC PURIFICATION OF TBG 
see text for details 
-2 
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125 I - T 4 
90 
50 
10 
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Step b 
The TBG and TBPA peaks ("A" and "B" respectively in figure 2.3A) were 
identified by radioactivity and were separately pooled. They were 
concentrated in an Amicon ultrafiltration cell with a UM-10 membrane, and 
were dialysed against starting buffer. They were then loaded onto a 
smaller column (40 cm x 2.5 cm) containing DEAE cellulose and were eluted 
with 50 - 500 mM Tris/HCL buffer using a preset gradient. Figures 2.3B 
and 2.4 show the results for the TBG and TBPA peaks respectively. 
Step c (Figures 2.3C and 2.5) 
The radioactive peaks from the previous stage were once again 
concentrated and were further fractionated using a Sephadex G-150 column 
(90 cm x 2.5 cm) and 40 mM Tris/citric acid with 550 mM NaCl, pH 8.6, as 
eluant. 
Step d. (Figures 2.6 and 2.7) 
Radioactive peaks were collected, .pooled, concentrated as above, and 
dialysed against distilled water for 16 hours at 4°C. They were then 
subjected to preparative polyacrylamide gel electrophoresis according to 
the method of Gordon and Louis (1967), using equipment manufactured by 
Quickfit and Quartz. The gel consisted of 90 ml of a 70 gil acrylamide 
gel with 5% cross-linking. Gel, tank and elution buffers were 8.3 mM 
Tris/25 mM glycine, pH 8.4 (8.7 for TBPA). The applied potential was 
250 V and the elution rate was 20 ml/hr. The individual fractions were 
monitored for radioactivity and concentrated as above. 5 ml aliquots 
Were then labelled with additional high specific activity 1251_T4 (1 fl, 
approximately 1000 cpm), and subjected to 2-D1EP with antibody to whole 
human serum (TBPA) or antibody to the 0(1 fraction of human serum (TBG -
obtained from the Department of Experimental Pathology, University of 
Birmingham). The plates were subjected to autoradiography while still wet, 
2 
o 
o 2.5 x 40 em Column 
~ 25 ml!hr 
~ Tris! HCL pH = 8 
r-
o 
rn 
Z 
V) 
-; 
-< 
'" 00
o 
~ 
3 
I 
I 
. 
-' 
/ 
i 
". 
;" 
./ 
." 
"." 
./ 
/./ 
/./. 
/" 
./ 
." 
",0/ 
". 
. "..-_ ....... _. --.-. 
./' N 
""",---
.", \Jl 
. -'-
1\ 
1\ 
, \ 
, \ 
I \ 
I \ 
I , 
, \ 
, \ 
. \ 
I , 
, \ 
. , \ 
, \ . 
, \ , 
I \ 
, \ 
I \ 
, \ , 
\ 
\ .... ---... ... 
I 
• 
I 
~-I 
(=) 
-0 
3 
~ 
c 
OJ 
[II 
>< 
o 
I 
VJ 
, \ I , 
OJ 
c: 
-n 
-n 
rT1 
;::0 
48 
z 
() 
rn 
Z 
-; 
;::0 
» 
-; 
o 
z 
2~ 
I 
. 
I 
L J I ---------~~ --~--- - -- --' 
---------------- -----------
, I 
" ~ 
---
\ 
' ... o 
Fraction No (13m I) 
days 
o 
o 
50 
2 
Fi~ure 2.4 PURIFICATION OF TBPA BY ION-EXCHAN GE CHHOMA TOGRAP HY WI TH DEAE-CELLULOSE 
·0.5 
0.05 
V1 
o 
4 
2 
o. 
. 
E 
c 
<::) 
co 
"-J 
>-I-
tn 
Z 
l..L.l 
o 
-.J 
« 
U 
I-
0.... 
o 
I. 
" 
--10 
" 
/ 
I , 
I 
I 
I 
I 
1 
I , 
I 
I 
I 
I 
I 
. / 
, 
/ , 
20 30 
2.5 x 90 em Column 
20 mllhr 
TrisiC itric acid! 
sodium chloride pH 8.6 
40 
N 
Vl 
I 
~-i 
- ~ (") 
"0 
:::j 
:::r 
c 
OJ 
rr1 
X 
a 
I 
w 
-
Fraction Number (1.5ml) 
Figure 2~5 PURIFICATION OF TBPA BY GEL-FILTRATION WITH SEPHADEX G-1S0 
10 
\J1 
..... 
5 
o 
Absorbance PREPARATIVE GEL ELECTROPHORES IS 
125 I -T4 
. cpm x 10-2 254nm I D I 
O. I I I 15.0 
I /, 
I ' 
VI 
10. 0 N 
I / IU L,"\. I 
0.05 _ 
I 
I 
I 
I 
: ~" I 5.0 I I I ~ I 
I 
I 
o J_-I/ 
I ' 
I ' 10 I 
0 40 50 60 70 
Fraction Number 
Figure 2.6 TaG PURIFICATION:- ABSORBANCE = CONTINUOUS LINE 
RADIOACTIVITY = HISTOGRAN 
0 
\J 7% GEL -t 
(") 250 VOLTS 
2 J ~ 25m IIhr .-.. 0 I"V 
rT1 Tris/glycine; pH = 8. 7 \J1 Z 
V> I 
-
-t L 10 
-t I ~ 
-< I (") 
I"V f :3 00 "'Cl 0 I I ~ 
::J , I c: \J1 VJ 3 , I OJ I rr1 
J . , I X 
I I , .-.. 
I . , 0 I 
( , VJ 
I \ I \ I \ r I \ I 1 \ I I \ 
I \ " 
I , , 
, 
.... -
0 I .... ./ 
--- 0 - -------..,.,-----~ ...... -( =- -
10 20 30 . -- 40 Fraction Number (3m I) 
Figure 2.7 TBPA PURIFICATION:- PREPARATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS 
- 54 -
and were then dried and stained. The TBPA preparation was shown by these 
means to contain albumin as a contaminant in a concentration estimated to 
be less than 1% on a weight basis (Fig. 2.8a and 2.8b). The "TBG" 
preparation consisted of at least ten proteins, of which one was shown to 
be TBG by 125 1_T4 labelling although no stained peak was visible (Fig. 2.9). 
ii) Preparation of antisera 
a) Anti-TBG 
The purification of TBG for use as an antigen was achieved by the 
technique of coupling antigen and antibody in agarose gel. This method 
was first described and applied to production of anti-TBG antiserum using 
2-D1EP by Bradwell et al (1976). 
5 ~l of partially purified TBG was labelled with 1251_T4 and 
subjected to 2-D1EP against sheep antibody to human ac 1 fraction as above. 
After "wet" autoradiography the gel was washed for one week with 60 mM 
barbitone buffer pH 8.6, with daily changes of buffer. The electrophoresis 
plate was then aligned with its autoradiograph, and the area corresponding 
to the positon of the radioactive TBG peak (marked 'V' in figure 2.9A) 
was cut from the gel. The fragment of gel was then homogenised, mixed 
with 250 fl of Freund's complete adjuvant and injected intramuscularly 
into a sheep (sheep 1). After 10 days, the sheep received a booster 
injection of TBG/anti-TBG complex in agarose, without adjuvant. The sheep 
was bled after a further 10 days, and was found to contain antibodies to 
2 human serum proteins, one of which bound 1251_T4 , when examined by 2 D1EP 
and autoradiography (Figure 2.10). The TBG/anti-TBG complex formed when 
serum from sheep 1 was electrophoresed against partially purified TBG was 
isolated in agarose as outlined above, washed and used for immunisation of 
another sheep (sheep 2), using a similar protocol. After 20 days, sheep 2 
Was shown to have produced a high-titre monospecific antiserum to human 
a b 
Figure 2.8.a. & b. 
2 DIEP plate of 
purified TBPA 
against antibody 
to whole human 
serum: 
a) stained plate 
b) autoradiograph. 
Albumin contaminant 
is not visible on 
stained plate, but 
can just be seen on 
the autoradiograph. 
V'1 
V'1 
A 
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Figure 2.9 
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Figure 2.10 
" 
'" .. '. " 
, . 
, I 
TBG PREPARATION 
II 
B 
2 DIEP of partially purified TBG (obtained after 
polyacrylamide gel electrophoresis), run into antiserum 
from sheep '1'. Serum contains antibodies to 2 proteins 
visible on stained plate (A). TBG peak was identified 
by autoradiography (B), and was removed from the gel 
(area 'V') and used for further immunisation. 
- 58 -
TBG (Figure 2.11). 
b) anti-TBPA 
Purified TBPA obtained after step 'd' of fractionation was used as 
antigen. Approximately 200 pg of protein in 0.5 ml of 154 mM NaCl was 
emulsified with 0.5 ml of Freund's complete adjuvant, and injected intra-
dermally (~10 sites) into a New Zealand white rabbit. After one month, 
the procedure was repeated and two weeks after the second injection the 
rabbit was found to be producing a high-titre monospecific antiserum to 
human TBPA (Figure 2.12). 
The rabbits were bled from an ear vein, the blood was allowed to clot 
and centrifuged. Suitable rabbit anti-TBPA antisera were used without 
fUrther purification in the assay of TBPA, but the sheep anti-TBG was 
further purified to obtain a ~ globulin preparation by fractionation on 
a DEAE cellulose column (Tris/HCL buffer, pH 8.0, 40 mM) after dialysis 
for 24 hours against the same buffer. 
C) Development of assays 
The assays of TBG, TBPA and albumin were established using the 
monoroc~t immunoelectrophoretic technique described by Laurell (1966). 
The method utilises a 60 mM barbitone/sodium barbitone buffer, pH 8.6 
and 1% agarose gel, and resembles the 2nd dimension of the 2-DIEP 
described earlier in this chapter (Chapter 2.2.A.i.). 
Glass plates measuring either 8 x 15 cm or 8 x 24 cm were used, and 
were layered with a 1 mm thickness of agarose, containing a suitable 
Concentration of antibodies. The plates were placed on a levelling table 
prior to pouring; a high degree of precision was necessary in using the 
24 cm 1 t P a es because of the magnification of any errors in levelling. 
I 
I" 
I 
A 
r 
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Figure 2.11 
. .. 
': 1 
I 
I 
~ 
TBG PREPARATION 
'" 
I ~ 
2-DIEP of human serum against antiserum 
from sheep 2. Monospecific antiserum to TBG is 
revealed on the stained plate (A) and by auto-
radiography (B). 
- 60 -
Figure 2.12 
TBPA PREPARATION 
2 DIEP of whole human serum against monospecific 
anti-TBPA. Monospecificity and T4-binding were confirmed 
by autoradiography after labelling with 125I _T4 (not 
illustrated) • 
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It was also found necessary to warm the larger plates to ensure smooth 
layering of the agarose, and for this purpose a heated levelling plate was 
used, the level of which was checked daily. 
A series of wells 2 mm in diameter were punched in the agarose, 
approximately 1 cm from a long edge of the plate. A carefully measured 
amount (1 - 3 ~l) of sample or standard was dispensed into each well, 
Using a 10 fl Hamilton syringe and Chaney adaptor in a specially developed 
holder (Department of Experimental Pathology, University of Birmingham). 
Standards usually consisted of 100%, 75%, 50% and 25% dilutions of a 
standard serum, and were repeated at each end of the 15 cm plates (which 
accommodated 30 wells) and at the ends and middle of the 24 cm plates (which 
accommodated 50 wells). A potential of 2 V/cm was applied overnight across 
the plate by means of lint wicks moistened with buffer. The plates were 
dried and stained as described for the 2-DIEP plates with the results shown 
in figure 2.13. 
As described for the second dimension of 2-DIEP, peaks were formed 
on the plate when the antigen/antibody complexes were at equivalence. The 
area under the peak is directly proportional to the concentration of 
antigen. If the peaks are narrow, this area approximates to the height of 
the peak, and peak height has therefore been used in the past for protein 
quantitation by the monorocket method. However, slow-migrating proteins 
may undergo considerable lateral diffusion during the electrophoresis which 
al ters the relationship between peak height and antigen conce'ntration. 
p. / r~nce, Burnett and Ramsden (1977) showed that peak height (Y) was related 
to antigen concentration (X) by the formula: Y = a X b + k. The constants 
a, band k t 11 bl may be determined statis ica y using a programma e desk 
calculator (Wang 600), and dilutions of standard serum. The programme 
devised by Princ~ et al (1977) was used for calculation of TBG, TBPA and 
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Figure 2.13 
• 
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STAINED PLATE SHOWING MONOROCKET ELECTROPHORESIS 
FOR TBG ESTIMATION 
, 
, 
I 
, . 
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albumin concentrations. 
i) Autoradiographic assay for TBG 
Prior to the development of monospecific antiserum to TBG, the 
visualisation of the TBG peak during Laurell immunoelectrophoresis 
necessitated the use of autoradiographic techniques. The TBG peak had 
no special staining characteristics, and was thus "lost" among many other 
proteins migrating in theoC1 position (Freeman and Pearson, 1969). 
Nielsen et al (1972) described a monorocket lEP technique for TBG 
measurement using anti-whole human serum and 1251_T4 labelling prior to 
electrophoresis, followed by autoradiography. This method was improved by 
Drysdale et al (1975), who used an antibody-free 'starter' gel, and 
phosphate buffer (pH 7.4, 50 mM) to improve radiolabelling. These methods 
had the disadvantage of requiring individual radiolabelling of samples, by 
addition of 1251_T4 to each well. It was found that this could be avoided 
by incorporating 1251_T4 into the starter gel, and allowing radiolabelling 
of samples to occur during electrophoresis (Burr and Ramsden, 1977). 
Monorocket lEP was performed for 12 hours at 2 V/cm using 50 mM 
phosphate buffer, pH 7.4. A 'starter' gel (Figure 2.14) consisting of 1% 
agarose and 500 nCi/ml of high specific activity 1251_T4 , was poured in a 
1.5 cm x 1 mm strip along a long edge of the electrophoresis plate. 
Antibody-containing agarose filled the remainder of the plate. Antibodies 
Were either sheep anti-whole human serum CWellcome Reagents Ltd.) or sheep 
anti-human oC 1 fraction. 
It was found that 1251_T4 had a greater electrophoretic mobility than 
TBG in the buffer system used. Antigen wells (2 mm diameter) were therefore 
Punched approximately 5 mm from the starter gel/antibody gel interface, so 
that 125 I-T4 would flow past the samples during an electrophoretic run. 
ANTIBODY GEL. 
STARTER GEL~ 
CO NTAINS 
125 1 T4 
~ A n ~ Ann n ~ /1 II n ~ Ann A 1\ n ~ 1\ 1\ 1\ ~ 11 
o 0 0 0 0 0 0 0 - 0-0 0 0 (f()~O 0 0 00 {) -0 0 0 
Figure 2.14 
AUTORAD10GRAPH1C ASSAY OF TBG 
Monorocket plate in which serum 
samples contained in wells punched 
into antibody-free 'starter gel', 
containing 1251T4 , have been 
electrophoresed into antiserum to 
whole human serum. Exposure of 
X-ray film for 12 hours allows 
visualisation of the TBG peak only. 
0'\ 
.p. 
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Dried plates were subjected to autoradiography for 12 hours before rapid 
processing of the X-ray film. 
Measurement of a single standard in 13 consecutive assays gave an 
inter assay precision of 5.6%. The sensitivity of this technique was 
approximately 500 ng/l under routine conditions, although this could be 
increased by increasing the sample size. 
ii) Monospecific anti-TBG assay for TBG 
Development of the monospecific anti-TBG antiserum allowed direct 
visualisation of the TBG/anti-TBG complex on a stained electrophoresis 
plate (Figure 2.11). The assay was normally carried out on a 15 x 8 cm 
plate using a 1 fl sample as described previously. Precison with this 
method under routine conditions (Whitehead, 1977) was as follows: 
TBG CONCENTRATION 
(mg/l) 
6.4 
9.8 
14.4 
PRECISION 
13.1 
7.2 
6.3 
Sensitivity of the routine assay was 50~g/1. 
Development of the TBG assay had been accomplished without the 
isolation of pure TBG, and thus standardisation of the assay was required. 
There is no international standard for TBG, and the TBG assay was therefore 
standardised against that of Dr. M. C. Gershengorn of the Arthritis, 
Metabolism and Digestive Diseases Unit, National Institutes of Health, 
Bethesda, Maryland, U.S.A. (Gershengorn, Larsen and Robbins, 1976a). 
Dr. Gershengorn kiodly measured a working standard serum in duplicate, 
Obtaining results of 10.8 and 10.4 mg/l, a value of 10.6 mg/l was therefore 
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assigned to the standard. 
iii) TBPA assay 
This was initially established using commercial rabbit anti-human TBPA 
(Dakop atts), but owing to the prohibitive cost of this, a monospecific 
antiserum was produced as described above (Chapter 2.2.8.ii). 
Details of the assay are similar to those just described for the assay 
of TBG using monospecific antiserum. The assay was standardised against a 
standard serum (ORDT 03) obtained from Behring Diagnostic Reagents. 
Interassay precision was approximately 5%, using a 2pl sample size. 
iv) Albumin assay 
Because of the characteristic staining of the albumin peak and the 
enormous excess of albumin relative to other serum proteins, a monospecific 
antiserum was not essential for albumin measurement by monoroc ket IEP. 
Instead, suitable dilution of serum samples and use of a sheep antiserum to 
whole human serum (Department of Experimental Pathology, University of 
Birmingham) produced peaks in which albumin was almost always the dominant 
protein and easily measured. A serum dilution of 1 in 31 was found to be 
SUitable for a sample of 2fl. Interassay precision was approximately 4%. 
D) HORMONE ASSAYS 
i) T + 
..:.q. T} 
Serum T4 and 
of Medicine (Miss 
T3 radioimmunoassays were carried out in the Department 
E. G. Black). Unextracted serum was used and 8-anilino-
1-naphthalene sulphonic acid was added to inhibit hormone binding by the 
thyr . 
oXlne-binding proteins. Specific rabbit antiserum to T3 or T4 and 
125 
I-T3 or 1251_T4 were added. Polyethylene glycol (M.W. 6000) was used 
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to precipitate the immunoglobulins. The mixture was centrifuged (2500 x G) 
for 30 minutes, the supernate was removed, and the precipitate assayed for 
radioactivity in an automatic gamma-counter (Tracerlab Gammaset 500). 
Interassay precision was 7% for T3 (10 replicates) and 4% for T4 (8 replicates 
(Black et aI, 1975). 
Serum T4 was also assayed in the Department of Clinical Chemistry, 
QUeen Elizabeth Hospital, Birmingham (Dr. S. E. Evans). This assay 
differed mainly in the use of an anion exchange resin (Dowex-1, mesh 200-
400, 8% cross-linked, Sigma Chemical Co., London) to separate free hormone 
from antibody-bound (Evans, Burr and Hogan, 1977). 
ii) Reverse-T3 
Two assays for rT3 were used in different phases of the work to be 
described. 
At the University of Berlin (Klinikum Steglitz der Freien Universitat 
Berlin - Dr. H. Meinhold), the assay involved extraction of serum with 
absolute ethanol and a double antibody technique to separate bound and 
free rT R 3' elative cross-reactivity to T4 ranged from 0.025 to 0.1 %, and 
inter assay precision (6 samples, 3 replicates) was 11% (Meinhold, Wenzel 
and Schurnbrand, 1975). 
In the Department of Medicine, University of Birmingham, the rT3 assay 
(Griffiths, Black and Hoffenberg, 1976) utilised non-extracted serum and a 
dOUble-antibody separation. 50% displacement of rT3 occurred with addition 
of 4000 nmol/l of T4 , while 10% displacement occurred with 100 nmol/l of T4 • 
The . lnterassay precision was 9% (4 samples, 6 replicates). 
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iii) Serum TSH 
TSH was measured in a radioimmunoassay, using method and reagents 
supplied by the Arthritis, Metabolism and Digestive Diseases Unit, 
National Institutes of Health, Bethesda, Maryland, U.S.A. The method 
utilised a rabbit anti-human TSH, and sheep anti-rabbit 19G to separate 
bound from free TSH. Interassay precision was approximately 7%. 
iv) Free T3 and T4-
Percentage free T3 and T4 was measured in a method based on that of 
Lee et al (1964), in which free hormone is taken up on a column of Sephadex 
gel (G25). Small disposable columns were used, consisting of the barrel 
of an insulin syringe (Steriseal Ltd., Redditch, Worcester). A double 
isotope method with 125 I _T and 131 I _T labelling allowed simultaneous 3 4 
measurement of percentage free T3 and free T4 • Interassay precision 
(1 sample, 10 replicates) was 9% for free T4 and 7% for free T3 (Finucane 
and Griffiths, 1976). 
v) 13 uptake 
This was measured in the Department of Clinical Chemistry, Queen 
Elizabeth Hospital, Birmingham (Dr. S. E. Evans) using a commercial kit 
method (Thyopac 3, The Radiochemical Centre, Amersham, U.K.). The test is 
based on the partition of 125 I _T3 between serum thyroxine-binding sites 
and an adsorbent (Sephadex G25) at equilibrium. Results are expressed as 
a percentage of a standard serum (supplied with each kit). Precision was 
approximately 4% (Bold and Browning, 1975). 
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Chapter 3 TBG IN EUTHYROID PERSONS AND THOSE WITH THYROID DISEASE 
1 ) Individuals studied 
a) Euthyroid volunteers 
b) Euthyroid hospital in-patients 
c) Pregnant women 
d) Contraceptive pill users 
e) Dysthyroid patients : thyrotoxicosis and myxoedema 
2) Results 
a) Healthy volunteers and in-patients 
b) Effect of age on TBG concentration 
c) Effect of pregnancy and contracepti ve pill treatment 
d) Effect of thyroid disease 
3) Discussion 
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Chapter 3 TBG IN EUTHYROID PERSONS AND THE EFFECT OF AGE, 
OESTROGENS, PREGNANCY AND THYROID DISEASE 
1) INDIVIDUALS STUDIED 
TBG was measured in the following people:-
a) Euthyroid volunteers 
116 healthy, euthyroid persons (70 male, 46 female), comprising 
laboratory staff, medical students and Civil Servants (subjected to an 
annual biochemical profile as part of a health screen). 
b) Euthyroid hospital in-patients 
180 hospital in-patients (89 male, 91 female), who were euthyroid, 
and had a normal biochemical profile (serum creatinine, urea, sodium, 
potassium, bilirubin, aspartate aminotransferase, alkaline phosphatase, 
albumin, globulin, calcium, urate, cholesterol and glucose). 
c) Pregnant women 
18 pregnant women in the second and third trimesters of pregnancy. 
d) Contraceptive pill-users 
12 women who were taking oestrogen/progestogen contraceptive pills. 
A fUrther 5 women who were taking oral contraceptives and one regularly-
menstruating women who was not taking the contraceptive pill were followed 
seqUentially by blood samples taken every 2 - 4 days for 40 - 50 days. 
e) Qysthyroid patients - thyrotoxicosis and myxoedema 
101 patients with thyrotoxicosis and 36 patients with myxoedema, 
selected from patients attending the Thyroid Clinic, Birmingham General 
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Hospital, or in-patients at the Queen Elizabeth Hospital, Birmingham. 
Patients were all seen by the author. Diagnosis was made by clinical 
criteria and measurement of T4 and T3 uptake. Where necessary serum T3 
and TSH were measured, and occasionally the TSH response to TRH injection 
( 131 200 f g i.v.), and the suppression of thyroidal I uptake by T3 
administration (40 ~g, 3 times daily for one week) were assessed. 
A sub-group of 30 newly-diagnosed thyrotoxic patients were re-examined 
and blood taken after 3 months and 6 months of treatment with Carbimazole 
or Propylthiouracil. 
2) RESULTS 
a) Healthy volunteers and euthyroid in-patients 
TBG concentrations in the different groups studied are shown in 
Table 3.1. TBG concentration in healthy persons did not differ from the 
concentration in euthyroid in-patients. 
The TBG concentration in euthyroid females was 9% greater than the 
concentration in males, the difference being significant (P( 0.001 by 
StUdent's t-test, pregnant and oestrogen-taking individuals having been 
exclUded). 
The distribution of TBG concentrations in males was found to be normal 
by testing for kurtosis and skewness (Table 3.1), but the female population 
was shown to be skewed towards higher values of TBG, giving a logarithmic 
d" " lstrlbution. The combined population of males and females was also best 
described by a logarithmic distribution (Table 3.1 and Fig. 3.1). 
b) Effect of age 
The effect of age on TBG concentration is shown in Table 3.2. The 
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Table 3.1 
n Mean S.D. Kurtosis Skewness 
EUTHYROID cr+f(. 296 12.1 2.6 0.54 0.46 
log TBG 6'+~ 0.05 -0.22 
EUTHYROID cf" 159 11.6 2.6 -0.68 0.11 
log TBG d"' 
-0.51 -0.35 
EUTHYROID ~ 137 12.7 2.6 1.22 0.87 
log TBG ~ 0.37 0.16 
ORAL CONTRACEPTIVE ~ 12 16.7 2.8 
PREGNANT 18 24.9 3.9 
THYROTOXIC ~+ ~ 101 10.8 2.4 
MYXOEDEMA cf'+£ 36 14.7 2.4 
TBG CONCENTRATIONS (mg/l) 
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figure 3.1 
60 
4S 
40 
o 7 • $ 10 11 12 13 14 15 16 11 18 19 20 :>20 
TBG mgt. 
DISTRIBUTION OF TBG CONCENTRATION IN 
-
EUTHYROID HEALTHY I-1ALES Ar~D FEHALES 
• 
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Table 3.2 
AGE (years) 
MALE 
- 0 (5 5-10 11-20 21-30 31-40 41-50 51-60 61-70 71+ 
NUmber 6 10 .4 9 13 20 40 33 16 8 
Mean TBG 
(mg/l) 14.5 14.5 12.9 11 .6 10.7 11.3 11.2 10.8 11.9 12.6 
S.D. 2.2 1.8 1.7 2.8 2.6 2.6 2.2 2.0 2.9 3.3 
FEMALE 
--
Number 6 7 5 17 21 14 23 17 14 13 
Mean TBG 
(mg/l) 16.4 14.3 12.4 11 .9 13.0 12.2 13.0 11 .8 12.5 11.8 
S.D. 1.2 2.7 1.9 1.7 2.5 3.1 3.4 2.5 1.9 2.0 
t1f.LE + FEMALE 
Number 12 17 9 26 34 34 63 50 3U 21 
Mean TBG 
(mg/l) 15.5 14.4 12.6 11.8 12.1 11.7 11.9 11 .2 12.2 12.1 
S.D. 2.0 2.1 1.7 2.1 2.8 2.8 2.8 2.2 2.5 2.5 
AGE AND TBG CONCENTRATION IN 296 EUTHYROID INDIVIDUALS 
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population of 296 euthyroid individuals was divided into twenty groups, 
according to age and sex, and the TBG results subjected to analysis of 
variance. This showed that significant differences existed between 
different age groups, whether these were processed with regard to sex or 
irrespecti ve of sex (F < 0.0001). 
TBG was elevated in neonates and in children under the age of 5 years. 
In males, adult TBG concentrations were fairly constant from age 11 years 
until age 60 years, with a tendency towards higher concentrations in the 
Over-sixties. In females a slight increase in TBG concentration occurred 
in the 21 - 30 year group, with a slight decrease after the age of 50 years 
(Table 3.2). 
c) Effect of pregnancy and oral contraceptive therapy 
When compared with untreated euthyroid females, TBG was increased by 
a mean of 31% in oral contraceptive users and 96% in pregnant women 
(Table 3.1). These increases were both significant (p < 0.0005 by Student's 
t-test) • 
Sequential TBG concentrations of five oral contraceptive users and one 
regularly-menstruating woman are shown in figure 3.2, and the mean values 
at 3-day time intervals through the menstrual cycle are shown in figure 3.3. 
TBG concentrations at various times in the cycle were compared with the 
concentration for the same individual at other time~ by paired t-testing. 
The results are shown in table 3.3.a. TBG concentration was significantly 
lower on days 10 - 12 of the cycle than on days 1 - 3 or 25 - 28. 
The ~-time of TBG in serum during the decrease in concentration after 
withdrawal of oral contraceptives was calculated from the slope of TBG 
concentration when the rate of fall was maximal (Table 3.3.b.). The mean 
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Table 3.3.a 
SUBJECT DAYS OF CYCLE (DAYS 1 - 7 = NO PILL) 
1 - 3 10 - 12 25 - 28 
F.B. 14.4 11 .7 13.7 
D.H. 20.0 16.0 17 .8 
F.A. 16.4 15.9 17 .1 
C.1. 17.6 16.1 19.0 
J.K. 22.0 18.8 22.0 
Mean 18.1 15.7 17 .9 
S.D. 3.0 2.5 3.0 
Signi ficance : Days 1 - 3 vs days 10 - 12, P ( 0.01 
(Paired t-test): Days 25 - 28 vs days 10 - 12, P < 0.0025 
TBG CONCENTRATIONS (mg/l) IN ORAL CONTRACEPTIVE USERS 
Table 3.3.b 
SUBJECT MAXIMUM DECREMENT IN TBG (mg/l) t~ (days) 
F.B. 14.1 12.3 (2 days) 10.0 
D.H. 19.2 - 17 .8 (2 days) 18.3 
F.A. 15.9 - 14.6 (2 days) 16.3 
C.l. 18.3 - 16.1 (3 days) 16.2 
J.K. 17.8 - 15.9 (2 days) 12.3 
Mean 14.6 
S.D. 3.4 
~TIME IN SERUM AFTER INTERRUPTION OF ORAL CONTRACEPTIVE THERAPY 
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~-time was 14.6 days, with a range of 10 - 18.3 days. 
No alteration of TBG concentration occurred during the menstrual 
cycle of the woman who was not taking oral contraceptives (Figure 3.2). 
d) Effect of thyroid disease 
In myxoedematous patients, TBG was elevated by 26% compared to the 
euthyroid population (Table 3.1). This was a highly significant elevation 
(p < 0.0005) whether compared with the whole euthyroid population or with 
females only. In thyrotoxicosis, the TBG concentration did not differ 
significantly from that of the whole euthyroid population, but when 
compared with the euthyroid female population there was a mean reduction of 
12% (p < 0.0005). 
Figure 3.4 shows the effects of antithyroid therapy on TBG and T4 
concentrations in thyrotoxicosis. There was a mean rise in TBG concentration 
of 2.7 mg/l (24%) to a mean of 13.8 ~ 3.4 mg/l during the first three months 
of treatment, while serum T4 concentration fell from 234 + 73 nmol/l to 
109 ~ 53 nmol/l. After 6 months, when all subjects were euthyroid, TBG 
concentration was 14.2 + 3.9 mg/l (p < 0.0005 for TBG at 3 and 6 months 
compared with pre-treatment TBG by paired t-test). The greatest increases 
in TBG concentration [6.7 mg/l (60%), 7.2 mg/l (51%) and 5.1 mg% (40%)] 
Were observed in three thyrotoxic women who were on treatment with oral 
Contraceptives. 
3) 21SCUSSION 
A number of direct assays for TBG have been described in recent years 
(Table 3.4), and almost as many different normal concentrations for TBG 
have been cited, with values ranging from 7.4 mg/l (Wagner et aI, 1975) to 
TBG " ~280 Figure 3.4 14, 
........... * ~ AND TBG CONCENTRATIONS 
12[ ~ ~240 IN 30 THYROTOXIC PATIENTS 
DURI NG MED ICAL TREATMENT 
IO~ ~ ~'80 OF THYROTOXICOSIS WITH 
-
CARB IMAZOLE OR I , 
'- c:l 
-J 1160 0 0 '- 8 E PROPYLTHIOURACIL 0' 
-
E 
JI20 
c 
~ (see text for significance (!) 
CO 6 T4 J- ! values) • 
, 4r- ~80 
2 40 
2 3 4 5 6 
" Duration of treatment (months) 
Table 3.4 
AUTHOR AND YEAR *METHOD NUMBER SEX MEAN ~ S.D. (mg/l) FINDINGS 
S.E.M. 
Levy et al, 1971 RIA 51 cr+~ 34 Thyrotoxicosis T~G~ 
Myxoedema TBG ~ 
Chopra et aI, 1972 RDA 59 cf+!?- 28.5 + O.B (SEM) Thyrotoxicosis TBG~ 
Myxoedema 18G ·~ 
Wagner et aI, 1975 RIA 10 rf 7.4 + 1.4 (SD) Thyrotoxicosis T~G~ 
26 ~ 8.4 + 1.1 (SD) ClJ 
-> 
Cavalieri et aI, 1975 RIA 6 21.5 + 5.1 (SD) 
X --Bradwell et aI, 1976 IEP 24 ~ 11.0 + 2.B (SD) 
20 ~ 12.1 + 2.3 (SD) 
Gershengorn et aI, 1976 RIA 98 If'+Q. 14.8 + 4.6 (5D) Female> Male (21%) 
If 13. 7 :;- 3. 7 ( SD ) log-normal distribution 
~ 16.6 :; 5.6 (SD) in males and females 
X RIA 34 cJ'+~ 9.7 + 1.4 (SD) Thyrotoxicosis (mild) TljG t Hesch R. -D et aI, 1976a 
Thyrotoxicosis (severe) TBG-t 
Myxoedema TBG l' 
normal distribution 
X RD5 O'+~ 25.5 + 5.0 (SD) Thyrotoxicosis TBG-t.. Rudorff et aI, 1976 37 
Myxoedema 18G t 
Burr et aI, 1977 IEP 29 d' 11.2 + 0.5 (SEM) Thyrotoxicosis TBG..v 
13 ~ 12.5 :;- 0.8 (SEM) Myxoedema TBG l' Female/male difference 
not significant 
DIRECT ASSAYS OF TBG CONCENTRATION 
==~==_=_"".-----:-=-_."£_"'. -~\:i;-:-T~. . .... :,.".....-... !.~--~ Ift« .,....."~W&.==== . ..--........---. 
AUTHOR AND YEAR 
K~gedal and K~llberg, 1977 
X Bastomsky et aI, 1977 
Parslow et aI, 1977 
XMulaisho and Utiger, 1977 
Horn et aI, 1977 
Oe Nayer and Luypaert, 1978 
Kallner et aI, 1978 
Bisset et aI, 1978 
*METHOD 
RID 
ROA 
RIA 
ROA 
RIA 
RID 
RIA 
RIA 
Table 3.4 (Cont.) 
NUMBER SEX 
127 d" 
95 ~ 
155 ci"+ ~ 
95 
38 
35 
0' 
0' 
~ 
MEAN + S.D. (my/I) 
S.E.M. 
13.8 + 2.0 (SO) 
15.4 + 2.4 (SO) 
31.6 ± 5.4 (SD) 
36.5 + 7.8 (SO) 
32.0 + 6.0 (SO) 
~+ ~ 23.0 + 4.0 (SO) 
10 
18 
20 
29 
114 
r!' 
~ 
O'+~ 
tf 
Q. 
18.3 + 4.5 (SD) 
20.2 :; 3.3 (SO) 
16.2 + 3.2 (SO) 
20.4 + 4.3 (SD) 
21.3 + 3.7 (SD) 
FINDINGS 
Female> Male (12%) 
Female distribution skewed 
towards high values 
Male distribution normal 
Thyrotoxicosis Tl::jG.J., 
Myxoedema TBG t 
Normal distribution 
Thyrotoxicosis Tl::jG-7 
Myxoedema Tl::jG t 
Female/Male difference 
not signi ficant 
Thyrotoxicosis TBG ~ 
Myxoedema mG-7 
Female/Male difference 
not significant 
Female/Male difference 
not significant 
Thyrotoxicosis Tl::jG~ 
Thyrotoxicosis TBG-? 
Female/Male difference 
not significant 
CD 
N 
* RIA = Radioimmunoassay ROA = Radiodisplacement assay RID = Radial immunodiffusion IEP = Immunoelectrophoresis 
x Method standardised against another assay 
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36.5 mg/l (Parslow, Oddie and Fisher, 1977). Gershengorn et al (1976a) 
measured the maximum T4-binding capacity and TBG concentration (RIA) in 64 
normal individuals and calculated the T4 :TBG binding ratio. By assuming 
a molecular weight for TBG of 57,000 Daltons, and a 1:1 molar ratio of T4 
to TBG, they predicted a T4 :TBG binding ratio of 13.6 ~g T4/mg TBG, and 
actually observed a ratio of 13.8 ~ 0.5 ~g T4/mg TBG. They took this to 
be good evidence that their assay was providing a measurement of the actual 
TBG concentration. 
The assay used in the present studies was standardised against that 
of Gershengorn et al (1976a). The mean TBG concentration obtained by IEP 
measurement was 18% less than the normal mean found by Gershengorn. The 
difference may have arisen because of losses during lyophilisation and 
reconstitution of the standard serum or may be due to methodological or 
Population differences. 
The IEP assay for TBG described in this thesis did not involve the 
isolation of pure TBG. However, the purification of TBG is not 
accomplished easily, as evidenced by the nine protein contaminants 
persisting after the first four purification steps described in Chapter 
2.2.B.i. Several preparations of "pure" TBG, already in use for radio-
immunoassays, have been examined by 2 DIEP and shown to contain other 
proteins as contaminants (Bradwell, Burnett and Ramsden, 1978). Such 
Contamination could account for some of the higher TBG concentrations 
reported. Until an international standard for TBG is agreed upon, there 
would appear to be no cogent reason for f avouring any particular value of 
TBG. 
The finding of a 9% increase in TBG concentration in females compared 
to m 1 (-a es agrees with a previous report K~gedal and Kallberg, 1977) although 
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Gershengorn et al (1976a) found 20% higher values in females, and others 
have failed to identify a sex difference (Horn et aI, 1977; Mulaisho and 
Utiger, 1977; De Nayer and Luypaert, 1978; Bisset et aI, 1978). 
The explanation for the sex difference in TBG concentration almost 
certainly lies in the effect of oestrogens tending to increase TBG 
concentrations in the female (Dowling et aI, 1965a, b; Robbins and Nelson, 
1958), and of androgens tending to depress concentrations in the male 
(Federman et aI, 1958). The effects of oestrogens have been confirmed in 
the present study in oral contraceptive users and pregnant women. 
No effects of the physiological hormonal changes of the menstrual 
cycle were manifest on the TBG concentration of the one woman in whom this 
Was studied. Her TBG concentrations were rather low, which would tend to 
diminish the precision of the TBG measurements, and it is also possible that 
Some alteration of TBG concentration might have been revealed if this had 
been expressed relative to total protein rather than serum volume (Wagner, 
1978). Horn et al (1977) also failed to show an association between 
menstruation and TBG concentration but Drysdale et al (1975) reported that 
a peak of TBG concentration occurred at about the time of ovulation. However, 
an oestrogen-induced peak of TBG concentration might be expected to occur 
later in the menstrual cycle, since approximately 5 - 6 days are required 
for TBG concentration to reach a peak after ~-oestradiol administration in 
the rhesus monkey (Glinoer et al, 1977a), and oestrogen concentrations are 
also considerably raised during the luteal phase of the menstrual cycle 
(Hall et aI, 1974). 
Oral contraceptive therapy with oestrogen/progestogen mixtures has 
been reported in the past to cause TBG elevation (Musa et aI, 1967; Laurell 
et 1 . 
a , 1968), but only Drysdale et al (1975) have observed sequent~al TBG 
I 
II 
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alterations during therapy. They found that cessation of an oral 
contraceptive was associated with a slow decline of TBG, reaching minimum 
levels after 14 - 16 days. 
In the present study, oestrogens were not withdrawn completely, but 
merely stopped for 7 days. TBG concentration reached a minimum 
approximately 10 - 12 days after cessation of the oral contraceptive, and 
the mean half-life of TBG calculated during this time was 14.6 days. Since 
the half life of TBG in normals i~ 4 - 6 days (Cavalieri et aI, 1975; 
Refetoff et aI, 1976), and oestrogen treatment (in rhesus monkeys) affects 
mainly TBG synthesis rather than degradation (Glinoer et aI, 1977 a, b), 
it would seem likely that there is a lag effect of oestrogen on TBG 
synthesis persisting. for several days after oestrogen withdrawal. There 
may also be only a gradual increase in TBG synthesis after reintroduction 
of oestrogens, since TBG falls for 3 - 5 days after reintroduction of the 
contraceptive pill. This would be in contrast to the finding of Glinoer 
et al (1977a), who observed a rise in serum TBG concentration within 24 
hours of 17p-oestradiol treatment in monkeys. The difference may be due 
to the low dose of oestrogen in the contraceptive pill. 
An association between age and TBG concentration has been reported in 
the past (Hesch et aI, 1976a, b, 1977; Horn et aI, 1977). These authors 
found high TBG concentrations until puberty, with lower levels in adult life 
and a rise after age 60. In the present study, high TBG concentrations were 
found in the neonate, which persisted until the age of five and then fell 
between the ages of five and ten years. During early adult life, there was 
a tendency for a slight decrease of TBG in males, and an increase in females. 
After the age of 60, there was a tendency for TBG to rise, and this was 
more marked in males. The high TBG in neonates presumably resulted from 
intra-uterine exposure to high concentrations of oestrogen, but this could 
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not account for the persistence of raised TUG until the age of 5. The 
alterations in TBG concentration occurring in mature men and women can be 
explained on the basis of altered oestrogen and androgen concentrations 
after sexual maturity, and the rise in TBG in senescent men may be due to 
the decreased testosterone production which is known to occur in elderly 
males (Vermeulen et aI, 1972). 
High TBG concentrations in myxoedema have frequently been observed I! 
(Hesch et aI, 1976a; Rudorff et aI, 1976; Burr et aI, 1977; Bastomsky et aI, 
1977; Mulaisho and Utiger, 1977), but in making comparisons between 
myxoedematous and euthyroid patients it is important to make allowance for 
the preponderance of females in the myxoedematous population (Means, J. H., II 
1948). Since we have shown increased TBG in females, the myxoedematous 
POpulation may well have a higher TBG concentration than the combined male 
and female euthyroid controls on the basis of sex difference alone. For 
this reason, we have also compared myxoedematous patients with euthyroid 
females, and shown that significant differences persist. 
Failure to allow for sex differences between the dysthyroid and control 
POpulations may also account for the failure of some authors to demonstr ate 
decreased TBG concentration in thyrotoxicosis (Hesch et al, 1976a; Mulaisho 
and Utiger, 1977). The high proportion of women in the thyrotoxic 
POPUlation (DeGroot and Stanbury, 1975) justifies the comparison of this 
group also with euthyroid females. 
The results now presented clearly demonstrate a 24% increase in TBG 
Concentration during the first three months of medical treatment for 
thYrotoxicoSis. The persistence of TBG elevation after six months precludes 
the possibility that the TBG increase was due to the induction of transient 
hYPothyroidism , since by six months all patients were unequivocally euthyroid. 
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It is interesting to note that the most marked elevation of TBG 
concentration occurred in thyrotoxic women who were taking the contraceptive 
pill. Thyrotoxicosis is known to elevate serum concentrations of sex 
hormone-binding globulin (SHBG) (Cr~py et aI, 1967), and this may cause 
lowering of free oestrogen levels and reduced oestrogen effect. Lowering 
of SHBG concentration during treatment of thyrotoxicosis could lead to a 
rise in free oestrogen concentration with stimulation of hepatic TBG 
synthesis (Glinoer et aI, 1976). A similar mechanism of increased SHBG 
Causing reduced negative and positive oestrogen feedback has been suggested 
to account for the amenorrhoea of thyrotoxicosis (Anderson, 1974) and for 
the increased LH levels found in thyrotoxicosis (Chopra et aI, 1972; Akande 
and Anderson, 1975). However, these observations are incompatible with the 
observation of an increase in free oestradiol-17p in thyrotoxic men (Chopra 
et aI, 1972; Chopra and Tulchinsky, 1974), unless one postulates a sex-
difference in the effect of thyrotoxicosis on free oestrogen levels. This 
may be possible in view of the increased peripheral conversion of testosterone 
and androstenedione to oestrone and oestradiol reported in thyrotoxic men 
and women (Southren yt aI, 1974). 
Other factors may account for the apparent antagonism of oestrogen-
induced TBG synthesis in thyrotoxicosis. TBG degradation may be increased 
in thyrotoxicosis (Refetoff et aI, 1976) so that any increased synthesis 
does not lead to increased serum concentration, or thyroid hormones may 
eXert a direct inhibitory effect on hepatic TBG synthesis, which counter-
acts the oestrogen stimulation (Gershengorn et aI, 1976b). 
Further investigation, possibly using an in vitro system, would be 
necessary to resolve these questions. 
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Chapter 4 THE EFFECTS OF SURGERY, NON-THYROIDAL ILLNESS AND 
STARVATION ON THYROID HORMONES AND BINDING PROTEINS 
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~hapter 4 THE EFFECTS OF SURGERY, NON-THYROIDAL ILLNESS AND 
STARVATION ON THYROID HORMONES AND BINDING PROTEINS 
1) INTRODUCTION - AIMS AND DESIGN OF STUDIES 
The object of this work was to study the response of thyroid hormones, 
free thyroid hormones and thyronine-binding proteins to the relatively 
reproducible stress of a surgical operation. It was hoped that some 
insight would be gained into the alterations in thyroid hormone metabolism 
induced by surgical stress, and also that further information regarding 
the interactions of thyroid hormones, free hormones and binding proteins 
Would be gained. 
Having observed some dramatic changes in thyroid hormones and binding 
proteins after surgical operation in the first part of the study, the 
observations were extended to a group of patients suffering from acute 
mYOcardial infarction, to determine whether other types of illness could 
elicit similar changes. In addition, a group of patients undergoing 
therapeutic starvation was also studied, because the profound effect of 
diet on thyroid function (see Chapter 1.5.b.iii.) indicated that this was 
an essential control, especially for the surgical patients. 
2) fATIENT GROUPS 
Patients were all selected from the medical and surgical wards of the 
QUeen Elizabeth Hospital, Birmingham. Informed consent was obtained in 
eVery case. All were clinically and biochemically euthyroid. 
a) M . ~or surgery 
This group consisted of sixteen patients, who underwent elective 
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surgery of the type shown in Table 4.1.a. All patients in this group 
underwent general anaesthesia, which was usually induced with a short-
acting barbiturate such as thiopentone together with a myo-neural blocking 
agent such as suxamethonium, and was maintained with inhaled nitrous oxide, 
oXygen and halothane, together with pancuronium or D-tubocurarine. 
Patients were studied by means of blood samples (20 ml), taken at 
9.00 a.m. daily for one or two days pre-operatively and at six hours post-
operatively and then daily for 6 - 10 days. 
b) Minor surgery 
These patients (Table 4.1.b.) underwent more minor procedures than 
group a, and did not undergo opening of a body cavity. One patient (19) 
received local anaesthesia. 
c) ~ocardial infarction 
Thirteen patients were studied who had undergone recent acute 
mYOcardial infarction (MI). Criteria for inclusion in this group were 
as fOll ows :_ 
1) History of severe chest pain of less than 24 hours duration, with 
no antecedent history of angina pectoris or other chest pains. 
2) ECG evidence of acute MI. 
3) Elevation of serum aspartate aminotransferase. 
These patients were studied by 20· ml blood samples, taken as soon 
after admission to hospital as possible, and daily at 9.00 a.m. thereafter 
for ten days. 
d) ~vation 
Studies were performed in eight obese women volunteers, aged 21 - 53 
PATIENT AGE 
1 76 
2 74 
3 81 
4 36 
5 55 
6 62 
7 55 
8 71 
9 45 
10 57 
11 49 
12 31 
13 23 
14 68 
15 35 
16 31 
SEX 
M 
F 
F 
F 
F 
F 
F 
F 
F 
F 
M 
F 
F 
M 
F 
M 
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Table 4.1.a 
DIAGNOSIS 
Carcinoma of colon 
Carcinoma of head 
of pancreas 
Choledocholithiasis 
Polycystic kidneys 
Abscess of gall 
bladder 
Duodenal ulcer 
Gastric ulcer 
Cholecys ti tis 
Pyloric stenosis 
Gastric ulcer 
Duodenal ulcer 
Cholelithiasis 
Idiopathic thrombo-
cytopaenia purpura 
Fibrosarcoma of 
diaphragm 
Ulcerative colitis 
Duodenal ulcer 
OPERATION 
R. hemicolectomy 
& cholecystectomy 
Cholecystogastro-
stomy. Anterior 
gastro-jejunost-
omy 
Cholecystectomy 
choledocho-duo-
denostomy 
R. nephrectomy 
Cholecystotomy 
Vagotomy and 
pyloroplasty 
Partial gastrectomy 
Cholecystectomy 
appendicectomy 
Pyloroplasty 
jejunal biopsy 
Billroth I partial 
gastrectomy 
Vagotomy & pyloro-
plasty, appendic-
ectomy 
Cholecystectomy 
Splenectomy 
Excision of 
fibrosarcoma 
Pan-proctocolect-
omy & eversion 
ileostomy 
Vagotomy & pyloro-
plasty 
PATIENTS SUBMITTED TO "MAJOR" SURGERY 
COMMENT 
Gram negative 
septicaemia 
died day 16 
Heart failure 
days 0 - 4 
Renal transplant 
recipient, 
t aking Prednisone, 
25 mg daily 
Wound infection 
day 6 
Prednisolone 
12.5 mg daily 
PUO days 1 - 7 
- 92 -
Table 4.1.b 
PATIENT AGE SEX DIAGNOSIS OPERATION COMMENT 
17 75 tv! Malignant melanoma Excision of melanoma 
+ skin graft to R. 
ankle 
18 14 M Pubertal mammary Bilateral mastectomy 
hypertrophy 
19 78 M Femoral hernia Herniorrhaphy Local 
anaesthetic 
20 45 M Thyroid adenoma Excision of adenoma 
21 16 M Pubertal mammary Bilateral mastectomy 
hypertrophy 
PATIENTS SUBMITTED TO "MINOR" SURGERY 
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years, whose body weights ranged from 34 - 140% above the ideal. All were 
clinically euthyroid, but one had an elevated basal TSH of 11 mUll and low 
normal T4 :TBG ratio (Burr et aI, 1979) suggesting a degree of thyroid 
failure. They were hospitalised and completely fasted for 4 days, during 
which they drank only a minimum of 2 litres tap water daily. Blood samples 
were taken at 9.00 a.m. daily. 
3) MEASUREMENTS AND STATISTICAL ANALYSES 
Group a) - Major surgery 
T3, T4 (Black et aI, 1975), TBPA and albumin were measured in all 
patients. For logistic reasons such as insufficient sample or non-
availability of assay, some tests could not be performed on all samples:-
TBG was measured in 13 patients (except patients 7 
TSH was measured in 11 patients (except patients 7 
9 inclusive) 
9, 12 and 13) 
% Free T3, % free T4 were measured in 11 patients (except patients 
12 - 16 inclusive) 
rT3 (Dr. H. Meinhold) was measured in patients 3, 12, 14, 16 ( group a) 
and 21 (group b) 
Group b) - Minor surgery 
Serum T3 , T4 and TBPA were measured in this group. 
Group c) - Myocardial infarction 
Albumin was not measured in these patients. 
% Free T3 and % free T4 were measured in 9 patients and rT3 in only 2. 
Group d) - Starvation 
T3, T4 , rT3 (Griffiths et aI, 1976), TSH, TBPA, TBG and albumin were 
measured in all samples. Free hormone concentration was not measured 
- 94 -
directly, but was computed from total hormone and binding protein 
concentrations by the method of Princ~ and Ramsden (1978). Serum 
acetoacetate (Miss S. A. Nutter, Biochemistry Department, General Hospital, 
Birmingham) was measured by the method of Price, Lloyd and Alberti (1977), 
with the exception that spectrophotometric measurements were made at 25° C 
with a Cecil Ultraviolet Spectrophotometer CEo 292 (Cecil Instruments Ltd., 
Milton Industrial Estate, Cambridge, U.K.). Absorbance readings at 340 nm 
Were taken at 0 mins and 1 min after addition of 3-hydroxybutyrate 
dehydrogenase, and the rate of change of absorbance calculated. The assay 
had an intra-assay precision of 4% at a plasma acetoacetate concentration 
of 0.2 mmol/l, and 3% at a plasma acetoacetate of 0.4 mmol/l. All samples 
from a single individual in sections a, b, c, and d above were measured 
in the same assay. 
All statistical analyses in this section were by means of paired t-test, 
comparing baseline and pre-operative or pre-fasting values with samples 
obtained on subsequent days. In the case of individuals suffering from 
mYOcardial infarction, no true baseline reading could be obtained, and 
initial samples were taken as soon after hospital admission as possible, 
and not ' later than 24 hours from the onset of symptoms. 
4) ~SULTS (mean figures + one standard deviation are given, and full 
results are tabulated in appendices H, C, D and E). 
a) ~or surgery (Tabulated results: appendix B) 
~rum T4 (fig. 4.1) 
Mean pre-operative T4 was 131 + 32 nmol/l. At 24 and 48 hours after 
operation, mean values of 123 + 38 and 125 + 29 nmol/l were obtained 
(p < 0.05) with subsequent return to pre-operative concentration. 
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Serum T3 (Fig. 4.1) 
Serum T3 fell rapidly and profoundly. Mean pre-operative concentration 
was 2.0 + 0.5 nmol/l, 6 hours post-operative was 1.5 ~ 0.3 nmol/l (P < 0.01), 
and 24 hours was 1.1 + 0.5 nmol/l (p < 0.0005). The concentration remained 
low for several days, with a nadir on day 5 (50% fall). On day 6, T3 began 
to increase, but on the seventh post-operative day, there was still a mean 
reduction of 27% (p < 0.025). 
Percentage Free T4 (%FT4) and Absolute Free T4 (AFT4 , figs. 4.2 and 4.3) 
Mean pre-operative %FT4 was 0.04 ~ 0.01, with an increase after 
operation which was significant by day 2 (0.05 ~ 0.01, P < 0.005), and was 
maintained until day 6 (0.05 + 0.01, P < 0.05). The maximum increase of 
33% occurred on day 3. 
AFT4 concentration tended to parallel the changes in %FT4• Mean pre-
operative concentration was 52 + 15 pmol/l, and a significant increase to 
66 ~ 27 pmol/l occurred on day 2 (p (0.025), and was sustained until day 6 
(63 ~ 17 pmol/l, P (0.05). A peak increase of 27% was reached on day 3. 
Percentage Free T3 (%FT3) and Absolute Free T3 (AFT3, figs. 4.2 and 4.3) 
The %FT3 pre-operatively was 0.29 ~. 0.06, and increased after 6 hours 
(0.36 ~ 0.09, P < 0.01) to reach a peak on day 2 (0.41 ~ 0.11, p( 0.0025), 
at which time there was a 41% increase above pre-operative. Following this 
there was a gradual fall, so that by day 6, %FT3 was no longer elevated. 
AFT3 decreased in spite of the increased %FT3• Pre-operative 
concentration was 5.5 + 1.0 pmol/l, falling to 3.6 ~ 1.3 pmol/l after 24 
hours (p< 0.0025). After 2 days, there was partial recovery of AFT3 
concentration, but the concentration remained less than pre-operative even 
after 6 days (4.1 + 1.5 pmol/l, p( 0.05). 
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TBG (Fig. 4.4) 
There was a slight reduction of TBG post-operatively, from 13.7 ~ 
2.6 mg/l to 12.9 + 2.6 mg/l on day 1 (P < 0.05) and to 12.4 ~ 2.2 mg/l on 
day 3 (p( 0.01), representing a 9% reduction compared to pre-operative 
concentration • 
.!§£A (Fig. 4.4) 
A profound and rapid fall in TBPA concentration was found. Pre-
operative TBPA was 210 + 84 mg/l, falling to 165 ~ 63 mg/l after 6 hours 
(p < 0.025) and to 164 + 61 mg/l after 24 hours (p( 0.0005). The nadir 
Was reached on day 2, at which time a 52% decrease had occurred. The 
concentration was still reduced when measurements ceased on day 8 
(111 + 58 mg/l, P < 0.0025). 
~bumin (Fig. 4.4) 
Albumin fell gradually until the sixth post-operative day. Pre-
operative concentration was 38 ~ 8 g/l, day 1 - 36 ~ 8 g/l (P< 0.01), 
day 6 - 30 + 8 g/l (p < 0.0005). A mean reduction of 22% was found on 
day 6. 
TSH 
~-
Serum TSH was 1.7 + 0.9 mU/l pre-operatively and no change was 
observed post-operatively. 
!:l.3 (Fig. 4.5) 
As mentioned previously, rT3 measurements were made on a sub-group of 
5 patients. There was a significant increase for the first 3 days after 
operation, from 0.40 ~ 0.13 nmol/l pre-operatively to a maximum of 0.68 + 
0.13 nmol/l on day 2 (p( 0.0025). Figure 4.5 shows rT3 results for five 
patients, with T3 results from the same individuals. 
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Figure 4.5 
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A summary of the main findings after major surgery is given in 
Table 4.2. 
Effect of overwhelming illness 
One patient in the major surgery group (patient 1) developed intra-
abdominal sepsis post-operatively, and died of gram-negative septicaemia 
on the sixteenth post-operative day. Thyroid function tests in this patient 
differed from other surgical patients and are shown separately in Fig. 4.6. 
T3 fell profoundly in this man, and became undetectable ( < 0.3 nmol/l) 
on the fifth day. TBPA fell from 264 mg/l pre-operatively to 19 mg/l on 
day 8, and T4 and TBG both fell by approximately 50% by the eighth day. 
b) ~inor surgery (Tabulated results: appendix C) 
Figure 4.7 shows the T3 and TBPA results after minor surgery and after 
major surgery. For statistical comparisons, the percentage changes from 
pre-operative concentration were compared by unpaired t-test. After 2 days, 
there was a 17% reduction in TBPA concentration after minor surgery, 
compared to 50% reduction after major surgery (P < 0.0025). A statistical 
difference was found from days 2 - 5 inclusive. 
Serum T3 fell by a mean of 15% on the third day after minor surgery, 
compared to a fall of 42% after major surgery (p( 0.005), an~ a statistical 
d' lfference was found from days 3 - 5 inclusive. 
c) ~ocardial infarction (Tabulated results: appendix D) 
Serum T (F ) ~ 4 ig. 4.8 
On the day of admission, T4 was 140 + 40 nmol/l, and a slight reduction 
occurred on the following day, with a nadir reached on day 4, (119 ~ 28 
nmol/l, P (0.05). T4 rose after this, to reach pre-illness concentration 
by day 8 (134 + 32 nmol/l, NS). 
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Table 4.2 
DAY 0 = DAY OF OPERATION 
MAXIMUM CHANGE 
T4 J, DAYS 1, 2 J, 6°' , 0 (DAY 1) 
%FT 4 l' DAYS 2 - 6 l' 36 ~~ (DAY 3) 
AFT4 l' DAYS 2 - 6 1- 27% (DAY 2, 3) 
T3 
-J, 6 hrs, DAYS 1 - 8 ~ 49% (DAY 5) 
~~FT 3 l' 6 hrs, DAYS 1 - 5 l' 41 ~~ (DAY 2) 
AFT3 J" DAY 1, 3 - 6 ~ 42~~ (DAY 5) 
rT3 l' DAYS 1 - 3 1- 70% (DAY 2) 
TSH NO SIGNIFICANT CHANGE 
TBPA 
-.i- 6 hrs, DAYS 1 - 8 -t 52% (DAYS 2 - 4) 
TBG 
-J" DAYS 1 - 4 t 9°' , 0 (DAY 4) 
ALBUMIN ~ DAYS 1 - 7 t 2m~ (DAYS 2, 5, 6) 
SUMMARY OF FINDINGS AFTER MAJOR SURGERY 
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figure 4.7 
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Figure 4.8 
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~erum T3 (Fig. 4.8) 
T3 fell after infarction from the admission level of 2.4 + 0.6 nmol/l 
to 1.9 + 0.6 nmol/l after two days (P (0.025). The nadir was reached on 
day 4 (1.7 + 0.6 nmol/l, P ( 0.0025) at which time a mean reduction of 29% 
had occurred. There was a gradual recovery following this, although T3 
concentration was still reduced on day 9 (1.8 ~ 0.3 nmol/l, P < 0.05). 
~~ FT ( ) 4 and AFT4 Fig. 4.8 
There was no significant alteration in either %FT4 or AFT4 after 
infarction. 
_
%FT3 and AFT3 (Fig. 4.8) 
%FT3 did not alter significantly after infarction, so that AFT3 
concentration fell in parallel with the total T3• The admission AFT3 was 
7.8 ~ 2.2 pmol/l falling to 5.4 ~ 1.2 pmol/l the following day (P < 0.05) 
and to a nadir of 5.0 ~ 1.1 pmol/l on hospital day 3 (P < 0.005). Following 
this AFT3 returned towards the admission concentration. 
~um TSH 
TSH on admission was 2.1 + 2.7 mull and was unchanged after myocardial 
infarction. 
~ (Fig. 4.9) 
TBPA was 262 + 39 mg/l. A significant reduction occurred on day 2, 
and low concentrations persisted until observations ceased on day 9. The 
lowest TBPA concentration was found on day 5 (136 ~ 45 mg/l, P < 0.0005). 
~m T UBLlG (F' 4 9) 
-----.;::. 1 g • • 
Serum TBG on admission ' was 11.7 ~ 2.4 mg/l and no significant change 
occurred after myocardial infarction. 
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Figure 4.9 
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rT3 (Fig. 4.10) 
This was only measured in two patients. In both there was a rise in 
rT3 concentration for up to four days after admission, while T3 fell on 
day 2, and then gradually increased. Marked fluctuations of T4 in one 
patient may have been due to volume changes during treatment of cardiac 
failure. Because of this, T3/T4 and rT3/T4 ratios are shown (Fig. 4.10). 
The findings after myocardial infarction are summarised in Table 4.3. 
d) Starvation (Tabulated results: appendix E) 
~etoacetate 
Acetoacetate concentration rose progressively in all subjects, 
confirming compliance with the fast. There was an inverse correlation 
between serum T3 and acetoacetate (group correlation r : 0.84, P < 0.0005) 
and a direct correlation between acetoacetate and rT3 (group correlation 
r = 0.77, p( 0.005). 
~'_T3~T3 (Fig. 4.11) 
Basal serum T4 was 130 ~ 31 nmol/l, and no significant change occurred 
during a 4-day fast (123 + 27 nmol/l). Serum T3 was 3.2 ~ 0.6 nmol/l 
basally, falling to 2.8 + 0.6 nmol/l after 24 hours (P( 0.05) and to 
1.9 ~ 0.4 nmol/l after 4 days (p < 0.0005). Basal rT3 was 1.0 ~ 0.1 nmol/l, 
rising to 1.5 + 0.3 nmol/l after 4 days' fasting (p( 0.0025)~ Fasting 
reSulted in a 41% reduction in T3 and a 54% increase in rT3 • 
~TBPA and albumin (Fig. 4.12) 
TBPA was reduced after 24 hours (basal: 392 ~ 77 mg/l, 24 hours: 
387 ~ 65 mg/l, P( 0.05) and fell by a mean of 28% to 281 ~ 38 mg/l after 
4 days (p (0.0005). TBG fell by a mean of 9% after 4 days (basal; 15.3 + 
2.7 mg/l, 4 days: 13.9 + 2.1 mg/l, P( 0.005). Serum albumin was not 
diminished by fasting. 
10 
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Table 4.3 
DAY 1 = ONSET OF INFARCTION 
MAXIMUM CHANGE 
T4 ~ DAYS 4, 5, 7 J,- 15 ~~ (DAY 4) 
~oFT 4 NO SIGNIFICANT CHANGE 
AFT4 NO SIGNIFICANT CHANGE 
T3 J, DAYS 3 - 9 J- 29% (DAY 4) 
~~FT 3 NO SIGNIFICANT CHANGE 
AFT3 J" DAYS 2 - 5, 8 ~ 35~o (DAY 3) 
rT3 t (?DAYS 2 - 5) 
TSH NO SIGNIFICANT CHANGE 
TBPA t DAYS 2 - 9 ~ 48~o (DAY 5) 
TBG NO SIGNIFICANT CHANGE 
SUMMARY OF FINDINGS AFTER MYOCARDIAL INFARCTION 
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Figure 4.11 
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Figure 4.12 
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~T3 and AFT4 (Fig. 4.13) 
Calculated free T4 was unchanged for the first 3 days of fasting and 
rose slightly on the fourth day (basal = 35 ~ 16 pmolll, day 4 = 39 + 16 
pmol/l, P (0.025). AFT3 was 7.0 + 2.2 pmolll before fasting, falling to 
5.6 ~ 1.9 pmolll after 24 hours (p < 0.025) and to 4.8 ~ 1.7 pmol/l after 
4 days (p( 0.0025). 
TSH 
--
TSH was significantly reduced on the second and third days of fasting, 
from a basal concentration of 5.3 ~ 4.0 mUll, to 2.6 + 1.5 mUll on day 2 
(p < 0.025) and 2.7 + 1.5 mUll on day 3 (P( 0.05). On day 4 there was a 
return towards pre-fasting concentration, and no longer a significant 
difference from basal values (3.4 + 1.9 mUll). 
The major findings during starvation are shown in table 4.4. 
Qg;CUSSION 
Although the patients investigated in this study underwent a variety 
of stressful stimuli, including surgery of variable severity, myocardial 
infarction and complete starvation, reference to tables 4.2 - 4 reveals 
that the various stresses induced remarkably similar alterations i n thyroid 
hormones and binding proteins. In order to simplify discussion of these 
changes, the effects of surgery on individual hormones and binding proteins 
will be mentioned in turn, together with any specific alterations noted 
after myocardial infarction or starvation. 
Reduction in TBPA after surgery has been noted in the past (Mi nchin-
Clarke et aI, 1971; Aronsen et aI, 1972; Kirby et aI, 1973; Wandall, 1974; 
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Table 4.4. 
MAXIMUM CHANGE 
T4 NO SIGNIFICANT CHANGE 
AFT4 1- DAY 4 t 15~6 (DAY 4) 
T3 ~ DAYS 1 - 4 ~ 41 % (DAY 4) 
AFT3 Jr DAYS 1 - 4 J.,- 3H6 (DAY 4) 
rT3 l' DAYS 2 - 4 t 50% (DAY 4) 
TSH ~ DAYS 2 - 3 .Jr 51~6 (DAY 2) 
TBPA ~ DAYS 1 - 4 J 28~6 (DAY 4) 
TBG ~ DAY 4 t 9 ~6 (DAY 4) 
ALBUMIN NO SIGNIFICANT CHANGE 
SUMMARY OF FINDINGS AFTER STARVATION 
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Ramsden et aI, 1979). Decrease in TBPA has been noted after anaesthesia and 
prior to skin incision (Wandall, 1974), and in the present study, a 12% fall 
Was noted by the time of the first post-operative sample after 6 hours. The 
TBPA reduction is by no means unique to surgery, and has been noted in 
chronic illness, after myocardial infarction and after fasting (see Chapter 
1.S.b.). Calorie withdrawal alone seems to account for only part of the 
TBPA change after surgery, since a complete fast for 4 days caused only a 
28% reduction in TBPA, while "major" surgery caused a S2 ?~ reduction, minor 
surgery 23% and myocardial infarction 48%. It is not known whether tissue 
injury or inflammation contribute to the TBPA change, and the role of 
catecholamines has not been investigated. The adrenocortical response to 
stress is unlikely to be a causative factor since synthetic steroids cause 
an increase in TBPA concentration (Oppenheimer and Werner, 1966; Burr et aI, 
1976). 
Studies using radio-iodinated purified TBPA have shown that the low 
concentrations after surgery and illness are probably due to reduced 
/ 
synthesis (Socolow et aI, 1965; Prince, 1978). 
Binding capacity measurements of TBG have been reported to show no 
conSistent alteration after operation (Surks and Oppenheimer, 1964; Kirby 
et aI, 1973), while a number of studies have claimed that the number of T4-
TBG binding sites (measured as resin uptake) is reduced after surgery 
(Brandt et aI, 1976; Adami et aI, 1978; Prescott et al, 1979). The above 
tests are either insensitive, indirect, or both, and cannot be considered 
to be strong evidence against the present finding of a slight (9%) but 
def o 0 lnlte post-operative reduction of TBG. No change of TBG concentration 
was found after myocardial infarction, but starvation caused a similar 
decrease to that found after surgery. In surgical patients, intravenous 
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fluid therapy and post-operative fluid retention may have contributed to 
the reduced TBG concentration. There have been no kinetic studies of TBG 
metabolism after surgery, although increased catabolism with normal TBG 
synthesis was found in one severely ill patient (Refetoff et aI, 1976). 
Reduced TBG concentration has been described previously in severe illness 
(Harvey, 1971), and a 50% reduction was noted eight days after surgery in 
a septicaemic patient in this study. 
~bumin 
A 22% reduction in serum albumin was found after surgery, and similar 
Changes have been reported previously after surgery (Birke et aI, 1959; 
Mouridsen, 1967), and in infection (Grossman, Yalow and Weston, 1960). The 
catabolic rate of albumin has been found to increase after operation 
(Birke et aI, 1959), although Mouridsen (1967) found no change in catabolic 
rate, and attributed the fall in concentration to a shift into the extra-
vascular space, especially the wound area. 
It seems probable that the reduction in albumin concentration is 
mediated, at least in part, via the action of adrenal corticosteroids 
(Grossman et aI, 1960). 
A slight post-operative reduction of T4 was found, and has been 
observed in some other studies (Adami et aI, 1978; Chan et aI, 1978). It 
has been suggested that the fall in T4 is due to reduced thyroidal secretion, 
(Chan et aI, 1978) but another explanation would be that the T4 reduction 
is secondary to the reduction of TBG concentration which occurred at the 
same time. 
It appears that T4 may undergo different responses after surgery 
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compared to those found after other stresses. Harland et al (1972a) found 
that T4 production rate was increased after surgery, while no increase 
occurred after myocardial infarction (Harland et aI, 1972b). These results 
have to be interpreted with caution, since certain anaesthetic agents, 
notably halothane, may have profound effects in displacing T4 from protein 
binding sites (Oyama, 1973), and in addition it has been suggested that 
anaesthetic agents may cause large alterations in T4 distribution between 
intravascular and extravascular fluids (Adami et aI, 1978; Chan et al, 1978). 
In the present study, there was a slight reduction in T4 concentration 
after myocardial infarction, although no change in TBG occurred. Starvation 
caUsed no significant change in T4 • 
I., + rT 
'J --- 3 
The marked changes in T3 and rT3 concentration found in the present 
study after surgery, myocardial infarction and starvation confirm the 
reports of many other groups with respect to changes in acute and chronic 
illness and malnutrition, after surgery, and after fasting (see Chapter 
1.5.b.). 
Kinetic studies of T4 , T3 and rT3 metabolism in the above situations 
SUggest that the changes result from diminished T3 production, together 
W"t 
1 h normal or increased rT3 production, and diminished rT3 degradation 
(Chopra, SaCKS and Fisher, 1975; Vagenakis et al, 1977; Eisenstein et al, 
1978; Suda et al, 1978). 
The results are compatible with the suggestion that there are 
separate deiodinases for thyroxine, acting at the 5' position to produce 
T3 from T4 and 3, 3' T2 from rT3' and at the 5 position to produce rT3 
from T4 and 3, 3' T2 from T3• Relative inhibition of the 5'-deiodinase 
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would lead to the changes described above. 
With regard to the reduction of T3 and increase of rT3 after surgery, 
it has been suggested that adrenocortical steroids might be responsible, 
since pharmacological doses of corticosteroids induced similar changes 
(DUick et aI, 1974; Burr et aI, 1976). However, this suggestion became 
untenable when Brandt et al (1976) showed that the changes of thyroid 
hormone s after surgery occurred with epidural anaesthesia, which blocked 
the cortisol response to surgery. The above authors speculated as to the 
role of psychic stress or of increased catecholamines in causing altered 
thyroid hormone metabolism. 
Another factor of possible aetiological significance, which was given 
little consideration in earlier studies, is that of altered dietary intake. 
In the present study, T3 was decreased by 49% after major surgery, by 25% 
after minor surgery, by 29% after myocardial infarction and by 41 % after 
fasting. The calorie intake of surgical and myocardial infarction patients 
Was not monitored, but it seems likely that major surgical patients would 
have been fasted completely for up to sixteen hours, whereas myocardial 
infarction and minor surgery patients would have had some reduction of 
calorie intake. The findings of the present study therefore raise the 
POSSibility that the low T3 concentrations after surgery and myocardial 
infarction may be due entirely to reduced calorie intake (Davidson and Chopra, 
1979). However, further analysis of the timing of T3 changes in relation to 
Surgery and fasting, shows that T3 was reduced by 25% within 6 hours of major 
Surgery, while starvation resulted in only a 12.5% fall after 24 hours. 
The timing of T3 changes after surgery and infarction would therefore suggest 
that there are additional influences apart from simple calorie withdrawal. 
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f~T3 and free T4 
A marked increase in percentage free T4 and in free T4 concentration 
Was found post-operatively, and confirmed previous reports (Surks and 
Oppenheimer, 1964; Kirby et aI, 1973; Chan et aI, 1978; Prescott et aI, 
1979). This was also consistent with the findings of Ramsden et al (1979), 
Who found an increase in urinary T4 after surgery which may have resulted 
from an increase in free hormone. The increased free T4 after surgery has 
been attributed to the low TBPA concentration (Surks and Oppenheimer, 1964), 
although other workers have maintained that additional factors must be 
invoked to account for such a marked increase (Kirby et aI, 1973). 
Increased free T in some illnesses has been attributed to the presence of 4 
inhibitors of T4 binding (Lutz et aI, 1969), and it may be pertinent to 
seek for evidence of such inhibitors after surgery. In order to do this, 
the measurements of total T3 , T4 , TBPA, TBG and albumin in the surgical 
patients have been used to derive predicted values of free T3 and free T4 
concentration, using a computer-based model of thyroid hormone - TBP inter-
action (Princ' and Ramsden, 1977). These results were then compared with 
actual free hormone measurements obtained in the same sera by the method 
of Finucane and Griffiths (1976). 
The results are given in Table 4.5. This shows that although there 
is a systematic difference between measured and predicted concentration, 
especially with respect to free T4 , when the respective percentage changes 
are compared, there is remarkably good agreement. This suggests that the 
binding protein changes are sufficiently large to account directly for 
Changes in free T4 and free T3 , without invoking the presence of binding 
inhibitors. After myocardial infarction, there were no significant changes 
in measured free T4 , and only slight changes were predicted by the computer 
mOdel (Table 4.5). Direct measurements of free hormone were not made after 
starvat" f f T 1 ltd lon, but a significant increase 0 ree 4 was ca cu a e on day 4. 
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Table 4.5 
SURGERY AFT4 
TIME MEASURED PREDICTED MEASURED PREDICTED M* 
pmol/l pmol/l ~~ CHANGE ~~ CHANGE pmol/l 
0 52.4 44.6 5.5 
6 hrs 67.4 55.6 +29 +25 5.4 
Day 1 57.0 46.1 + 9 + 3 3.6 
" 2 65.8 55.5 +26 +24 4.5 
" 3 66.3 55.9 +27 +25 4.0 
" 4 63.6 52.1 +21 +17 3.6 
" 5 62.9 55.9 +20 +25 3.2 
" 6 63.3 59.2 +21 +33 4.1 
MYOCARDIAL INFARCTION 
Day 1 59.5 54.9 7.8 
" 2 60.8 51.6 + 2 - 6 5.4 
" 3 57.7 54.2 
- 3 -13 5.0 
" 4 67.3 50.4 +13 
- 8 5.6 
" 5 69.2 52.0 +16 
- 5 5.2 
" 6 53.0 
- 3 6.2 
" 7 64.2 52.1 + 8 
- 5 5.7 
" 8 62.5 53.0 + 5 
- 3 5.5 
* M Measured P Predicted 
~ISON BETWEEN ME~SURED AND PREDICTED FREE T4 AND FREE T3 
~NTRATION AFTER SURGERY AND MYOCARDIAL INFARCTION 
AFT3 
P M P 
pmol/l 0 1 0 1 10 10 
5.4 
4.8 
- 2 -11 
3.3 
-35 -39 
4.2 
-18 -22 
3.8 -27 
-30 
3.6 -35 -33 
3.5 -42 -35 
4.9 -25 
- 9 
7.9 
6.7 -31 -15 
6.3 -36 -20 
5.8 -28 
-27 
5.8 -33 -27 
6. 6 -21 
-13 
6.2 -27 
-22 
6.0 
- 29 
-24 
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Measured and predicted free T3 concentration were reduced after surgery, 
infarction and starvation, and this occurred in spite of an increase in 
percentage free T3• 
No change in TSH concentration occurred after surgery in the present 
stUdy, and this is in agreement with several previous reports (Kirby et aI, 
1973; Chan et aI, 1978; Prescott et aI, 1979). An early (12 - 24 hour) 
post-operative reduction of TSH was however noticed by Charters et al (1969) 
and by Kehlet et al (1979). A significant reduction of TSH on the second 
and third days of fasting was noted in the present study, and there is 
considerable conflict in the literature regarding the effect of starvation 
on TSH. No change in basal TSH was found by several groups (Port nay et aI, 
1974; Carlson et aI, 1977; Merimee and Fineberg, 1977), while reduced 
basal TSH was noted in other studies (Rothenbuchner et aI, 1973; Croxson 
et al, 1977; Palmbl ad et aI, 1977; Azizi, 1978). Conflicting TSH results 
have also been reported after TRH injection during fasting. The response 
has been found to be normal (Portnay et aI, 1974; Gardner et aI, 1979) or 
reduced (Vinik et aI, 1975; Carlson et aI, 1977; Azizi, 1978). In spite of 
the conflicting results reported above, it is evident that both the TSH 
basal concentration and response to TRH injection in fasting are either 
normal or reduced, but are nevertheless inappropriate for the marked 
reduction in free T3 concentration which occurs. The same is also true of 
the normal or low TSH concentration after operation; in spite of very low 
free T3 concentration. In the case of post-surgical patients however, 
there is a clear incre ase of free T4 , while in starvation, an increase of 
free T4 was not noted until day 4, when TSH concentration was returni ng to 
normal. It is possible that an increase of free T4 concentration after 
Surgery may compensate for a low free T3 concentration and this raises the 
qUestion of the relative importance of free T4 and free T3 in pituitary 
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feedback inhibition of TSH. Recent work by Larsen and co-workers (Silva 
and Larsen, 1978; Larsen et al, 1979) has demonstrated that a s ignificant 
proportion of pituitary intra-nuclear T3 is derived from T4 deiodination 
within the pituitary cell. This serves to emphasise the possible 
importance of free T4 in governing TSH levels. 
In conclusion, the results of the present study would suggest that 
after surgery TSH is unchanged in spite of low free T3 concentration, and 
that this may be due to feedback inhibition by increased free T4• In 
contrast, in starvation, TSH levels are reduced at a time when free T3 
concentration is low, and no increase in free T4 concentration has occurred. 
It is suggested that in starvation there are additional factors which 
mediate TSH suppression at either hypothalamic or pituitary level. 
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Chapter 5 HEREDITARY ABNORMALITIES OF TBG CONCENTRATION 
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Chapter 5 HEREDITARY ABNORMALITIES OF TBG CONCENTRATION 
INTRODUCTION 
The first report of inherited variation of TBG was that of Beierwalte s 
and Robbins (1959), who described a family with increased TBG. Sporadic 
cases of decreased and absent TBG were also reported, (Tanaka and Starr, 
1959a, b) but the first family with diminished TBG was described by 
Nicoloff, Dowling and Patton (1964). It is now established that the mode 
of inheritance of increased, decreased and absent TBG is of the sex-linked, 
codominant type (see Chapter 1). 
Most individuals with abnormal TBG concentration have been clinically 
euthyroid, but an association of diminished TBG and thyrotoxicosis was 
found in five individuals by Horwitz and Refetoff (1977) and in another 
two cases by Strunge (1974) and Gerstner and Caplan (1976). In one well-
documented case of thyrotoxicosis, hereditary TBG elevation was inferred 
from study of the patient's family (Hodgson and Wahner, 1972), but in four 
other patients with increased TBG who were treated for thyrotoxicosis, the 
eVidence for thyrotoxicosis was unconvincing (Florsheim et aI, 1962; 
Ingbar, Waterhouse and Cushman, 1964; Fialkow, Giblett and Musa, 1970; 
Shane, Seal and Jones, 1971). 
In the years 1975 - 1979, during which TBG assays were performed for 
the present study, a number of individuals with hereditary TBG abnormalities 
were identified. From the clinical histories of these patients, it was 
apparent that considerable problems could be associated with the diagnosis 
of TBG abnormality, especially when this co-existed with thyroid disease. 
For this reason, the case histories of several individuals have been 
eXamined in an attempt to identify the causes of diagnostic difficulty. 
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The typical biochemical features of TBG abnormality have been tabulated, 
and immunoelectrophoretic studies have been carried out to confirm earlier 
reports that hereditary TBG abnormality results from abnormal concentrations 
of an immunologically and electrophoretic ally normal protein (Refetoff et aI, 
1972, 1976). 
2) PATIENTS AND FAMILIES STUDIED 
A total of 32 index cases with abnormal TBG concentration were studied. 
These comprised individuals seen by the author, as well as other cases 
referred from hospi tals in the Birmingham area. Serum samples for individual 
and family studies were also received from other hospitals in the United 
Kingdom, with a particularly large contribution from Dr. W. van't Hoff, 
Consultant Physician, North Staffordshire Royal Infirmary, Stoke-an-Trent. 
FUll clinical details were obtained of those individuals referred from 
other centres. 
Family studies were carried out which confirmed the hereditary nature 
of TBG abnormality in 19 families (A - S). In 13 other individuals 
hereditary TBG abnormality was inferred from the absence of any other factors 
known to alter TBG concentration. A total of 15 males with absent TBG and 
15 females heterozygotic for absent TBG were identified; 14 males had 
eXcess TBG and 44 females were heterozygotic for increased TBG. 48 family 
members were found to have normal TBG, and comprised the control population 
for statistical comparisons. 
Although the majority of individuals with abnormalities of TBG 
concentration were eventually shown to be euthyroid, 4 individuals were 
found to have co-existent TBG excess and thyrotoxicosis, and 3 individuals 
had TBG excess and myxoedema. 
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3) RESULTS 
a) Clinical material 
The clinical details and family studies of 9 probands are included 
(Families A-I), together with 2 further individuals in whom family studies 
were not performed. In general, the cases have been selected to demonstrate 
the mode of inheritance of TBG abnormalities, together with the diagnostic 
and management problems associated with these patients. 
Family trees of a further ten probands (J-S) are given in appendix F. 
£§se reports 
Euthyroid individuals with increased TBG 
1) Family A III 3 (Fig. 5.1, Table 5.1). This 33-year-old male presented 
with an S-month history of lassitude, increased sweating, heat intolerance, 
loose bowel actions and weight loss of 3 kg. in spite of good appetite. 
On examination his pulse was SO beats/minute and regular, there was no 
finger tremor and the thyroid was not palpable. 
Investigations: T4 300 nmol/l, T3 uptake 130%, FTI 231, T3 6.S nmol/l. 
131 24-hour thyroidal I-uptake 49.9% basal, and after L-T3 
40 fg thrice daily for one week, 16.S%. TRH test (200~g 
iv at time 0) TSH 0 min = 7 mUll, 30 min = 16 mUll, 
60 min = 15 mUll. 
The patient was thought to be thyrotoxic on the basis of clinical 
history and raised FTI and T3• However, the absence of a palpable thyroid 
and the presence of raised T3 uptake led to a suspicion of raised T4-
binding protein. Dynamic tests excluded thyrotoxicosis, and serum TBG was 
found to be elevated at 43.6 mg/l, with normal T4 :TBG ratio (6.9). The 
patient was treated for anxiety with propranolol for 3 months. This was 
B 
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Figure 5.1 
o Unaffected Male 
o Unaffected Female 
<> Number of Offspring 
2 
]II 
• Affected Male 
• Affected Female 
1&'1 Not Tested 
~-r---<t 
2 
l 4 
2 
@ Normal TBG 
? Heterozygote 
t Deceased 
~ Index Case 
! 
• • 7 • 
• 
HEREDITARY TBG INCREASE, FAM ILIES A - C 
1-
2. 
2. 
Case T4 T3 
(nmol/ll 
A III 260 3.4 
A III 3 300 6.8 
A III 7 267 4.6 
B III 4 257 5.8 
C II1 240 4.5 
F III 2 440 
G II 250 5.8 
G II 2 203 6.2 
Q II 300 
S I 242 6.4 
U 320 7.8 
U 3 210 7.2 
U 4 300 5.6 
U 5 301 3.2 
Mean 273 5.7 
so 33 2.3 
Number 11 10 
Range 210-320 3.2-7.8 
Refer-
ence 
values 60-130 1.6-3.6 
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Table 5.1 
TBG 
(mglll 
41.9 
43.6 
40.2 
40.7 
47.0 
49.8 
42.0 
37.8 
42.6 
45.2 
36.0 
36.3 
39.7 
45.4 
41.2 
3.1 
11 
36.0-45.4 
6.0-17.0 
T3U 
(% ) 
1 50 
138 
160 
'141 
154 
161 
144 
140 
132 
142 
139 
139 
133 
142 
8 
10 
132-160 
93-117 
FTI 
173 
217 
167 
182 
156 
273 
174 
145 
227 
170 
151 
216 
226 
190 
28 
10 
151-227 
56-137 
T4:TBG 
---
6 .2 
6.9 
6.6 
6.3 
5.1 
8.8 
6.0 
5.4 
7.0 
5.4 
8.9 
5.8 
7.6 
6 . 6 
6.7 
1.0 
11 
5.4-8.9 
4.8-11.7 
TBPA 
(mg/l 1 
430 
225 
225 
321 
246 
207 
223 
275 
86 
6 
223-430 
1. Thyrotoxic on therapy: results excluded from calculation of mean 
2. Thyroxine '\ for myxoedema: results excluded from calculation 
of mean 
THYROID FUNCTION TE.STS IN MALES ~/ITH INCREASED TBG 
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discontinued, and eighteen months later the patient remains well on no 
medication. 
Family studies (Fig. 5.1) confirmed the presence of raised TBG in 
the patient's mother, step-brother and maternal aunt. Two daughters had 
elevated TBG, but one daughter had thyroid function tests within normal 
limits (Fig. 5.1, Table 5.2, Case A IV 6). 
Elevated FTI and serum T3 together with suggestive history very nearly 
caused mis-diagnosis of hyperthyroidism in this patient. However, abnormal 
elevation of T3 uptake suggested the need for further tests which 
established the correct diagnosis. This illustrates how misleading FTI can 
be when TBG is markedly elevated. 
2) Case U1 (Table 5.1). This man presented at the age of 46 in June, 1978. 
He had atrial fibrillation and congestive cardiac failure of unknown cause. 
Serum T4 was estimated as a routine and was found to be 265, 255 and 320 
nmol/l on three occasions, T3 was 7.8 nmoi/i. The patient was thought to 
be thyrotoxic and was treated with digoxin and referred for ablative therapy 
With 131 1• 24-hour 131 1 thyroidal uptake was found to be normal (28%), and 
serum TBG was subsequently found to be elevated at 36 mg/l, while T4 :TBG 
ratio (8.9) was normal. The patient has remained clinically euthyroid 
during follow-up for one year with no antithyroid medication. 
3) Family B II 3 (Fig. 5.1, Table 5.2). This female patient aged 42 years, 
presented with symptoms of lethargy, cold intolerance and hair loss, and 
Was noted to have a small firm goitre. Thyroxine was 211 nmol/l, T3 
UPtake 141% and FTI 148. Four hour thyroidal 131I_uptake was 21.9% (normal 
range 6 - 36%), and basal TSH was 3.8 mUll, rising to 10.6 mUll 30 minutes 
after TRH. 
Case 
A II 2 
A II 10 
A IV 1 
A IV 2 
1. A IV 3 
1. A IV 4 
A IV 5 
1. A IV 6 
A IV 7 
A IV 9 
B II 1 
B II 2 
B II 3 
T4 T3 
(nmo 1/l) 
201\ 4.8 
168 2.0 
149 4.6 
184 4.B 
123 
150 
260 
111 
185 
147 3.8 
202 3.1 
226 4.7 
211 4.7 
B II 7 250 4.4 
B II 8 204 3.7 
BIll 1 199 3.4 
2~ B III 3 269 4.3 
2. B III 5 283 3.8 
C I 2 
2. C II 5 
o II 3 
3. 0 II 4 
o III 
3. E I 2 
E II 3 
F II 1 
F II I 1 
206 5.0 
343 5.1 
114 3.0 
236 4.7 
142 3.0 
280 4.9 
153 2.6 
300 3.9 
276 9.0 
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Table 5.2 
-
TBG 
(mg/l ) 
20.6 
22.2 
19.8 
28.1 
12.5 
13.2 
29.5 
12.8 
26.0 
18.6 
34.4 
46.9 
32.9 
45.0 
38.6 
32.3 
47.6 
51.7 
49.3 
57.6 
16.6 
30.4 
25.8 
32.7 
21.0 
45.5 
37.6 
T3U 
(% ) 
129 
131 
126 
140 
124 
121 
145 
119 
122 
124 
131 
141 
141 
139 
145 
131 
145 
141 
127 
129 
108 
135 
118 
135 
111 
152 
153 
FTI 
158 
128 
118 
131 
99 
124 
179 
93 
152 
119 
154 
160 
150 
180 
141 
152 
186 
201 
162 
266 
106 
175 
120 
207 
136 
197 
160 
T4:TBG 
9.9 
7.6 
7.5 . 
6.5 
9.8 
11. 4 
6.6 
6.7 
7.1 
7.9 
5.9 
4.8 
6.4 
5.6 
153 
6.2 
5.6 
5.5 
4.2 
6.0 
6.8 
7.B 
5.5 
B.6 
7.3 
6.6 
7.3 
THYROID FUNCTION TESTS IN FEMALES WITH INCREASED TBG 
TBPA 
(mg/l ) 
215 
245 
210 
230 
185 
200 
190 
150 
225 
298 
276 
250 
253 
316 
237 
310 
245 
133 -
lable 5.2 (Cont.) 
Case T4 T3 TBG T3U FTI T4:TBG TBPA 
(nmolll) (mg /l ) ( % ) (mg/l ) 
G I 2 226 41 35.0 134 169 6.5 
H II 2 204 4.2 35.3 126 16 2 5.8 
H II 3 183 3.8 22.8 122 150 8.0 382 
4. H II 4 80 2.8 19.1 121 66 4.2 346 
H III 2 144 3.7 29.5 118 122 4.9 240 
J II 7 210 5.3 30.4 130 162 6.9 200 
J III 4 174 4.6 18.9 127 137 9. 2 
J IV 1 190 4.4 21 .1 142 134 9.0 
Q III 2 140 2.9 18.1 111 126 7.7 
S II 1 128 4.0 21.1 116 110 6.0 327 
S II 2 166 3.7 21.4 120 138 7.8 211 
S II 3 172 4.0 23.0 125 138 7.5 321 
3. U 2 376 11. 2 29.6 122 308 12.7 
U 6 186 4.0 25,2 12.8 145 7.4 
U 7 205 3.6 26.0 140 14fJ 7.9 
U 8 282 3.4 29.0 126 224 9.7 248 
U 9 230 4.5 44.7 5.1 353 
Mean 189 4.1 27.9 129 145 7.2 251 
SO 47 1 .1 10.0 11 27 1.6 58 
Numb e r 37 32 37 36 36 37 23 
Range 111-300 2~0-9.0 12.5-49.3 108 - 153 93-224 4.2-11.4 1 50-38 2 
Refer-
ence 
Values 60-130 1.6 - 3.6 6.0-17.0 93-117 56-137 4. 8 -11.7 
1 • TBG normal, pre s ume d heterozygot e 
2. Oral contraceptive Px: re s ults exclud e d from c a lcul a t i on o f mea n 
3. Thyrotoxic on th e r a py: resu lts ex clud e d from c a lcul a t i on of mea n 
4. Borderl i ne hypothyroid: results exclud e d from calcul a t i on o f mea n 
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Myxoedema had been suspected clinically, but the elevation of T4 and 
T3 uptake suggested elevation of TBG, and this was confirmed with a serum 
TBG of 32.9 mg/l and normal T4 :TBG ratio of 6.4. Dynamic studies confirmed 
that the patient was euthyroid and showed that four sisters and four of the 
patient's six children also had high TBG (Fig. 5.1). 
Thyrotoxic individuals with increased TBG 
4) Family C II 1 (Fig. 5.1, Table 5.1). This 41-year-old man presented to 
another hospital on 26.08.75 with a 7-month history of weight loss (20 kg), 
Sweating, diarrhoea and protrusion of the eyes. He was noted to have a 
pulse rate of 120, fine finger tremor, proximal myopathy and pretibial 
myxoedema. He had severe proptosis, with limitation of eye movements in 
all directions, bilateral papilloedema, conjunctival oedema and exposure 
Conjuncti v itis and keratitis. T 4 was) 12 fg/100ml ( > 154 nmol/l). He 
Was treated by orbital decompression, and received carbimazole 10 mg three 
times daily and propranolol 40 mg three times daily for three months. 
Shortly after the drugs were discontinued, he redeveloped heat intolerance 
and weight loss. His physicians were puzzled by an apparent discrepancy 
between raised serum T4 levels combined with an elevated T3 uptake. 
Treatment was not recommenced over the course of several months, and the 
patient was lost to follow-up. 
On 16.12.76 he presented at the Queen Elizabeth Hospital, Birmingham, 
and Was grossly thyrotoxic with bilateral proptosis, ophthalmoplegia and 
seVere chemosis. 
Investigations: T4 505 nmol/l, T3 uptake 118%, FTI 428. 
He was treated with 131 1 5 mCi, and subsequently with carbimazole. 
The chemosis resolved and the proptosis diminished. 
Serum TBG was found to be elevated at 47 mg/l, and family studies 
o I 
]I 
][ 
E I 
]I 
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Figure 5.2 
o Unaffected Male ~ Affected Male 
o Unaffected Female o Affected Female 
<> Number of Offspring ~ Not Tested 
F I 
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·HEREDITARY TBG INCREASE, FAMILIES D - F 
Normal TBG 
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t Deceased 
~ Index Case 
6 7 
- 136 -
confirmed high TBG in his mother and one sister (Fig. 5.1, Table 5.2, 
Cases CI 2 and C II 5). 
This patient's thyrotoxicosis was left untreated for several months 
because of confusion resulting from the combination of raised T4 and 
raised T3 uptake results. The delay may have caused deterioration of his 
eye condition. 
5) Family 0 II 4 (Fig. 5.2, Table 5.2). This lady presented at the age 
of 50 years with protuberance of the eyes, heat intolerance, tremulousness 
and 20 kg weight loss in spite of good appetite. She had a pulse rate of 
120, fine finger tremor, bilateral exophthalmos with chemosis and 
8cleritis, but no goitre. 
Investigations: T4 390 nmol/l, T3 uptake 88%, FTI 443, T3 3.3 nmol/l, 
TBG 17.1 mg/l, T4 :TBG ratio 22.8. 
A diagnosis of Graves' thyrotoxicosis was made, in spite of the normal 
T3 Value, and treatment was commenced with carbimazole, the dose being 
adjusted according to clinical response and FTI measurement. After 6 weeks, 
she Was clinically hypothyroid, in spite of a T4 of 137 nmol/l and FTr of 
108. After a further month clinical hypothyroidism was gross although T4 
Was 76 nmol/l and FTI 58 nmol/l. TBG was found retrospectively to have 
risen from 17.1 mg/l to 30.4 mg/l during the first 4 weeks of treatment 
(Fig. 5.3), and the T4 :TBG ratio had been in the hypothyroid range when 
hypothyroidism was first suspected clinically. She was subsequently 
managed according to T4 :TBG ratio results, and remains euthyroid on 
carbimazole therapy with T4 189 nmol/l, FTI 160, T3 3.0 nmol/l and T4 :TBG 
9.0. Other members of her family were investigated, and elevated TBG was 
found in a sister and niece (Fig. 5.2, Table 5.2, Cases 0 II 3, 0 III 1). 
At the time of presentation, TBG was only minimally elevated in this patient, 
and further TBG measurements were not performed routinely because large 
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alterations of TBG concentration were not anticipated. Measurement of T4 : 
TBG ratio was found to correlate well with her clinical state and simplified 
management. 
~) Family E I 2, (Fig. 5.2, Table 5.2). This lady presented at the age of 
37 with a history of heat intolerance, palpitations, exertional dyspnoea 
and weight loss of 8 kg. She was found to have a pulse rate of 100, s weaty 
palms and a fine finger tremor. 
Investigations: T4 336 nmol/l, T3 uptake 118%, FTI 285, 20-minute thyroidal 
99mTc uptake 5.7% (normal limit 4%), 4 hour thyroidal 131 1 
uptake 57.5% (normal limit 36%). 
The clinical diagnosis of thyrotoxicosis was confirmed, and she was 
treated with carbimazole for 2 years. Problems were encountered during 
treatment because of a persistent elevation of FTI in the face of clinical 
hypothyroidism. After two months without drug therapy, T4 was found to be 
280 nmol/l and FTI 207. Relapse was suspected, but TRH injection (200 f g iv) 
produced a T~H rise from 5.9 mUll to 11.1 mUll after 30 minutes. TBG was 
found to be elevated (32.8 mg/l), with a normal T4 :TBG ratio of 8.5. Family 
studies confirmed the presence of raised TBG in her daughter (Fig. 5.2, 
Table 5.2, Case E II 3). 
7) Case U 2 (Table 5.2). This lady underwent partial thyroidectomy in 1958 
and presented in 1974 at the age of 53 years. She was thought to be 
thyrotoxic and was treated with carbimazole until 1977. In 1978, she 
relapsed clinically and investigations revealed a T4 of 351 nmol/l, T3 
uptake 120%, FTI 293 and serum T3 20.8 nmol/l. The 20-minute 99mTc uptake 
was 15.8% (normal up to 4%), and there was no TSH response to TRH injection, 
200. ~g iv. After treatment with 131 1 and carbimazole she became clinically 
euthyroid, but her physicians were puzzled by persistent elevation of T4 and 
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FTI (T4 = 286 nmol/l, T3 uptake 138%, FTI 207). The problem was resolved 
when she was found to have elevated TBG (29.6 mg/l) and normal T4 :TBG 
r abo ( 9. 7) • 
Over a 2-year period there were management problems with this 
thyrotoxic patient because of persistent elevation of T4 and FTI which 
did not correspond with her clinical state. 
Myxoedematous individuals with increased TBG 
8) Family FIll 2, (Fig. 5.2, Table 5.1). This boy presented in 1967 at 
the age of 4 months. His birth weight was 3.8 kg, and he had been jaundiced 
for the first 10 days of life. After 6 weeks, his mother noticed his large 
tongue, and that he was a slow feeder. 
On examination he had cretinous facies, pallor, supraclavicular fat 
pads and an umbilical hernia. PBI was 0.5,g/100 ml (equivalent to a T4 
of approximately 10 nmol/l), bone age was retarded at the tenth centile. 
Hypothyroidism was diagnosed, and treatment with L-thyroxine 12.5 jUg 
daily was commenced. The dose was increased to 75 f g daily and three months 
later PBI measured 15.0 fg/1 00 ml (T 4 IV 300 nmol/l). T 4 was reduced to 
50 jJg daily, and PBI rose to 22.8 fg/1 00 ml (T 4 ~ 450 nmol/l). T 4 was then 
reduced to 25 f g daily. At age 2 years he was constipated, at the 3rd 
centile for height and with a wide fontanelle. Bone age was 6 months, and 
PBI 9.6 fg/1 00 ml (T 4 IV 190 nmol/l). T 4 was increased to 50 f g daily, and 
at age 4 years, to 100JU9 daily, despite the fact that PBI determinations 
remained above the limit of assay ( > 15 fg/100 ml, T 4> 300 nmol/l). At 
the age of 6, bone age was less than 3 years, serum T4 219 nmol/l and 
T3 uptake 152%, and at 8 years, bone age was 5 years, T4 300 nmol/l, T3 
UPtake 126%, FTI 238 and TSH 19.5 mUll. Serum TBG measured at this time 
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was 49.8 mg/l, and elevated TBG was also found in the patient's mother 
and sister (Fig. 5.2, Table 5.2, Cases F II 1 and FIll 1). The T4 dose 
was increased to 150 and then 200 f g daily. On this dose, serum T4 was 
440 nmol/l, FTI 273, T4 :TBG ratio 8.B (normal) and TSH undetectable. 
Three years later the patient is progressing normally. Elevated PBI 
and T4 estimations caused by his hereditary TBG elevation resulted in 
under-treatment of his hypothyroidism for the first eight years of life. 
Inadequate treatment was confirmed by the advent of TSH assay. 
9) Family G II 2, (Fig. 5.4, Table 5.1). This 19-year-old male was 
commenced on thyroxine treatment for hypothyroidism at the age of thirteen 
months. Some doubts arose concerning the diagnosis when thyroid function 
tests revealed a T4 of 203 nmol/l and a serum T3 of 6.2 nmol/l while on 
treatment with 100 ~g of L-T4 daily. The doubts were resolved by the 
finding of an elevated TBG concentration of 37.B mg/l and family studies 
Confirmed the hereditary nature of the condition (Fig. 5.4). A raised 
serum TSH of 16 mUll suggested that he was not on adequate replacement 
therapy, in spite of an elevated FTI of 145. 
10) Family H II 2, (Fig. 5.4, Table 5.2). Thyroid function tests were 
performed in this 56-year-old lady to exclude myxoedema as a cause of 
Obesity. T4 was 204 nmol/l, T3uptake 126%, FTI 162, TBG 35.3 mg/l and 
T4 :TBG ratio normal at 5.B. Family studies confirmed hereditary TBG 
elevation in the patient's two sisters and daughter (Fig. 5.4, Table 5.2 
cases H II 3, H II 4 and HIlI 2). However, in one sister (H II 4) serum 
T4 Was 80 nmol/l, T3 uptake 121%, FTI 66, TBG 19.1 mg/l and T4 :TBG ratio 
4.2 (low). Serum TSH was elevated at 39 mUll, although serum T3 was normal 
(2.8 nmol/l). In this relative, who was clinically euthyroid, some degree 
of thyroid insufficiency was suggested by the T4 :TBG ratio and confirmed 
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o Unaffected Male II Affected Ma Ie 
O · Unaffected Female • Affected Female 
(> NUmber of Offspring ~ Not Tested 
][ 
][ 
2 
J[ 
2 
t Io--~-----< t 
1 2 
3 
3 .. 
2 
;) 
® Normal TBG 
? Heterozygote 
t Deceased 
;( I ndex Case 
HtREDITARY TeG INCREASE AND DECREASE FAMILIES G - I 
- 142 -
by TSH measurement, although FTI was within normal limits, and serum T4 
was well within normal limits. 
11) Family I II 2 (Fig. 5.4, Table 5.3). This 11-year-old boy with growth 
retardation and TBG deficiency has been reported previously (Barragry and 
Burr, 1977). He had been born by vaginal delivery at 38 weeks' gestation, 
birth weight 1932 g. Parental heights were: father 156 cm, mother 144 cm. 
He had no history of serious childhood illness. He was an alert boy, 
122 cm in height (6 cm below the third centile). He had no goitre and 
Was clinically euthyroid, and full clinical examination revealed no other 
abnormalities. Bone age at the wrist was 5 years (Greulich and Pyle, 195U), 
and skull X-ray was normal. Insulin-induced hypoglycaemia revealed no 
abnormality of growth hormone or cortisol production. Serum T4 was 
23 nmolll, Thyopac 3 was 63%, FTI 37, serum T3 1.5 nmol/l, serum TSH was 
2.0 mUll and serum TBG was undetectable. Two brothers, aged 15 and 9 years 
had undetectable TBG also, although TBG concentration was within normal 
limits in both parents (Fig. 5.4, Tables 5.3, 5.4). 
In addition to the above cases and families J-S, four sporadic cases 
(T1-4) of diminished TBG, and 7 additional cases of elevated TBG (U 3-9) 
Were also studied. 
Tables 5.1 - 5.4 contain data on a total of 14 males hemizygotic for 
elevated TBG, 44 females heterozygotic for elevated TBG, 15 males with 
absent TBG and 15 females heterozygotic for diminished TBG. 
b) lmmunological and electrophoretic properties of TBG in familial 
IBG abnormality 
In 2-dimensional IEP the electrophoretic mobilities of TBG from 
individuals with normal, elevated or diminished TBG concentration were 
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Table 5.3 
Case T4 T3 TBG T3U FTI TBPA 
(nmol/l) (nmol/l) (mg/l) ( % ) (mg/l) 
I II 1 17 1 .8 NO 64 27 24:3 
I II 2 23 1.5 NO 63 36 
I II 3 23 1 .8 NO 63 37 325 
K I 1 30 1 .0 NO 76 39 374 
L II 1 40 1 .0 NO 64 63 346 
L II 3 43 1.2 NO 69 62 379 
M I 1 17 0.8 NO 51 33 
N II 1 16 1.5 NO 52 31 225 
N II 2 25 0.6 NO 47 53 236 
0 II 1 30 1.9 NO 164 
P I 1 43 1 .3 NO 73 59 566 
R III 3 24 1 • 1 NO 59 41 432 
T 2 21 O.B NO 51 41 
T 3 17 NO 42 40 
T 4 16 NO 61 26 
Mean 26 1 .3 60 42 329 
SO 10 0.4 10 12 11 B 
Number 15 13 14 14 10 
Range 16-43 0.6-1.9 42-76 27-63 164-566 
Refer-
ence 
values60-130 1.6-3.6 6.0-17.0 93-117 56-137 
rHYROID FUNCTION TESTS IN MALES WITH ABSENT TBG 
1. 
1. 
1 • 
1 • 
1-
Case T4 
(nmolll 1 
I I 2 71 
K.. II 3 55 
L III 4 68 
M II 2 57 
M II 3 74 
M II 4 70 
N I 2 43 
0 I 2. 78 
P II 94 
R II 2 28 
R II 4 
R III 4 59 
R III 6 .38 
R III 7 61 
T 25 
Mean 59 
SO 20 
Number 14 
Range 25-94 
Refer 
ence 
values 60-130 
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Table 5.4 
THYROID FUN CTION TE STS IN FEMALE S 
WITH DECRE ASED TBG 
13 TBG 13U FTI 
(nmol/ll (mglll (% 1 
3.1 9.5 100 71 
1.6 4.7 57 96 
1.6 6.9 86 79 
1.1 5.0 66 86 
1.8 8.0 76 97 
1.3 5.0 80 88 
1.2 1.0 66 65 
1.8 7.1 81 96 
5.6 
1.4 0.5 55 51 
6.2 
1.6 4.5 78 76 
1.5 3.4 75 51 
1.9 3.3 83 73 
2.4 
1.7 4.9 75 77 
0.5 2.5 13 16 
12 15 12 12 
1.1-3.1 0.5-9.5 55-100 51-97 
1.6-3.6 6.0-17.0 93-117 56-137 
T4:TBG 
7.5 
11.7 
9.9 
11.4 
9.3 
14.0 
43.0 
11.0 
16.8 
56.0 
13.1 
11.2 
18.5 
10.4 
17.4 
14.1 
14 
7.5-56 
4.8-11.7 
1 • TBG normal. presumed heterozygote. 
THYROID FUNCTION TESTS IN FEMALES WITH DECREASED TBG ~~~~--~~--~~--------~~--~-------~ . . - ~-
TBPA 
(mgll ) 
401 
278 
312 
333 
306 
414 
317 
368 
408 
349 
50 
9 
278-414 
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similar (Fig. 5.5). In addition, near-perfect Gaussian peaks were obtained 
in both TBG elevation and deficiency, which would suggest that no 
heterogeneity of electrophoretic mobility was present. A band of immuno-
logical identity was found between TBG from normal persons and individuals 
with TBG elevation, as shown in the composite IEP plate in figure 5.6 
c) Serum TBPA concentration 
In males and females with hereditary TBG elevation, mean serum TBPA 
(~ S.D.) in 31 euthyroid individuals was 257 ~ 63 mg/l. This was 
significantly less than the concentration found in 24 relatives with normal 
TBG concentration (327 + 82 mg/l, P (0.0005). TBPA concentration in 19 
euthyroid males and females with absent or diminished TBG was 338 + 91 mg/l, 
which was not significantly different from the concentration in relatives 
with normal TBG concentration. 
d) Inheritance of TBG abnormalities 
Table 5.5 summarises the inheritance of TBG abnormalities in 19 
families. 
No cases of father-to-son transmission occurred out of 9 possibilities 
(6 for high TBG, 3 for absent TBG). Fathers with high TBG produced 
daughters with normal TBG concentration on 3 occasions (cases A IV 3, 
A IV 4 and A IV 6 - table 5.2), while on 9 occasions the daughters had 
elevated TBG. On two occasions, fathers with absent TBG had daughters 
With normal TBG (cases L III 4 and M II 3, table 5.4). Out of a total of 
42 male and female offspring of mothers with high or low TBG, 28 inherited 
the condition while 14 were normal. 
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e) Thyroid function tests in TBG abnormality 
i) TBG elevation 
TBG concentration in the presumed hemizygous males with TBG increase 
was remarkably constant (Table 5.1), with a mean (+ S.D.) of 41.8 ~ 2.7 mg/l. 
Serum T4 was uniformly elevated (269 + 31 nmol/l), and serum T3 usually 
raised (5.4 + 1.4 nmol/l). T3 uptake was elevated (142 + 8%), and FTI was 
above the normal range in all cases (mean = 190 + 28, P ( 0.0005 compared 
to normal relatives). T4 :TBG ratio (6.4 + 0.6) was significantly lower 
than the ratio in normal relatives (p < 0.0005), but in no case did the 
ratio fall outside the normal range. 
In females who were presumed to be heterozygous for increased TBG, 
there was a wide scatter of TBG values, ranging from normal to the high 
values found in hemizygous males (mean ~ S.D. = 29.1 + 10.8 mg/l, Table 5.2). 
The highest TBG concentrations noted in this study occurred in 2 women who 
were presumed to be heterozygous for TBG excess and who were taking the 
contraceptive pill (cases BIll 5, C II 5 - Table 5.2). In heterozygous 
women, thyroid function tests were affected to an intermediate and highly 
Variable degree, but FTI was significantly greater than in normal relatives 
(149 ~ 30, P ( 0.0005) and exceeded the normal range in 25/39 individuals. 
T4 :TBG was significantly less than in normals (7.2 ~ 1.6, P( 0.0005), but 
only fell below the normal range in 1 out of 40 individuals. Serum free T4 
concentration was measured in 12 individuals (10 male, 2 female) with high 
TBG, and in 21 normal controls. Mean control conce~tration was 37 ~ 9 pmol/l, 
With a range of 27 - 47 pmol/l, and the concentration did not differ in 
TBG elevation (mean = 37 + 10 pmol/l, range 23 - 57 pmol/l, Fig. 5.7). 
ii) TBG decrease 
Mean values of thyroid function tests for hemizygous males with 
absent TBG are shown in Table 5.3. FTI (42 + 12) was significantly 
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lower than in normals (p < 0.0005), and fell below the normal range in 
11/14 individuals. T4 :TBG ratio could not be applied. 
Heterozygous females (Table 5.4) had TBG concentrations ranging from 
0.5 mg/l up to the normal range. FTI (77 + 16) was significantly reduced 
(p < 0.0025) and fell below the normal range in 2/12 individuals, while 
T4 :TBG ratio was significantly elevated (17.4 + 14.1, P < 0.0005) and 
exceeded the normal range in 8/14 individuals. Free T4 was not measured 
in TBG decrease. 
4) DISCUSSION 
Electrophoretic and immunological characteristics of TBG 
The results of electrophoretic and immunological studies reported 
here support the suggestion that the inherited abnormalities of TBG are 
due to varying concentrations of an immunologically normal protein. Serum 
thyroid hormone concentrations would further suggest that the protein is 
functionally normal. These results are in agreement with the studies of 
Hamada, Takemura and Sterling (1971), Hansen and Siersbaek-Nielsen (1972) 
and Refetoff et al (1972). Refetoff et al (1976) have further shown that 
the probable defect in TBG abnormality lies in alterations in TBG synthetic 
rate. 
~erum TBPA 
A significant decrease in TBPA concentration was found in individuals 
With TBG elevation, when compared with normal family members, but no 
Significant alterations were found in TBG decrease or absence. The co-
existence of absent TBPA and increased TBG (both measured as binding 
capacity) has been reported on one occasion in the past (Thomson et aI, 
1972), although in view of the poor sensitivity of TBPA capacitance assays, 
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(Premachandra and Wu, 1979), total absence of TBPA was not convincingly 
proved. There are several interesting examples of reciprocity between 
TBG and TBPA levels. In active acromegaly TBG capacity has been found to 
be diminished, while TBPA capacity was increased (Inada and Sterling, 1967c). 
Adrenal corticosteroids (Oppenheimer and Werner, 1966) and anabolic steroids 
(Braverman and Ingbar, 1967) apparently produce the same effects, but no 
satisfactory explanation for these findings has been advanced. The present 
finding of decreased TBPA in hereditary TBG increase could be taken to be 
eVidence in favour of a genetic influence on TBPA concentration. This has 
already been proposed for a link observed between decreased TBPA and 
o(-1-antitrypsin deficiency (Premachandra and Wu, 1979). However, another 
explanation lies in the fact that TBPA concentration varies with age 
(Braverman, Dawber and Ingbar, 1966), and our family populations were not 
age-matched. 
The failure to find TBPA increase in the absence of TBG argues against 
any simple reciprocal relationship between TBPA and TBG accommodation. 
c) Inheritance of TBG abnormality 
The first case reports of TBG abnormality were thought to show an 
autosomal dominant inheritance (Beierwaltes and Robbins, 1959; Nicoloff 
et aI, 1964), but were also compatible with an X-linked dominant inheritance 
which was suggested in later studies (Nikolai and Seal, 1966; Marshall, 
Levy and Steinberg, 1966). Refetoff et al (1972) reviewed 20 families 
with abnormal TBG concentration and described 4 new kindreds. From a tatal 
of 19 families with diminished or absent TBG and 6 with excess TBG, they 
derived strang support for X-linked inheritance of TBG decrease and excess. 
The nineteen families described here in general satisfy the criteria 
for X-linkage enunciated by Refetoff et al (1972), namely a) full expression 
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of the defect is manifest in hemizygous subjects (possessing a single X 
chromosome), b) heterozygous subjects have intermediate expression of the 
defect and have two X-chromosomes, c) all female offspring of affected 
males are heterozygous for the trait, d) all male offspring of affected 
males are normal, e) affected males are offspring of heterozygous females, 
and f) heterozygous females are offspring of affected males or females. 
With regard to criterion a) above, it should be mentioned that although 
no female with absent TBG has been found, a concentration of only 0.5 mg/l 
occurred in subject R II 2 (Table 5.4), and in females with high TBG, 
SUbjects BIll 5 and C II 5 (Table 5.2), who were taking oestrogens, had 
TBG concentrations higher than the hemizygous males. These extremes of 
TBG concentration, occurring in females, do not necessarily disprove 
X-linkage, but may be due to an unusually great degree of inactivation of 
the normal X-chromosome, according to the Lyon hypothesis of random 
X-chromosome inactivation (Lyon, 1962). The Lyon hypothesis may also 
explain why some presumably heterozygotic females had TBG concentrations 
in the normal range (e.g. A IV 3, A IV 4, and A IV 6, Table 5.2). The 
final proof of the heterozygotic state of these subjects will depend on 
testing of their eventual offspring. 
With the above exceptions, X-linkage was fulfilled and no case of 
father to son transmission occurred out of nine possible instances 
(T able 5.5). 
The marked elevation of TBG concentration in the two women with TBG 
elevation who were also taking the contraceptive pill is an interesting 
Observation. Although the additional TBG increase above the levels 
normally seen in women with familial TBG increase may be due to the 
response of hepatocytes bearing a "normal" X chromosome, the extreme 
MALES NO. OF 
FATHERS 
High TBG 5 
Absent TBG 4 
FEMALES NO. OF 
MOTHERS 
High TBG 11 
Low TBG 5 
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Table 5.5 
SONS 
AFFECTED NORMAL 
o 6 
o 3 
8 7 
7 3 
PROGENY OF AFFECTED PARENTS 
DAUGHTERS 
AFFECTED NORMAL 
9 3 
4 2 
10 4 
3 o 
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elevation of TBG which was found suggests the possibility of an increased 
sensitivity to the effects of oestrogens. There is some conflict among 
reports of the effect of oestrogens in TBG excess. Some authors have found 
an increase in both men and women (Jones and Seal, 1967; Shane et aI, 1971) 
while others found no effect in a woman (Ingbar et aI, 1964). The results 
are of considerable theoretical interest, because if the defect in 
familial TBG excess lies in a repressor gene, one might expect that oestrogen 
would no longer control TBG synthesis, whereas an exaggerated response 
would be more consistent with a gene duplication (Robbins, 1973; Jones and 
Seal, 1967). These questions could be resolved by studies involving 
oestrogen administration to hemizygous males with TBG excess, but for 
ethical reasons, these were not undertaken in the present study. 
d) Association of TBG abnormality and thyroid dysfunction 
TBG abnormality has been reported in association with growth retardation 
(Penfold et aI, 1971; Leiba et aI, 1972; Barragry and Burr, 1977), with 
mental subnormality (Thomson et aI, 1972) and with hypertrophic cardio-
myopathy (Kallee et aI, 1978). An association with thyroid disease was 
first reported by Shane et al (1971) who studied a large kindred with TBG 
increase and goitre. Apart from probable mis-diagnosis (Florsheim et aI, 
1962; Ingbar et aI, 1964, Fialkow et aI, 1970; Shane et aI, 1971), the only 
reported link between increased TBG and thyroid dysfunction was a thyrotoxic 
woman with suspected TBG increase reported by Hodgson and Wahner (1972) • . 
The four cases of thyrotoxicosis and three cases of myxoedema documented 
here would appear to be the only cases in which an association with TBG 
elevation has been directly confirmed. Out of a total of 58 individuals 
With TBG elevation, 7 had thyroid dysfunction, but because of bias in case 
selection, we cannot take this to be definite evidence in favour of a 
Positive association between TBG increase and thyroid dysfunction. No 
cases of thyroid disease and low or absent TBG were found in this series, 
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although an association between thyrotoxicosis and TBG deficiency has been 
reported in the past (Strunge, 1974, Gerstner and Caplan, 1976, Horwitz 
and Refetoff, 1977). 
e) Diagnostic and management problems associated with TBG abnormality 
In past years patients have been subjected to radioiodine treatment 
because of TBG elevation (Ingbar et aI, 1964). In the present series, no 
ablative antithyroid therapy was incorrectly given, although diagnostic 
problems almost led to this error in one patient. An error of this type 
could result from placing reliance on T4 measurement, without measurement 
of binding protein, or from reliance on the FTI result, which has been shown 
in the present study to give spurious high values in TBG excess (see 
Chapter 6). 
When thyrotoxicosis co-existed with TBG excess (C II 1, D II 4, 
E I 2 and U 2), problems were encountered with biochemical assessment, 
and at least one patient was untreated for several months in spite of 
severe thyrotoxicosis (C II 1). In another individual (0 II 4), 
difficulties in biochemical assessment arose because of a 78% increase 
in TBG during control of thyrotoxicosis. This led in turn to errors in 
management because of misleading elevation of the FTI in a hypothyroid 
individual. Management was simplified by TBG measurement and use of T4 : 
TBG ratio in controlling drug dosage. 
Considerable morbidity seems to have occurred due to under-treatment 
of myxoedema in one patient with TBG excess (case FIll 2), and a further 
instance of inadequate thyroxine replacement therapy was found in another 
individual with co-existent myxoedema and TBG excess (case G II 2). These 
problems resulted from the fact that FTI was spuriously high even when the 
patient was hypothyroid and had an elevated TSH. 
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In TBG deficiency, the usual diagnostic problem consists of 
distinguishing the condition from myxoedema because of the low T4 and 
FTI results which occur in this condition. 
There is considerable disagreement in the literature regarding 
absolute free T4 values in TBG abnormality, with some authors finding 
abnormal free T4 (Bayley et aI, 1969; Heinonen, Lamberg and Virtaino, 
1970; Henneman, Docter and Dolman, 1971; Thomson et aI, 1972; Dussault 
et aI, 1973) and others normal free T4 (Refetoff and Selenkow, 1968, 
Jones and Seal, 1967; Siersbaek-Nielsen, Hansen and Hippe, 1969). Free 
T4 was found to be normal in TBG elevation in this study, and the fact 
that TSH responses to TRH are normal in TBG deficiency would suggest that 
effective free hormone levels are normal in this condition also (Hansen 
et aI, 1975; Kbnno, 1976). 
In the patients with TBG excess, it was found that the T4 :TBG ratio, 
although significantly lower than in normal persons, still gave results 
within the euthyroid range, and was diagnostically helpful. In subjects 
with TBG absence or deficiency, both T4 :TBG ratio and FTI gave misleading 
results. Knowledge that serum TBG was absent or very low has proved 
helpful in clinical practice, because of the consistent biochemical 
findings in this condition (Table 5.3), which allowed some prediction of 
appropriate T4 and T3 levels. In general, where TBG concentration was very 
low, it was found necessary to rely on other tests such as TSH and dynamic 
tests of thyroid function to resolve the diagnosis. 
f) Prevalence of TBG abnormality 
The prevalence of hereditary increased TBG is not known, while that 
of hereditary decreased TBG has been reported to be 0.06% (Horwitz and 
Refetoff, 1977), or 0.006% (Dussault, Coulombe and Laberge, 1975). 
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In a 4-year period using a direct assay of TBG, 88 individuals with 
probable familial TBG abnormality have been encountered. These patients 
were highly selected, but nevertheless, it was felt that the hereditary 
abnormalities of TBG concentration may be more common than previously 
recognised, and may be more frequently recognised with increasing use of 
TBG assays. 
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Chapter Six TBG MEASUREMENT IN THE ASSESSMENT OF THYROID FUNCTION 
1) Introduction: aims and design of study 
2) Patients and methods 
3) Results: 
a) T3-uptake and TBG concentration 
b) Relationship of T4 and TBG concentration 
c) T4 :TBG ratio and FTI 
d) Retrospective comparison of T4 :TBG and FTI 
4) Discussion 
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Chapter 6 TBG MEASUREMENT IN THE ASSESSMENT OF THYROID FUNCTION 
1) INTRODUCTION: AIMS AND DESIGN OF STUDY 
As mentioned in Chapter 5.4, the study of euthyroid individuals with 
hereditary TBG abnormalities led to the discovery that conventional thyroid 
function tests were not always reliable when TBG concentration was very 
high or very low. In particular, the Free Thyroxine Index (FTI = 
T4 x 100, (Clarke and Horn, 1965) gave results in the thyrotoxic 
T3 uptake 
range in hereditary TBG elevation, and in the myxoedematous range in TBG 
deficiency. Since free T4 concentration in hereditary TBG abnormality is 
generally considered to be normal (see Chapter 5.3.e.i.), the abnormality 
of FTI implies either a defect of T4 measurement or T3 uptake measurement. 
Problems may be encountered with T4 RIA, when TBG concentration is high, 
because of inadequate blockade of TBG-binding sites with 8-anilino-1-
naphthalene sulphonic acid or merthiolate (Burr, Evans and Hogan, 1977; Evans, 
Burr and Hogan, 1977). Allowance was made for this in the present studies 
by re-measurement of T4in diluted samples.Abnormalities of FTI persisted, 
Suggesting that the problem was due to defects of T3 uptake measurement. 
The theoretical basis of the FTI lies in a simplified statement of 
the law of mass action as applied to thyroid hormones and binding proteins:-
= [bound T4] 
k[unbound TBG] 
- (1) 
In euthyroid serum, total T4 approximates to bound T4 , and [unbound 
TBG] may be considered equal to [total TBG - total T4]. Substituting in 
equation (1):-
= [total T4] 
total TBG]\ 1 
[total T41)-
- (2) 
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= 1 ( [total T4] -1 ) 
k [total TB~] ) - (3) 
Equations (1 - 3) represent a very simplified view when compared with the 
multi-ligand/multi-protein-binding site system described earlier 
(Chapter 1.4.a.v.), but because of the predominance of TBG among the T4-
binding proteins, the assumptions may be legitimate and of practical value. 
It follows from equation (3), that any alteration in serum TBG will be 
accompanied by appropriate factorial changes in total T4 , so as to keep 
free T4 constant. It also follows that the ratio of T4 :TBG should maintain 
a factorial relationship to free T4 , and may therefore be of diagnostic 
Value. 
The work described in this section had several aims:-
1) To evaluate the T3 uptake test as a measure of [unbound TBG] over a 
wide range of TBG concentrations. 
2) To examine the relationship between total T4 and total TBG concentration 
in euthyroid individuals. 
3) To compare the ability of FTI and T4 :TBG ratio to discriminate between 
thyrotoxic, euthyroid and myxoedematous individuals. 
4) To compare FTI and T4 :TBG ratio in individuals with abnormal TBG 
concentration. 
5) To test the diagnostic value of FTI and T4 :TBG ratio in a hospital-
based trial. 
2) PATIENTS AND METHODS 
Serum samples were taken from one hundred and sixteen healthy, 
euthyroid volunteers, and 122 euthyroid hospital in-patients, comprising 
together 138 men and 100 women. One hundred and one patients with 
thyrotoxicosis and 36 patients with myxoedema were also studied, together 
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with 65 persons with high TBG concentration (9 males and 37 females with 
hereditary TBG elevation, 10 pregnant women and 9 women taking oral 
contraceptives). Twenty individuals with low or absent TBG were studied 
(16 male, 4 female), and ten patients on treatment with diphenylhydantoin 
(DPH). TBG, T3 uptake and T4 (Evans et aI, 1977) were measured in all 
sera. FTI (T4/T3U x 100) and T4 :TBG ratio were calculated for all patients. 
In order to compare the diagnostic value of T4 :TBG ratio and FTI, 
TBG and T3uptake were measured in 104 consecutive in-patients with 
T4 > 110 nmol/l and 40 consecutive patients with T4 < 40 nmol/l. The case 
notes of all individuals in whom T4 :TBG ratio or FTI gave results outside 
the 95% confidence limits for normal subjects were examined to establish 
their thyroid status. 
3) RESULTS 
a) !3-uptake and TBG concentration 
Figure 6.1 shows the relationship between T3 uptake and TBG 
concentration in 82 euthyroid individuals with a wide range of TBG 
concentrations. The subjects comprised normal people (42), contraceptive 
pill-treated (9), pregnant (10) and those with hereditary TBG abnormalities 
(21) • 
At high concentrations of TBG, the relationship became non-linear, 
With T3 uptake values reaching a plateau at about 130%, above which little 
or no increase occurred despite a doubling of TBG concentration from 
25 to 50 mg/l. In TBG absence (Chapter 5 - Table 5.3), mean T3 uptake 
(.:tS.D.) was 60 .!. 10%, with a range of 42 - 76%. 
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b) Relationship of T4 and TBG concentration 
In 315 euthyroid individuals, there was a linear correlation between 
T4 and TBG (Fig. 6.2, r = 0.92, p( 0.0005, falling to r = 0.54, p( 0.0005 
when individuals with abnormal TBG concentration were excluded). 
The relationship between TBG and T4 can be expressed as a simple 
linear equation: 
Y = A + BX 
where 'Y' is T4 concentration, 'A' represents the T4 concentration at 
zero TBG concentration (which corresponds to the T4 bound by TBPA and 
albumin) and 'X' is TBG concentration. Further analysis of the points in 
figure 6.2 shows that in fact there is a slight, but significant, curvature 
to the line linking the points, so that the relationship is best described 
by a polynomial expression of the form: 
3 Y = A + BX + DX • 
In support of this, the coefficient D is significantly different from 0 
(p ( 0.005, using an 'F' test). The value of A calculated from the above 
eXpression was 23 nmol/l. 
c) ~:TBG ratio and FTI 
The mean T4 :TBG ratio (~ S .u.) in healthy volunteers (8.2 ~ 1.6) did 
not differ from the ratio in euthyroid in-patients (8.2 + 1.7). The 95% 
confidence limits for the T4 :TBG ratio derived from the control population 
of 238 were 4.8 - 11.5. Figure 6.3a shows the T4 and TBG concentrations in 
77 euthyroid individuals with raised or low TBG, plotted with the 95% 
confidence limits for the T4 :TBG ratio. The ratio cannot be applied to the 
males with undetectable TBG, but in a few individuals with low TBG, the 
ratio exceeds the 95% confidence limits. In individuals with raised TBG, 
the T4 :TBG ratio remains within these limits in all but one case. 
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Figure 6.3b shows the T4 and T3 uptake results for the same individuals 
plotted with the 95% limits for the FTI (56 - 137). When TBG is absent or 
low, the FTI lies below the confidence limits, and when TBG is high, FTI 
frequently exceeds these limits. The T4 :TBG ratio is clearly superior to 
FTI in correctly assigning euthyroid status to these patients. T4 :TBG 
ratio and FTI are comparable in their ability to distinguish patients with 
abnormal thyroid function from normal, as shown in figures 6.4a and 6.4b, 
in which thyrotoxic and myxoedematous patients are plotted against the 95% 
confidence limits for T4 :TBG and FTI respectively. 
Thyroid function tests of 10 patients treated with DPH are shown in 
Table 6.1. Mean serum T4 concentration is towards the lower end of the 
reference range, with several individuals having values below the reference 
range. Serum TBG and T3 uptake did not differ from controls so that both 
FTI and T4 :TBG ratio were low, with some individuals falling below the 
reference range. 
d) Retrospective comparison of T4 :TBG and FTI 
The T4 :TBG ratio and FTI exceeded the 95% limits in 43 of the 144 
patients selected because of high or low T4 concentration, and details are 
giVen in Table 6.2. In 23 patients both tests were abnormal and thyroid 
disease was confirmed. In 20 patients the tests were discordant, but 
Unfortunately a firm diagnosis could only be made in 9 patients. 
The FTI gave two false negative results, euthyroid values being 
obtained in one thyrotoxic and one myxoedematous patient. Six false 
Positives were obtained with FTI, comprising three normal persons in whom 
myxoedema was predicted, and three normals incorrectly assigned as 
thyrotoxic. T4 :TBG ratio gave one false negative in a thyrotoxic patient 
and no false positives. 
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Table 6.1 
Thyroid function tests in patients trea ted with diphl!nylhydantoin 
Patient No. T4 nmol/I TBG mg I T3U FTt T4:TBG 
101 17-2 112 90 S'9 
2 46 11 ·3 93 49 4·1 
3 92 13·3 97 9S 6·9 
4 68 7·8 98 69 g'7 
S 63 12·2 112 56 5·2 
6 62 13-4 108 57 4·6 
7 68 11 ·7 104 65 5-8 
8 68 12·4 118 S8 5'S 
9 46 9·5 lOS 44 4·8 
10 92 11·2 98 94 g'2 
Mean( ±SD) 71 ± 19 12·0±2·S IOS±8'0 68± 19·0 6·0± I'S 
Reference 60-130 6.0-17 .0 93-117 56-137 4.8-11.7 
values 
THYROID FUNCTION TESTS IN PATIENTS TREATED WITH DIPHENYLHYDANTOIN 
Table 6.2 
ABNORMALITY NUMBER NUMBER LHAGNOSIS COMiVlENT 
DIAGNOSED 
'lr4: TBG , tFTI 21 21 17 Thyrotoxic 4 T4 Treatment 
tT4:TBG, N FTI 9 1 1 Thyrotoxic 1 x False negative FTI 
NT 4: TBG, l' FTI 4 4 3 Euthyroid (2 with TBG) 3 x False positive FTI 
1 Thyrotoxic 1 x False negative T4:T~G 
--" J, T 4: TBG, ~ FTI 2 2 1 Myxoedema -...J 
--" 
1 T3 Treatment 
tT 4: TBG, N FTI 1 1 1 Myxoedema 1 x False negative FTI 
NT 4: TBG, {, FTI 6 3 3 Euthyroid 3 x False positive FTI 
ABNORMAL T4:TBG AND FTI RESULTS IN PATIENTS WITH T4 ;>110 NMOL/L OR (40 NMOL/L 
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DISCUSSION 
The relationship between T3 uptake and TBG concentration was non-
linear, with the result that T3 uptake tended to underestimate TBG 
concentration when this was high. The effect was most pronounced in 
hereditary TBG elevation, but also occurred with T3 uptake values as low 
as 130, which are found during oral contraception and pregnancy. An 
underestimate of TBG binding sites would account for the high FTI values 
noted in TBG elevation in this study and in previous reports (Goolden, 
Gartside and Sanderson, 1967; Souma et al, 1968). One explanation of the 
limitations of the T3 uptake (and red-cell uptake) tests lies in the fact 
that they are related to TBG capacity by an expression of the type 
Y = mx + c, and not the y = mx relationship which is assumed for calculation 
of the FTI (Osorio et al, 1961). Another technical defect (for Thyopac 3 
125 
measurement) may be that insufficient tracer I - T3 is supplied to 
saturate large amounts of TBG (Davies and Allison, 1977). 
The relationship between T4 and TBG in euthyroid persons remained 
Very nearly linear through a wide range of TBG concentrations. The slight 
tendency towards a curvilinear relationship may have been caused by a 
slight reduction in TBPA when TBG was elevated (v.s Chapter 5.3.c.). 
From the graph relating T4 and TBG concentratiDns (Fig. 6.2), it was 
calculated that 23 nmol/l of T4 would be associated with TBPA, albumin 
and other binding proteins in the absence of TBG. In practice, a figure 
of 26 + 10 nmol/l was found in fifteen men with absent TBG (v.s. Table 5.3). 
The linear relationship between T4 and TBG forms the basis for suggesting 
the use of a T4 :TBG ratio in thyroid diagnosis. The use of this simple 
ratio does not take account of the contribution of other binding proteins 
mentioned above. However, reference to Fig. 6.3.a. shows that the ratio 
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provides a useful index of thyroid status throughout a wide range of TBG 
concentrations. A spurious elevation of T4 :TBG ratio only occurs at 
extremely low TBG concentrations such as those found in TBG deficiency. 
In these rare cases, an indication of thyroid status might be gained by 
a plot of T4 against TBG concentration, as in Fig. 6.2. T4 :TBG ratio 
appears to be diagnostically superior to FTI, which gives falsely low 
values in TBG deficiency and falsely high values in TBG excess. 
Patients on treatment with DPH are known to have low serum T4 and 
FTI values (Heyma et al, 1977). This may be due to displacement of T4 
from TBG binding sites (Oppenheimer and Tavernetti, 1962), or due to a 
stimulation of T4 catabolism (Larsen et al, 1970), or a combination of 
both (Heyma et al, 1977). It was therefore anticipated that T4 :TBG ratio 
would be low, and results confirmed this. 
The retrospective analysis of hospital patients with high and low T4 
concentrations was undertaken in an attempt to assess the frequency of 
false positive and false negative diagnoses using FTI and T4 :TBG ratio. 
In a high proportion of cases there was insufficient clinical data to 
arrive at a definite diagnosis, but such results as were obtained suggested 
that T4 :TBG ratio may produce fewer false positives and negatives than FTI. 
In conclusion, the results obtained in this study and in Chapter 5 
Suggest that T4 :TBG ratio has considerable advantages over FTI in the 
diagnosis of thyroid dysfunction. This is particularly true in the common 
occurrence of TBG elevation due to oestrogen treatment or pregnancy. The 
ideal test of thyroid function would provide some measure of thyroid hormone 
activity at tissue level; failing this, an assay of free hormone in serum 
would be valuable. At present, such assays are not routinely available, or 
are insufficiently tested (Boss, Diahanbakheh and Kingstone, 1978; 
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Ekins, 1979), and the T4 :TBG ratio appears to provide the best alternative 
for the routine assessment of thyroid function. 
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CHAPTER 7 DISCUSSION 
The purification of human TBPA and partial purification of human TBG 
by chromatographic techniques have been described in this thesis. 2DIEP 
Was used to assess the success of protein purification, and in the case of 
TBG, 2DIEP was used to isolate a TBG/anti-TBG complex. 
Purified TBPA and the TBG/anti-TBG complex were used to raise 
monospecific antisera in rabbits and sheep respectively, and these 
antisera were used in monorocket IEP assays for TBPA and TBG. The assays 
were found to be rapid, inexpensive, simple and precise. 
The IEP assay for TBG represented a considerable advance over 
existing radioimmunoelectrophoretic techniques in allowing direct 
Visualisation and measurement of the protein peak, hence dispensing with 
the need for handling radio-isotopes and performing auto-radiography. The 
assay also had some advantages over RIA measurement of TBG since it did 
not require chromatographic isolation and pOSSible denaturation of TBG. 
Use of IEP was found to be suitable for assay of proteins present in serum 
in concentrations above 50 fg/l, and was therefore suitable for in vivo 
studies of TBG and TBPA. The relatively low sensitivity of IEP compared 
to RIA does however impose limitations on the use of IEP for in vitro 
studies. 
The IEP assay was used to measure TBG in healthy persons, and the 
variation of TBG concentration with age and gender was noted. Elevation 
of TBG concentration in myxoedema, and reduced TBG in thyrotoxicosis wi th 
recovery on treatment were clearly shown. 
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In Chapter 4, the alterations of TBG, TBPA and albumin in surgery 
and non-thyroidal illness were studied, together with the inter-
relationships of changes of free thyroid hormones and binding proteins. 
It was found that the alterations of binding protein and hormone 
concentration were sufficiently great to account for post-operative 
changes in free hormone concentration without invoking the presence of 
binding inhibitors. 
Comparison of the binding protein and hormone changes after surgery, 
illness and starvation showed that although there was considerable 
similarity in the changes after all three, there were differences in 
timing of changes which suggested that additional factors other than 
calorie restriction were involved. 
Use of the TBG assay allowed identification of a large number of 
individuals with hereditary TBG abnormalities, including seven individuals 
with combined TBG abnormality and thyroid disease. IEP techniques were 
Used to confirm that in hereditary TBG excess and deficiency there are 
abnormal concentrations of electrophoretically and immunologically normal 
TBG. 
The FTI in TBG excess and deficiency was frequently observed to give 
misleading results. It was shown that this probably resulted from 
insensitivity of the T3-uptake test to changes in TBG concentration. It 
Was shown that in theory a T4 :TBG ratio should provide an index of thyroid 
function. The T4 :TBG ratio was compared retrospectively with FTI, and 
Was shown to differentiate at least as well as FTI between thyrotoxic, 
myxoedematous and euthyroid individuals. In addition, T4 :TBG ratio was 
able to correctly assign individuals with abnormal TBG concentration to 
a euthyroid status. In a hospital-based prospective trial, T4 :TBG ratio 
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gave fewer false positive and false negative diagnoses than FTI. 
In conclusion, the work contained in this thesis does suggest that 
thyroxine-binding proteins may have a physiological role in certain 
situations in governing free hormone concentration. TBPA, TBG and 
albumin may all contribute in this respect. However, studies of 
hereditary increase and deficiency of TBG suggest that this protein can 
only be of secondary physiological significance. 
The most important clinical significance of TBG lies in its 
influence on diagnostic tests of thyroid function, especially measurement 
of T4 and T3 concentration. This work shows that the direct measurement 
of TBG concentration would beneficially replace indirect measurements such 
as the T3uptake test in the routine assessment of thyroid function. 
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APPENDIX A 
References - Table 5. 
SURGERY: Surks and Oppenheimer, 1964; Socolow et aI, 1965; Mouridsen, 1967; 
Charters et aI, 1969; Minchin-Clarke et aI, 1971; Aronsen et aI, 1972; 
Harland et aI, 1972; Kirby et aI, 1973; Bermudez et aI, 1975; Burr et aI, 
1975; .Brandt et aI, 1976; Ramsden et aI, 1978; Adami et aI, 1978; Chan et aI, 
1978; Halevy et aI, 1978; Kehlet et aI, 1979; Prescott et aI, 1979. 
ACUTE AND CHRONIC ILLNESS: Bellabarba et aI, 1968; Harland et aI, 1972; 
Johansson et aI, 1972; Carter et aI, 1974; Chopra et aI, 1974; Bermudez 
et aI, 1974; Chopra et aI, 1975; McLarty et aI, 1975; Ramsden et aI, 1978; 
Ratcliffe et aI, 1978; Helenius and Liewendahl, 1979. 
FEBRILE ILLNESS: Gregerman and Solomon, 1967; Shambaugh and Beisel, 1967; 
Lutz et aI, 1972; Burger et aI, 1976; Talwar et aI, 1977; Maharajan et aI, 
1978. 
APPENDIX B 
DAY 
0 .!,. .. 1 2 3 4 5 6 
T4 nmol/l 131+ 32 139+26 123+38 125+29 128+36 121+37 126+34 133+38 
P < NS 0.05 NS NS NS NS NS 
T3 nmol/l 1.98+0.48 1.49+0.30 1.09+0.45 1.21+0.45 1.10+0.35 1.06+0.51 1.01+0.46 1.37+U.44 
I 
p( 0.01 0.0005 0.0005 0.0005 0.0005 0.0005 0.0025 N 
0 
\J1 
I 
rT3* nmol/l 0.40+0.32 0.67+0.45 0.68+0.31 0.62+0.48 0.48+0.48 0.42+0.42 U.38+U.20 
P ( 0.025 0.0025 0.05 NS NS I'JS 
TBG mg/l 13.7+2.6 13.1+2.7 12.9+2.6 12.4+2.3 12.7+2.2 12.4+2.5 12.4+2.6 12.4+2.5 
P < NS 0.05 0.01 0.005 0.01 NS NS 
TBPA mg/l 210+84 165+63 164+61 103+56 101+59 101+48 107+60 133+70 
p( 0.025 0.0005 0.0005 0.0005 0.0005 0.0005 0.UU25 
ALBUMI N gi l 38+8 34+7 36+8 31+7 31+7 32+10 31+9 30+8 
p( NS 0.01 0.0005 0.0005 0.0005 0.0005 0.UOU5 
* Measured in 5 patients only THYROID FUNCTION AND MAJOR SURGERY 
APPENDIX B (Cant.) 
DAY 
0 ~ 
" 
1 2 3 4 5 6 
TSH mU/l 1.7+0.9 1.7+0.9 1.6+1.3 1.9+1.5 1.6+1.0 1.5+0.8 1.4+0.9 1.7+1.1 
p< NS NS NS NS NS NS NS 
~~FT 4 0.042+0.008 0.048+0.012 0.048+0.009 0.053+0.012 0.056+0.009 0.054+0.008 0.052+0.009 0.049+0.008 
p( NS NS 0.005 0.0025 0.0005 0.0005 0.05 
AFT4 pmol/l 52+15 67+22 57+19 66+27 66+21 64+19 63+19 63+17 N 0 
0'-
p( NS NS 0.025 0.0025 0.025 0.005 0.05 
%FT3 0.29+0.06 0.36+0.09 0.38+0.09 0.41+0.11 0.40+0.07 0.37+0.08 0.35+0.08 0.31+0.04 
p< 0.01 0.0005 0.0025 0.0005 0.005 0.01 NS 
AFT3 pmol/l 5.5+1.9 5.4+1.5 3.6+1.3 4.5+1.6 4.0+1.1 3.6+1.8 3.2+1.8 3.2+1.5 
p( 0.0025 NS 0.0025 0.01 0.0005 U.025 
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APPENDIX C 
DAY 
o 1 2 3 4 5 6 
T4 nmol/l 102+18 101+21 93+18 105+21 104+28 107+22 100+15 
p( NS NS NS NS NS NS 
T3 nmol/l 2.3+0.4 1.7+0.5 1.7+0.5 1.9+0.6 1.9+0.5 2.1+0.5 1.9+0.4 
p( 0.0125 0.0025 NS 0.05 NS 0.05 
TBPA mg/l 191+67 182+69 154+44 147+46 166+48 169+42 173+78 
p( NS NS 0.05 NS NS NS 
THYROID FUNCTION AND MINOR SURGERY 
APPENDIX D 
DAY 
1 2 3 4 5 6 7 8 9 
T4 nmol/l 140+ 133+ 131+ 119+ 124+ 127+ 126+ 134+ 130+ 
31 28- 24- - 29- 24-40 28 17 32 
P< NS NS 0.05 0.05 NS 0.25 NS NS 
T3 nmol/l 2.4+ 2.1+ 1.9+ 1.7+ 1.7+ 2.0+ 1.9+ 1.9+ 1.8+ 
- 0.9- 0.6- - 0.5- 0.3-0.6 0.6 0.7 0.5 0.6 
P< NS 0.025 0.0025 0.01 NS 0.01 0.025 0.05 N 0 
CD 
TBG mg/l 11.7+ 12.0+ 12.0+ 11.5+ 12.0+ 12.0+ 12.2 + 12.8+ 12.8+ 
2.4- 2.9- 2.2- -2.1 2.5 2.2 2.8 3.1 2.8 
P< NS NS NS NS NS NS NS NS 
TBPA mg/l 262+ 230+ 174+ 141+ 136+ 153+ 138+ 158+ 157+ 
39- 52- 46- 53 - - 76- - 56- 34-45 36 
P< 0.0025 0.0005 0.0005 0.0005 0.005 0.0005 0.0005 0.0005 
~6FT 4 0.045+ 0.053+ 0.053+ 0.059+ 0.056+ 0.052+ 0.048+ 0.051+ 
- -
- 0.014- 0.014- 0.020-0.017 0.018 0.015 0.019 0.011 
p( NS NS NS NS NS NS NS 
THYROID FUNCTION AFTER MYOCARDIAL INFARCTION 
APPENDIX D (Cant.) 
DAY 
1 2 3 4 5 6 7 8 9 
AFT4 pmol/l ·60+ 61+ 58+ 67+ 69+ 64+ 63+ 65+ 
16- 15- 15- 25- 17 - 26-15 21 
P <- NS NS NS NS NS NS NS 
~6FT 3 0.34+ 0.33+ 0.34+ 0.40+ 0.33+ 0.34+ 0.33+ 0.32+ 
0.12 - 0.03 0.05 0.12 0.06 0.U4- 0.07 0.06 
P< NS NS NS NS NS NS NS N 
0 
\.0 
AFT3 pmol/l 7.8+ 5.4+ 5.0+ 5.6+ 5.2+ 5.7+ 5.5+ 6.0+ 
2.2- 1 .1 1.0- 1.7 - 1.2- - 1.3 -1.2 1.3 
p( 0.05 0.005 0.025 0.025 NS 0.0005 NS 
TSH mU/l 2.1+ 1.1+ 1.0+ 1.4+ 1.2+ 1.0+ 1.5+ 1.5+ 1.5+ 
- 0.9- - 1.5- 0.4- -2.7 0.6 1.2 1 .5 0.8 1.3 
P( NS NS NS NS NS NS NS NS 
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APPENDIX E 
DAY 
0 1 2 3 4 
T4 nmol/l 130+31 118+29 115+27 121+29 123+27 
p( NS NS NS NS 
T3 nmol/l 3.2+0.6 2.8+0.6 2.1+0.5 2.0+0.6 1.9+0.4 
p( 0.05 0.0025 0.005 0.0005 
rT3 nmol/l 1.0+0.1 1.0+0.1 1.1+0.1 1.2+0.1 1.5+0.3 
p( NS 0.025 0.0025 0.0025 
TBG mg/l 15.3+2.7 15.6+2.5 14.7+2.7 14.9+2.6 13.9+2.1 
P( NS 0.025 0.05 0.005 
TBPA mg/l 392+77 387+65 357+47 329+38 281+38 
P( 0.05 0.025 0.01 0.0025 
ALBUMIN gil 49.0+4.7 50.7+3.5 51.7+7.5 55.6+6.3 45.9+6.3 
P( NS NS 0.05 NS 
TSH mUll 5.3+4.0 4.2+3.2 2.6+1.5 2.7+1.5 3.4+1.9 
P< NS 0.025 0.05 NS 
AFT4 pmol/l 35.0+15.6 29.5+12.1 30.8+13.3 32.7+12.8 38.7+15.8 
P( NS NS NS 0.025 
AFT3 pmol/l 7.0+2.2 5.6+1.9 4.6+1.6 4.3+1.3 4.8+1.7 
p( 0.025 0.0025 0.0025 0.0025 
THYROID FUNCTION DURING COMPLETE STARVATION 
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APPENDIX F (For key see Fig.5.1) 
I 
J 
II 
11I 
I 
I{ 
]I 
3 
I 
L 
][ 
~1 3 4 
][ 
2 3 4 
HEREDITARY TBG INCREASE (FAMILY J) AND DECREASE (F AM ILIES K AND L) 
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APPENDIX F (Cont.) 
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APPENDIX F (Cont.) 
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HEREDITARY TBG INCREASE (FAMILIES Q AND S) AND DECREASE (FAti.l~_.Y H) 
